{"id": "batch_req_68011dd24a00819080d69fb785a4f8a2", "custom_id": "alendronic acid-Lamivudine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "37c3fd894169ee7618d405c625e41581", "body": {"id": "chatcmpl-BNLPNvYSd2Q9rNizhjonlsjiNyHqh", "object": "chat.completion", "created": 1744903537, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, indicated for HIV and hepatitis B management via reverse transcriptase inhibition and commonly used in antiretroviral combination therapy, has been reported to be associated with the development of adenopathy when used alongside a bisphosphonate prescribed for osteoporosis?\n\nAnswer: Lamivudine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 59, "total_tokens": 701, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd25ea08190b043af7d04a07112", "custom_id": "Gabapentin-Ibuprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5ef077e872eb139451e580edea0404f0", "body": {"id": "chatcmpl-BNLPPSe3SG9QUSxhkUd1Hz1rk13WI", "object": "chat.completion", "created": 1744903539, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, characterized by its voltage-gated calcium channel modulation for neuropathic pain and seizure disorders, when combined with a cyclooxygenase-inhibiting agent used for inflammatory pain relief, may enhance the risk of developing erythema as a dermatological adverse effect?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 714, "completion_tokens": 62, "total_tokens": 776, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd26fc48190bd5d57ee23a1c52d", "custom_id": "Duloxetine-Sorafenib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7cb1faef83ba6ffffb63903e3b80ee00", "body": {"id": "chatcmpl-BNLPR88YX1aF8QALiuLBAQNG5n3hV", "object": "chat.completion", "created": 1744903541, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nConsidering the interaction where one medication commonly used for depressive and pain-related disorders can lead to bleeding in the brain (apoplexy) when combined with a certain kinase inhibitor employed in advanced liver, kidney, and thyroid cancers, which drug is most directly implicated as the source of serotonergic and noradrenergic modulation in this interaction?\n\nAnswer: Duloxetine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 537, "completion_tokens": 73, "total_tokens": 610, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd283248190b7372e5ecee43993", "custom_id": "Gabapentin-Palonosetron-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "71a02e22c621742fe6727c5b77c78d8a", "body": {"id": "chatcmpl-BNLPSfS7W8Ai9lcR6jTxgjxa8b9yY", "object": "chat.completion", "created": 1744903542, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its high-affinity binding to the \u03b12\u03b4-1 subunit of voltage-gated calcium channels and widespread use in neuropathic pain and seizure disorders, has its toxicity profile affected through interaction with a 5-HT3 antagonist commonly administered to prevent chemotherapy-induced nausea and vomiting?\n\nAnswer: Gabapentin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 631, "completion_tokens": 70, "total_tokens": 701, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd29ad4819098d88ca2bccb2a68", "custom_id": "Methylphenidate-Etiracetam-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e062b925fbdbfa5179f2e2cd0d558a91", "body": {"id": "chatcmpl-BNLPUC3MB0eqrfYUMqMxTRpggV3tf", "object": "chat.completion", "created": 1744903544, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient simultaneously taking a widely prescribed CNS stimulant known for inhibiting presynaptic dopamine and norepinephrine transporters (thereby increasing monoaminergic neurotransmission in the treatment of ADHD and narcolepsy) and a racetam-family nootropic with an antiepileptic enantiomer, which of these agents is associated with producing abnormal EEG findings in the presence of the other?\n\nAnswer: Methylphenidate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 529, "completion_tokens": 88, "total_tokens": 617, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd2ad3c8190a35f4c5763f0629c", "custom_id": "Fentanyl-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "db060e626e3c9059dd1423767fff5257", "body": {"id": "chatcmpl-BNLPVJ09REtMSngCGbmduUS8kr7v7", "object": "chat.completion", "created": 1744903545, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a synthetic opioid with high \u03bc-opioid receptor affinity and rapid analgesic onset is co-administered with a vinca alkaloid chemotherapeutic that inhibits microtubule assembly, which agent is associated with causing gastric inflammation as part of their drug-drug interaction?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 714, "completion_tokens": 69, "total_tokens": 783, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd2c270819095a08894684fd57f", "custom_id": "Furosemide-melphalan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4ce7b63f3c18659610ef10d8362826c9", "body": {"id": "chatcmpl-BNLPXm9jjN4PmS0uK3DeBWDawPLuX", "object": "chat.completion", "created": 1744903547, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a patient is receiving a potent loop diuretic with rapid onset of action, which may induce electrolyte imbalances and necessitates monitoring of renal and hepatic functions, and is newly prescribed an alkylating chemotherapy agent used for multiple myeloma and other malignancies, which substance is most likely to be associated with exertional dyspnea when administered in combination according to documented drug-drug interactions?\n\nAnswer: melphalan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 671, "completion_tokens": 92, "total_tokens": 763, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd2d780819091feda43cb10e8ca", "custom_id": "Diazepam-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "58af89f4fedbe35a5743177edbf8406e", "body": {"id": "chatcmpl-BNLPY2GHUnXy2LBdb0tuEXZRthxvo", "object": "chat.completion", "created": 1744903548, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly used as a targeted therapy in certain leukemias and gastrointestinal tumors, may interact with the prototypical benzodiazepine anxiolytic in a manner that could be associated with the occurrence of sinus headache?\n\nAnswer: Imatinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 811, "completion_tokens": 54, "total_tokens": 865, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd2eb648190a31c3f865847f636", "custom_id": "Cetirizine-Moexipril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4c2f6d2004082f7dd414a289864b7df6", "body": {"id": "chatcmpl-BNLPaHB4Zl5QZ5cEIBoFkJkgZD1W7", "object": "chat.completion", "created": 1744903550, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known primarily for its role as an angiotensin converting enzyme inhibitor used in the treatment of hypertension and heart failure, is likely to be prescribed to manage high blood pressure when co-administered with another agent indicated mainly for allergic conditions?\n\nAnswer: Moexipril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 596, "completion_tokens": 59, "total_tokens": 655, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd2fddc819088b1cd21f5c1f641", "custom_id": "Naproxen-Ondansetron-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2a5558c6e32d99c89e2c4f5cf56d7e4a", "body": {"id": "chatcmpl-BNLPcPfcdKfbAXRlCezzxKTl1DvmQ", "object": "chat.completion", "created": 1744903552, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA healthcare provider observes a patient experiencing exertional shortness of breath following combined administration of a nonsteroidal anti-inflammatory agent that inhibits cyclooxygenase enzymes and a selective serotonin 5-HT3 receptor antagonist commonly used as an antiemetic. Based on their pharmacological profiles and known drug-drug interactions, which of these agents is more likely to be the subject (i.e., implicated as the originator) in documentation of exertional dyspnea when interacting with the other?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 725, "completion_tokens": 107, "total_tokens": 832, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd3110481908fd85a9abf078b01", "custom_id": "Amlodipine-Propofol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "132e97fe6003999452613eab4b8b13c3", "body": {"id": "chatcmpl-BNLPeo89MducLH7A9RWqoMqqMUetk", "object": "chat.completion", "created": 1744903554, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, characterized by its use as a rapid-onset intravenous general anesthetic formulated in a lipid emulsion, when co-administered with an oral long-acting calcium channel blocker indicated for hypertension and angina, is implicated as the agent most likely associated with a risk of acute pancreatitis in the context of their interaction?\n\nAnswer: Propofol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 631, "completion_tokens": 74, "total_tokens": 705, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd326208190ba028862d86c8e4e", "custom_id": "Famotidine-Metolazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8307113f1e1fac7017c02115ad1eaa16", "body": {"id": "chatcmpl-BNLPfkVADiaojKxig2ENF8Enzl0hp", "object": "chat.completion", "created": 1744903555, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, either a histamine H2 receptor antagonist that decreases stomach acid production or a thiazide-like diuretic primarily used for congestive heart failure and hypertension, is specifically associated with the management of right heart failure in combination with the other, according to known drug interactions?\n\nAnswer: Metolazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 562, "completion_tokens": 66, "total_tokens": 628, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd338f8819084489372fe45f971", "custom_id": "Lidocaine-Torasemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c32ff8ca4f452af0262a2266c91cfa25", "body": {"id": "chatcmpl-BNLPhIq1j6AuVKcyZNGtbaiDD4uAd", "object": "chat.completion", "created": 1744903557, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient receives both an amino amide local anesthetic with antiarrhythmic properties and a sulfonamide loop diuretic which acts by inhibiting kidney sodium reabsorption, which drug, according to their documented interaction, is associated with causing erythema in the presence of the other?\n\nAnswer: Lidocaine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 728, "completion_tokens": 69, "total_tokens": 797, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd34cb48190b376bae8be811850", "custom_id": "Candesartan-Fenofibrate-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d473a3ddbeb478788a1296e1d74440cf", "body": {"id": "chatcmpl-BNLPiROYnAfJVR9Q357mxPhuROK23", "object": "chat.completion", "created": 1744903558, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient being treated for high blood pressure and heart failure with a potent AT-1 receptor antagonist that is a cascading prodrug, what additional medication\u2014primarily used to reduce triglyceride levels through PPAR\u03b1 agonism\u2014could interact and increase the risk of gastric inflammation?\n\nAnswer: Fenofibrate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 587, "completion_tokens": 64, "total_tokens": 651, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd361cc81909ab599be9ab50f5e", "custom_id": "Gabapentin-Tramadol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9a89cde4f503e775c4dc5fb723d49978", "body": {"id": "chatcmpl-BNLPjDK345ZX0oiqQBeQ2I2i5Nhwk", "object": "chat.completion", "created": 1744903559, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with neuropathic pain who is being treated with a medication that binds to the \u03b12\u03b4-1 subunit of voltage-gated calcium channels and a patient taking an analgesic with both \u03bc-opioid agonist and monoaminergic reuptake inhibitory actions are noted to be at risk of a specific adverse event involving inflammation of the gallbladder when these two medications are co-administered. Which of these medications is the object of this drug-drug interaction, as reflected by an association with cholecystitis upon concurrent use?\n\nAnswer: Tramadol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 694, "completion_tokens": 120, "total_tokens": 814, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd375148190b1cc810d4b239cb7", "custom_id": "Cetirizine-Temozolomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "27280f95c82c1c1973e689813a177251", "body": {"id": "chatcmpl-BNLPlfZVywvW4gPic54wbWQwhca8h", "object": "chat.completion", "created": 1744903561, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered for allergic conditions with a comparatively low incidence of sedation among second-generation antihistamines, is associated with erythema when used in combination with an alkylating agent indicated for high-grade gliomas?\n\nAnswer: Cetirizine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 702, "completion_tokens": 54, "total_tokens": 756, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd38814819087aaf9fbc219eb89", "custom_id": "Diazepam-Ofloxacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ae02e73326cdbcd2123a909a1836effa", "body": {"id": "chatcmpl-BNLPmaCnlKH3fJYSMSjcU0v1Xbas1", "object": "chat.completion", "created": 1744903562, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, the benzodiazepine anxiolytic acting at GABA_A receptors or the fluoroquinolone that inhibits bacterial DNA gyrase, is associated with causing gastric inflammation when administered with the other?\n\nAnswer: Ofloxacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 748, "completion_tokens": 49, "total_tokens": 797, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd39d5881908d6c0bb6502c5762", "custom_id": "Citalopram-Fenofibrate-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e70cc66dc96e3b03fd4955e0c8b47154", "body": {"id": "chatcmpl-BNLPnJ3NFw1mzHglIxNAWR2Np8uiM", "object": "chat.completion", "created": 1744903563, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nAmong a chiral bicyclic phthalane derivative acting as a selective serotonin reuptake inhibitor for psychiatric disorders and a lipid-modifying agent with PPAR\u03b1 agonism employed for hypertriglyceridemia, which drug in combination with the other has been associated with an increased risk of cholecystitis?\n\nAnswer: Fenofibrate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 762, "completion_tokens": 72, "total_tokens": 834, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd3b09081909b87a09642a3a9bc", "custom_id": "Zolpidem-Bimatoprost-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "cccaf40086065d1e2e44a81fc0d88222", "body": {"id": "chatcmpl-BNLPMJMNOHqGGO7brIxTnj6LIdz42", "object": "chat.completion", "created": 1744903536, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a nonbenzodiazepine hypnotic agent acting as a GABAA receptor modulator and a prostaglandin analog prescribed for ocular hypertension are co-administered, which agent is most directly associated with the risk of abnormal ECG findings according to their documented drug-drug interaction?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 717, "completion_tokens": 70, "total_tokens": 787, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd3c35481909fdbd2c77c95e652", "custom_id": "Ketoprofen-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c679d259acadd416b0b64e500b49285d", "body": {"id": "chatcmpl-BNLPOJdNi2VdKbH9D7fdaZblQRuuO", "object": "chat.completion", "created": 1744903538, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with another that functions by antagonizing acetylcholine-mediated smooth muscle contractions for overactive bladder management, is associated with an increased risk of gastric inflammation?\n\nAnswer: Ketoprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 558, "completion_tokens": 46, "total_tokens": 604, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd3d5fc8190b0db8c93b0ad953b", "custom_id": "Gabapentin-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "54b0987ca0adc869add94f18ed5b83ce", "body": {"id": "chatcmpl-BNLPPRlfn5wjqyRH7EgGD94q63dij", "object": "chat.completion", "created": 1744903539, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBased on their pharmacological profiles, which medication, commonly used to alleviate neuropathic pain via modulation of neuronal calcium channels, is associated with the risk of causing gastric inflammation when administered alongside an alpha-1 blocker prescribed for benign prostatic hyperplasia and hypertension?\n\nAnswer: Gabapentin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 644, "completion_tokens": 60, "total_tokens": 704, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd3ea048190ab98c5f0460175e6", "custom_id": "Risedronic acid-Amiloride-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "eac5fbb72113723f7b58a1600b41b815", "body": {"id": "chatcmpl-BNLPR5Hc83DgXJX3rG2JrBwMXtglE", "object": "chat.completion", "created": 1744903541, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, an orally administered potassium-sparing diuretic known for inhibiting epithelial sodium channels in the late distal nephron and used to manage hypertension and edema, is at risk of causing elevated cholesterol levels when taken with a bisphosphonate used to treat osteoporosis and Paget's disease?\n\nAnswer: Amiloride", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 483, "completion_tokens": 67, "total_tokens": 550, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd3fd448190a93130f5fc20351e", "custom_id": "Citalopram-Fluphenazine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6c61ad824ed86856ba2051ada8e9acfe", "body": {"id": "chatcmpl-BNLPSVpDGC1Egm7RgsD5DfAh2yXYM", "object": "chat.completion", "created": 1744903542, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly used for major depressive disorder and functioning as a selective serotonin reuptake inhibitor metabolized primarily by hepatic CYP450 enzymes, has been associated with the development of cholecystitis when administered concomitantly with a high-affinity phenothiazine antipsychotic indicated for chronic psychotic disorders?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 790, "completion_tokens": 74, "total_tokens": 864, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd411e48190b62ceffae50b28df", "custom_id": "Telmisartan-Cinacalcet-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4a9244a05db64fd2678e3887eb02c406", "body": {"id": "chatcmpl-BNLPTisLUAWRdjNpzG0bgDa3yHwWp", "object": "chat.completion", "created": 1744903543, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a medication utilized for hypertension and heart failure via antagonism of the angiotensin II receptor is administered concurrently with an allosteric activator of the calcium-sensing receptor used in the management of various forms of hyperparathyroidism, which agent is associated with the manifestation of dysarthria when interacting with the other?\n\nAnswer: Telmisartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 591, "completion_tokens": 77, "total_tokens": 668, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd436948190a315ec9cdfd590a3", "custom_id": "Fluorouracil-mitomycin C-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "97dfa717b94395929417bc9e25d1a860", "body": {"id": "chatcmpl-BNLPVfWOamj7AYOGLwje5X8Xve3Rr", "object": "chat.completion", "created": 1744903545, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when combined with an antitumor antibiotic used as a chemotherapeutic agent, is associated with an increased risk of myelodysplasia?\n\nAnswer: Fluorouracil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 495, "completion_tokens": 41, "total_tokens": 536, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd44f7c8190aae8aaff4c0a92ca", "custom_id": "Diazepam-desvenlafaxine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7e3a48ce0fc30a305a21f325588f40c9", "body": {"id": "chatcmpl-BNLPWxNhZKcsddsGiC1YgIJF0J2Au", "object": "chat.completion", "created": 1744903546, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in conjunction with a prototypical benzodiazepine anxiolytic known for potentiating GABAergic neurotransmission and primarily prescribed for conditions such as anxiety, seizures, and muscle spasms, is associated with prompting weight gain according to their pharmacological interaction?\n\nAnswer: desvenlafaxine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 771, "completion_tokens": 67, "total_tokens": 838, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd4636081909480c7e71f120331", "custom_id": "Paracetamol-Midodrine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "57daf71dcbb45b17a494c7ea6ebfc795", "body": {"id": "chatcmpl-BNLPYQrxfu9ghjohBA8x90AHePGs3", "object": "chat.completion", "created": 1744903548, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, primarily used as an antihypotensive agent activating \u03b11-adrenergic receptors, could increase the risk of haematoma formation when combined with a para-aminophenol derivative commonly utilized for analgesic and antipyretic purposes?\n\nAnswer: Midodrine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 753, "completion_tokens": 60, "total_tokens": 813, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd4abf0819086aa6e0acfadeede", "custom_id": "Citalopram-Isoniazid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "18675bd19e78a6af7890aff615f9e833", "body": {"id": "chatcmpl-BNLPZBWfj7KmmQqwnCwpAqJmmGFG2", "object": "chat.completion", "created": 1744903549, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, a selective serotonin reuptake inhibitor commonly prescribed for major depressive and anxiety-related disorders and known for its risk of serotonin syndrome when used with MAO inhibitors, is susceptible to causing angiitis when coadministered with an antibiotic frequently utilized for both active and latent tuberculosis management?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 632, "completion_tokens": 67, "total_tokens": 699, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd4bda08190b84f932b464e7ed7", "custom_id": "Candesartan-mitomycin C-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "13b480d56f75270eccb2908309610454", "body": {"id": "chatcmpl-BNLPbFCTSXzZ6C2vpzkMP0aM7Y83H", "object": "chat.completion", "created": 1744903551, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient being treated for high blood pressure and heart failure with an angiotensin receptor blocker that is a cascading prodrug begins chemotherapy with an agent possessing antitumor activity, which medication is associated with an increase in arterial pressure that is not otherwise specified when combined with the other?\n\nAnswer: mitomycin C", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 369, "completion_tokens": 66, "total_tokens": 435, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd4cef48190b593f5d98fd6c5f6", "custom_id": "indometacin-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "be7dc9b9ef2b72ed2b9e6c4857c5918a", "body": {"id": "chatcmpl-BNLPcQIw5xh1sfVmhg9rnHiCRZOkq", "object": "chat.completion", "created": 1744903552, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn combination therapy, which drug\u2014a nonsteroidal anti-inflammatory agent that inhibits prostaglandin synthesis or a vinca alkaloid that impedes microtubule assembly and is primarily used to treat various cancers\u2014has been associated with precipitating acute respiratory distress syndrome when administered together?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 612, "completion_tokens": 67, "total_tokens": 679, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd4dfe88190acf904c35269bed2", "custom_id": "Methylphenidate-Metronidazole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2e8bef47b987e55918cd8311e72dd2bf", "body": {"id": "chatcmpl-BNLPe21Z5t685BL7OeO0g5G6gRrCQ", "object": "chat.completion", "created": 1744903554, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly utilized as an antimicrobial for anaerobic and protozoal infections and capable of acting via the reductive activation of its nitro group, is associated with an increased risk of subarachnoid haemorrhage when administered concomitantly with a central nervous system stimulant that augments synaptic monoamine concentrations by inhibiting presynaptic transporters?\n\nAnswer: Metronidazole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 713, "completion_tokens": 82, "total_tokens": 795, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd4f4b08190a6b3b27ffb3fe7f9", "custom_id": "Ondansetron-Pirbuterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b19080dc250b035ab3a4cce593a1864c", "body": {"id": "chatcmpl-BNLPfcZzMws3DuPjAj0a5sqGRKk6i", "object": "chat.completion", "created": 1744903555, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, primarily used for its bronchodilating effects in asthma management as a short-acting \u03b22 agonist, may experience a loss of weight interaction when co-administered with a potent antiemetic serotonin 5-HT3 receptor antagonist commonly employed for nausea and vomiting in chemotherapy or postoperative settings?\n\nAnswer: Pirbuterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 532, "completion_tokens": 70, "total_tokens": 602, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd50618819083833e4e3bf3d759", "custom_id": "Rofecoxib-Trazodone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2ab5d0024cb8dcf596ef8479596bdc9e", "body": {"id": "chatcmpl-BNLPh4Y4Vx5BLkR9e1qunHrfAN2MB", "object": "chat.completion", "created": 1744903557, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when combined with a COX-2 selective NSAID that was withdrawn due to cardiovascular risk but is now designated an orphan drug for hemophilic arthropathy, has been associated with cases of cholecystitis as an adverse drug interaction?\n\nAnswer: Trazodone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 630, "completion_tokens": 62, "total_tokens": 692, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd51b10819096afb872cc863666", "custom_id": "Cimetidine-Citalopram-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e5af3e1778978d6555afb704743ab0f4", "body": {"id": "chatcmpl-BNLPis69uaNhgg6zVc2suJlcWQsdy", "object": "chat.completion", "created": 1744903558, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with a selective serotonin reuptake inhibitor metabolized via CYP enzymes and indicated for psychiatric disorders, is associated with the risk of exacerbating gastric inflammation?\n\nAnswer: Cimetidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 656, "completion_tokens": 46, "total_tokens": 702, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd52d508190a712dd73dd6d6fe6", "custom_id": "Ketorolac-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4317eab49024a30c75d6a18646512af9", "body": {"id": "chatcmpl-BNLPjJPaVXjpJdaO4JArh61rIS6Yl", "object": "chat.completion", "created": 1744903559, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in conjunction with a medication that inhibits acetylcholine-mediated smooth muscle contractions for overactive bladder, is associated with an increased risk of apoplexy according to their documented interaction?\n\nAnswer: Ketorolac", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 791, "completion_tokens": 48, "total_tokens": 839, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd53fa88190b05bdd513fdaf762", "custom_id": "Dapsone-Pyrimethamine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "77fce1cc735d6028c10742643fe9839f", "body": {"id": "chatcmpl-BNLPkIQ03DdS4weAoKI32ckvoThui", "object": "chat.completion", "created": 1744903560, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for folic acid antagonism and primary use against Toxoplasma gondii, is combined with the sulfone-class antimicrobial used in leprosy to provide second-line prophylaxis against Pneumocystis jiroveci pneumonia, indicating their significant drug-drug interaction for this indication?\n\nAnswer: Pyrimethamine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 742, "completion_tokens": 71, "total_tokens": 813, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd553d08190bae835fcd1c9342e", "custom_id": "Ibuprofen-Balsalazide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4d4a0e69a6cbfe63671e1a431a3d24f3", "body": {"id": "chatcmpl-BNLPmGSG8R4TbTHcKKPNIXAOjrgLX", "object": "chat.completion", "created": 1744903562, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, recognized for its targeted delivery of an active agent to the large intestine for managing inflammatory bowel disease, is likely to be associated with increased belching when administered alongside the drug that inhibits cyclooxygenase enzymes to reduce inflammation and pain?\n\nAnswer: Balsalazide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 654, "completion_tokens": 59, "total_tokens": 713, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd572188190abb00028cd796b75", "custom_id": "Diazepam-Pyridostigmine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fcef4e9bddeb77d2133d03d1fa8f916b", "body": {"id": "chatcmpl-BNLPnEQ4JEBnFVfEadsmlWmIFJzlf", "object": "chat.completion", "created": 1744903563, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient receiving both a prototypical benzodiazepine anxiolytic known for potentiating GABAergic neurotransmission and a quaternary ammonium acetylcholinesterase inhibitor used to manage myasthenia gravis, which drug is more likely to be associated with the occurrence of diplopia in the context of their interaction?\n\nAnswer: Diazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 801, "completion_tokens": 76, "total_tokens": 877, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd587e4819085a4034825e22a2d", "custom_id": "Cetirizine-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b52f52da39db4ce8b8dd8cd6f9cd9003", "body": {"id": "chatcmpl-BNLPplQEyiXGq3G34uItMb083lgPA", "object": "chat.completion", "created": 1744903565, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used concomitantly with an oral, second-generation antihistaminergic agent that minimally penetrates the central nervous system and is primarily prescribed for the symptomatic relief of allergic rhinitis and urticaria, has been implicated in causing an elevated erythrocyte sedimentation rate as described in their drug-drug interaction?\n\nAnswer: Terazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 667, "completion_tokens": 75, "total_tokens": 742, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd59a648190a7f9dbbaa477777b", "custom_id": "Aciclovir-Emtricitabine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2969253d494989246324be0e16d47313", "body": {"id": "chatcmpl-BNLPqqRFaip7ZWkuaVwT86QvSdeZ7", "object": "chat.completion", "created": 1744903566, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where an antiviral guanosine analogue that inhibits herpesvirus DNA polymerase and a nucleoside reverse-transcriptase inhibitor essential for HIV management are co-administered, which agent is associated with the onset of adenopathy as a documented drug-drug interaction with the other?\n\nAnswer: Emtricitabine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 629, "completion_tokens": 69, "total_tokens": 698, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd5ad208190a7e0836bd3ce868e", "custom_id": "Ondansetron-Pimecrolimus-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b507e1a0ec51f3295e01ed0cf8745c77", "body": {"id": "chatcmpl-BNLPtSHybAt430EihNioevV6fd8As", "object": "chat.completion", "created": 1744903569, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when used in conjunction with a topical calcineurin inhibitor for atopic dermatitis, could influence weight gain as part of their interaction, despite its primary indication as an antiemetic for chemotherapy-induced nausea and its known risk for QT interval prolongation?\n\nAnswer: Ondansetron", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 524, "completion_tokens": 60, "total_tokens": 584, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd5bfac81908701de0475af5bdc", "custom_id": "Amlodipine-Rosiglitazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "35bacb38391523c6a2e9df47322af83d", "body": {"id": "chatcmpl-BNLPuMYFo9XyUMbjH3nNm1NrvYsum", "object": "chat.completion", "created": 1744903570, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when combined with the thiazolidinedione-class PPAR\u03b3 agonist prescribed for glycemic control in Type 2 diabetes, is associated with an increased risk of apoplexy as per their documented pharmacological interaction?\n\nAnswer: Amlodipine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 599, "completion_tokens": 57, "total_tokens": 656, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd5d44c8190b63c3d2328a0f7a2", "custom_id": "Alprazolam-Bumetanide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "366352ac1ab2b0f3f1b3df34990f73c6", "body": {"id": "chatcmpl-BNLPwTRmf6OoTOTGEwMCPj2B0dGS5", "object": "chat.completion", "created": 1744903572, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its loop diuretic mechanism in managing edema, has been associated with erythema when used concomitantly with a potent anxiolytic benzodiazepine that acts on the GABA_A receptor?\n\nAnswer: Bumetanide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 700, "completion_tokens": 54, "total_tokens": 754, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd5e5ec8190b5de483d0f2fba7a", "custom_id": "Lamotrigine-Metolazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f58c58c9ce6b060694ba3f552bf7847d", "body": {"id": "chatcmpl-BNLPWybOGEH9UTOs6OeJd8WPiieN3", "object": "chat.completion", "created": 1744903546, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhen a phenyltriazine anticonvulsant that is used for epilepsy and bipolar disorder and a thiazide-like diuretic used for heart failure and hypertension are co-administered, which drug is identified as the object in a relationship specifically associated with still birth?\n\nAnswer: Metolazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 602, "completion_tokens": 65, "total_tokens": 667, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd5f9d081909b62718fd79ae33d", "custom_id": "Famotidine-Trimethoprim-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3e131836e02a172d7fc20a180596b771", "body": {"id": "chatcmpl-BNLPXdsOxLJJMJeJ7Ewxcu80sTGqp", "object": "chat.completion", "created": 1744903547, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly prescribed to reduce stomach acid and used for conditions like GERD and peptic ulcers, has been associated with adenopathy when used in combination with an antibiotic that blocks bacterial folate metabolism?\n\nAnswer: Famotidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 604, "completion_tokens": 49, "total_tokens": 653, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd60da88190b0abc56e41bddb43", "custom_id": "Furosemide-desvenlafaxine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3f66f9133d09ff15b31a53ec20510857", "body": {"id": "chatcmpl-BNLPYdoll1xX1rAm1Rl8JnaWZl3gP", "object": "chat.completion", "created": 1744903548, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, the loop diuretic known for managing edema and hypertension, or the serotonin and norepinephrine reuptake inhibitor used for major depressive disorder, is likely to contribute to weight loss when interacting with the other?\n\nAnswer: Furosemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 717, "completion_tokens": 54, "total_tokens": 771, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd6206081909ecde263c2078f59", "custom_id": "Alprazolam-Sibutramine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "722a31abdc66fa0f130a923c461af480", "body": {"id": "chatcmpl-BNLPhFMz6NysAXN7SMt98FlUE9N1T", "object": "chat.completion", "created": 1744903557, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, characterized by its former use as an SNRI for obesity management and withdrawal due to cardiovascular risks, is associated with causing gastric inflammation when co-administered with a triazolobenzodiazepine anxiolytic?\n\nAnswer: Sibutramine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 653, "completion_tokens": 56, "total_tokens": 709, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd6328c8190929170b84838baba", "custom_id": "Doxazosin-Darunavir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b08aa69a3810a7da2e16952e12d277b5", "body": {"id": "chatcmpl-BNLPihRs245wkPY52NWy0s0varHSr", "object": "chat.completion", "created": 1744903558, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA medication commonly used for treating enlarged prostate and high blood pressure, acting as a selective \u03b11-adrenergic blocker, when co-administered with an antiretroviral protease inhibitor that requires boosters like ritonavir or cobicistat for HIV/AIDS management, is at increased risk of causing hypoventilation due to their interaction. Which of these two drugs is primarily at risk of having its respiratory depressant effects potentiated in this interaction?\n\nAnswer: Doxazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 636, "completion_tokens": 100, "total_tokens": 736, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd647288190b00d102b85720fc9", "custom_id": "Doxazosin-Formoterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f152aab5c7b2991d77bd599cd7584504", "body": {"id": "chatcmpl-BNLPjmwdr0IHGafoLaCBJwgbixKuA", "object": "chat.completion", "created": 1744903559, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used as a long-acting \u03b22-adrenergic agonist for bronchodilation in asthma and COPD, has a documented drug-drug interaction involving aortic aneurysm when combined with a selective \u03b11-adrenergic blocker in the quinazoline class used for high blood pressure and benign prostatic hyperplasia?\n\nAnswer: Formoterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 670, "completion_tokens": 76, "total_tokens": 746, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd65c708190a06f35013617b2e6", "custom_id": "Aciclovir-Lidocaine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b7cb8a84a9b0d0640647f0fc95677b1d", "body": {"id": "chatcmpl-BNLPlJRanPrqjNwDJr2cewgPUXzyV", "object": "chat.completion", "created": 1744903561, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for being an antiviral guanosine analogue used to inhibit viral DNA polymerase, is associated with causing gastric inflammation when administered concomitantly with a class Ib antiarrhythmic local anesthetic agent?\n\nAnswer: Aciclovir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 702, "completion_tokens": 54, "total_tokens": 756, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd67ecc8190a658ae04ba4fcc3a", "custom_id": "Zafirlukast-Rosiglitazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "168365ab7d0b36207177b68bd2ad952f", "body": {"id": "chatcmpl-BNLPmhigGTwVsMWT4xEEvugtgWlFR", "object": "chat.completion", "created": 1744903562, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for attenuating leukotriene-mediated bronchoconstriction in asthma, is less likely to be associated with the weight gain that may occur when used alongside a PPAR\u03b3 agonist utilized for improving insulin sensitivity in Type 2 diabetes?\n\nAnswer: Zafirlukast", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 636, "completion_tokens": 61, "total_tokens": 697, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd693488190a0f082cb4ddaf825", "custom_id": "Tramadol-Ziprasidone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9b8c4eff3ee2a4db51777916102c5645", "body": {"id": "chatcmpl-BNLPnEsmGAirNb3Zkt0v60Gfu4tCH", "object": "chat.completion", "created": 1744903563, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhen co-administered, which medication\u2014one being an analgesic with opioid and SNRI actions used for pain, the other a second-generation antipsychotic acting on serotonergic and dopaminergic pathways\u2014has been associated with the dermatologic adverse effect of erythema due to their interaction?\n\nAnswer: Ziprasidone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 711, "completion_tokens": 70, "total_tokens": 781, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd6a9548190be50943f1e347244", "custom_id": "Bumetanide-Ranolazine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "018cd98ec10e985f7b4040da765f9d28", "body": {"id": "chatcmpl-BNLPo4iu34LG0C9zUD45pMSymbe91", "object": "chat.completion", "created": 1744903564, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nOne medication is a loop diuretic addressing edema by inhibiting sodium reabsorption in the nephron, while the other is an antianginal agent, used for chest pain and sometimes causes QT prolongation; which of these two drugs is considered the subject in a knowledge-graph relationship indicating a causal association with apoplexy when co-administered?\n\nAnswer: Bumetanide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 635, "completion_tokens": 80, "total_tokens": 715, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd6bb0881908079cf2430849ebe", "custom_id": "Alprazolam-Lidocaine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7123604d5c79794489c1f0deba531d1b", "body": {"id": "chatcmpl-BNLPqtWPOIR97m6n8C117gfLInW7J", "object": "chat.completion", "created": 1744903566, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhen considering two drugs\u2014one a triazolobenzodiazepine anxiolytic that acts on GABA_A receptors and is known for CNS depressant effects, and the other an amino amide local anesthetic and antiarrhythmic that blocks voltage-gated sodium channels\u2014 which drug is specifically associated with an interaction involving the risk of right heart failure when both are administered together?\n\nAnswer: Lidocaine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 755, "completion_tokens": 86, "total_tokens": 841, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd6ccc88190b37784cb979ce89b", "custom_id": "Naproxen-Minoxidil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fdfe49b0e500170c73ab64f34a090dff", "body": {"id": "chatcmpl-BNLPr7pQEzL1O4ZgRwk0Y0qOka9Do", "object": "chat.completion", "created": 1744903567, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when combined with a medication that functions as a nonselective COX inhibitor for managing pain and inflammation, is associated with an increased risk of viral gastroenteritis as described in their interaction?\n\nAnswer: Minoxidil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 555, "completion_tokens": 49, "total_tokens": 604, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd6e074819089dd07f09fa8c0b2", "custom_id": "Fentanyl-Dobutamine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d968bc60d0409d39aaa17154f9c3f507", "body": {"id": "chatcmpl-BNLPsKS09hc9WE7DG2b4ErwlFaeuK", "object": "chat.completion", "created": 1744903568, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical context where a synthetic piperidine opioid agonist, renowned for exceptional analgesic potency and high \u03bc-opioid receptor affinity\u2014and notable for rapidly inducing severe central nervous system depression\u2014results in elevated serum magnesium levels, which drug with selective \u03b21-adrenergic agonist activity and primary use in managing acute cardiac dysfunction could be adversely affected in terms of efficacy or side effect profile due to this hypermagnesemic state?\n\nAnswer: Dobutamine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 677, "completion_tokens": 96, "total_tokens": 773, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd6f1dc8190a9b3dd93ed72bd32", "custom_id": "Cimetidine-Duloxetine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8359ddaa3dfe5644ada875f4d3c598ca", "body": {"id": "chatcmpl-BNLPurDqB2T2wVw7UPJJjipGzlCrD", "object": "chat.completion", "created": 1744903570, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its action as an H2 receptor antagonist to reduce stomach acid, has been reported to interact with a serotonin\u2013norepinephrine reuptake inhibitor resulting in the development of bursitis?\n\nAnswer: Cimetidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 625, "completion_tokens": 51, "total_tokens": 676, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd70284819090afbf2c9b8d4bac", "custom_id": "Orphenadrine-Sumatriptan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6a4a0bb961e6ed684121e336d8f1b160", "body": {"id": "chatcmpl-BNLPv820vigSIwbsM0tpizqerrPqW", "object": "chat.completion", "created": 1744903571, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when taken with a selective serotonin 5-HT1B/1D receptor agonist used for acute migraine attacks, may be associated with the adverse reaction of erythema according to documented drug-drug interaction data?\n\nAnswer: Orphenadrine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 577, "completion_tokens": 56, "total_tokens": 633, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dd717d8819081b6bb70b6279d09", "custom_id": "Alprazolam-Indapamide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bfa875c0e33bbbf6818657e38d3213b6", "body": {"id": "chatcmpl-BNLPwy8f3zx18Pi4OGY3SMQODgwaL", "object": "chat.completion", "created": 1744903572, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with a thiazide-like sulfonamide diuretic used to reduce plasma volume and vascular resistance, is associated with a risk of gastric inflammation due to its action as a high-affinity triazolobenzodiazepine anxiolytic that modulates GABA_A receptor activity?\n\nAnswer: Alprazolam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 683, "completion_tokens": 75, "total_tokens": 758, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd72bb081908746678470e16289", "custom_id": "Aciclovir-Dapsone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b914a7b94e3afdd4009f881061e8a22e", "body": {"id": "chatcmpl-BNLPxduut6GamSGAcnQexFMPTk7be", "object": "chat.completion", "created": 1744903573, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario featuring a guanosine analogue antiviral with notable nephrotoxicity risk and a sulfone-class antimicrobial prone to inducing hematologic complications such as hemolytic anemia and methemoglobinemia, which agent has been more directly associated with causing gastric inflammation when both are prescribed?\n\nAnswer: Dapsone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 678, "completion_tokens": 67, "total_tokens": 745, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd741c0819083c209e95843dd5b", "custom_id": "Furosemide-Lamotrigine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5d1f125adbaff8124e08038aa303b60a", "body": {"id": "chatcmpl-BNLPzCZQiKlORcM6zjhHkYqEptRZh", "object": "chat.completion", "created": 1744903575, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its use as an anticonvulsant and mood stabilizer, has been associated with weight gain when taken in conjunction with a potent loop diuretic used for managing edema?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 704, "completion_tokens": 49, "total_tokens": 753, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dd753808190acec8c23524de2da", "custom_id": "Aciclovir-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "531083725eb12930bc480fb9f228f7dd", "body": {"id": "chatcmpl-BNLQ0OOFroc24fNuu5awb1HNqC34Y", "object": "chat.completion", "created": 1744903576, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when used in combination with a nitrogen-containing bisphosphonate indicated for osteoporosis prevention that was patented in 1971, has been reported to be associated with myelodysplasia as a potential interaction?\n\nAnswer: Aciclovir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 463, "completion_tokens": 52, "total_tokens": 515, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd765808190b5832d52410c679f", "custom_id": "Megestrol-Duloxetine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "40d5536e163183b7fcc67c80968ff384", "body": {"id": "chatcmpl-BNLQ16nCFHzllacGnXC82jat8wWJb", "object": "chat.completion", "created": 1744903577, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a progestin used for cancer treatment and disease-related weight loss, is associated with causing cholecystitis when interacting with a serotonin\u2013norepinephrine reuptake inhibitor commonly prescribed for mood and pain disorders?\n\nAnswer: Megestrol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 588, "completion_tokens": 56, "total_tokens": 644, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dd776a88190a65c0d33d219b522", "custom_id": "Ranitidine-Thalidomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e9b771f7c8cd76ed10797bbe8f6c0ecb", "body": {"id": "chatcmpl-BNLQ3ISQl805I48Vvq53JfVb69AmW", "object": "chat.completion", "created": 1744903579, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its teratogenic effects and immunomodulatory actions in hematologic malignancies and leprosy, is associated with cholecystitis as an adverse interaction outcome when combined with an H2 antagonist historically used for acid-related disorders but withdrawn due to carcinogenic concerns?\n\nAnswer: Thalidomide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 765, "completion_tokens": 68, "total_tokens": 833, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dd78a448190a0a3cb549feeb58b", "custom_id": "Ranitidine-Fosphenytoin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "809bf8dccb26e6eb57dd30dc6af59771", "body": {"id": "chatcmpl-BNLQ4S0MCtggT0J3c31BJoVZGpoBR", "object": "chat.completion", "created": 1744903580, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich agent, known for its gastric acid suppression and associated with concerns of NDMA-related carcinogenicity, has been reported to agitate the prodrug utilized for acute management of convulsive status epilepticus?\n\nAnswer: Ranitidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 593, "completion_tokens": 50, "total_tokens": 643, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd79c8c81908620744f1f0dc27c", "custom_id": "Alprazolam-Gemfibrozil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "88c5e7517713418e90812fa6e2531460", "body": {"id": "chatcmpl-BNLQ5V2ZinLVXmxDF5fRvcz1dcAIG", "object": "chat.completion", "created": 1744903581, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, the one used primarily as an anxiolytic agent with strong affinity for the GABA_A receptor, or the one from the fibrates class used to treat abnormal blood lipid levels, is associated with causing gastric inflammation when interacting with the other?\n\nAnswer: Gemfibrozil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 650, "completion_tokens": 60, "total_tokens": 710, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd7ae60819089ebe534b5d70fed", "custom_id": "Etiracetam-Erlotinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f94508b498930bac51aa388af0fbab44", "body": {"id": "chatcmpl-BNLQ6oPvwPzXRmjC49Shq8WuBYoEm", "object": "chat.completion", "created": 1744903582, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly used to treat cancers with specific EGFR mutations and known for side effects such as rash and diarrhea, has been associated with causing dysarthria when interacting with a member of the racetam family developed as a nootropic?\n\nAnswer: Erlotinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 492, "completion_tokens": 56, "total_tokens": 548, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd7c73c8190bf11f2e256ec642c", "custom_id": "Amphetamine-Modafinil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "38ce1125bb2c6c68d483b128506ff24d", "body": {"id": "chatcmpl-BNLPm3ZJWucyk2NukAYjuftQDuAkD", "object": "chat.completion", "created": 1744903562, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for treating narcolepsy and shift work sleep disorder by promoting wakefulness, is associated with the onset of apoplexy when interacted with a potent stimulant that augments norepinephrine and dopamine neurotransmission?\n\nAnswer: Modafinil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 712, "completion_tokens": 53, "total_tokens": 765, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd7daa48190b3ebd8acc95e9b13", "custom_id": "Pamidronic acid-thiotepa-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4810d30a838b1ce37eb85dd824221556", "body": {"id": "chatcmpl-BNLPnUxCeUdkhy1mntT3usJ6frB2C", "object": "chat.completion", "created": 1744903563, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered with an anti-cancer organophosphorus compound known for the formula (C2H4N)3PS, has been associated with an increased risk of erythema?\n\nAnswer: Pamidronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 360, "completion_tokens": 50, "total_tokens": 410, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd7ed488190b7cebb53abe97e04", "custom_id": "Naproxen-alendronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f3dddc5fe50f48c499104f1e9ea54f1e", "body": {"id": "chatcmpl-BNLPo8FzOC4Ajr9YPs53A10J2hMjm", "object": "chat.completion", "created": 1744903564, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its COX inhibition and use in managing pain and inflammation, has the potential to exacerbate gastric inflammation when used concomitantly with a bisphosphonate prescribed for osteoporosis and bone disorders?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 670, "completion_tokens": 51, "total_tokens": 721, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd7fde88190b6a370241579bb5f", "custom_id": "Carvedilol-Efavirenz-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fb38fc4362c518fdf92b7114f8bd5e2a", "body": {"id": "chatcmpl-BNLPpoObtQEQM3hSoaKnSNRUClmwo", "object": "chat.completion", "created": 1744903565, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, the nonselective beta-adrenergic and alpha-1 blocker primarily used for hypertension and heart failure, or the NNRTI antiretroviral used to inhibit HIV replication, is more likely to directly contribute to blood pressure lowering when co-administered, potentially making blood pressure a clinical concern in their interaction?\n\nAnswer: Carvedilol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 668, "completion_tokens": 76, "total_tokens": 744, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd810148190909a1b6cdf5b9921", "custom_id": "Carvedilol-Dobutamine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ccd6ba75210644b0c81b50d92639829e", "body": {"id": "chatcmpl-BNLPrD0CvvCHGcuoFr5fWJVNof5RY", "object": "chat.completion", "created": 1744903567, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of heart failure treatment, which agent, despite being a nonselective beta-blocker with alpha-1 antagonism, has a known drug-drug interaction involving hepatitis when co-administered with a synthetic \u03b21-adrenergic agonist primarily used for short-term inotropic support?\n\nAnswer: Carvedilol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 636, "completion_tokens": 70, "total_tokens": 706, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd8236081908fffe32f89e84e86", "custom_id": "chlortalidone-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "68dd90ee492f9094447288697651ba17", "body": {"id": "chatcmpl-BNLPsXIEWnmAX9E4nKkNY3aQLyqg1", "object": "chat.completion", "created": 1744903568, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly used to manage cardiovascular-related conditions such as edema or hypertension, is associated with the loss of weight when administered alongside a selective PDE5 inhibitor that promotes smooth muscle vasodilation?\n\nAnswer: chlortalidone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 751, "completion_tokens": 48, "total_tokens": 799, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd836088190aec20c253fd60b4f", "custom_id": "Ibuprofen-Metoprolol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1585d7f2f03802177c7ed5e1bd05b5f3", "body": {"id": "chatcmpl-BNLPuILyMYvbhK1yPpZTPXbCiRnKB", "object": "chat.completion", "created": 1744903570, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when co-administered with a beta-1 adrenergic antagonist commonly prescribed for cardiovascular conditions, may increase the risk of inflammation of the gallbladder (cholecystitis) due to its impact on prostaglandin synthesis and gastrointestinal integrity?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 62, "total_tokens": 749, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd847788190b51e2cbdd210bb41", "custom_id": "Candesartan-Citalopram-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a6a00754360da4fbe8d85512d467fced", "body": {"id": "chatcmpl-BNLPzv1FEm1urkOdT8NEYTFQBe3C2", "object": "chat.completion", "created": 1744903575, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient experiencing high blood pressure who is treated with an angiotensin receptor blocker notable for being a cascading prodrug with high potency among AT-1 antagonists, what is the risk if they also begin taking a selective serotonin reuptake inhibitor commonly prescribed for major depressive disorder, obsessive-compulsive disorder, and social phobia, particularly concerning the potential development of myelodysplasia?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 607, "completion_tokens": 87, "total_tokens": 694, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd859f8819093ac7510def125e5", "custom_id": "Ibuprofen-desvenlafaxine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b2c1a651df03ad5f6788d67da0efa696", "body": {"id": "chatcmpl-BNLQ0YQtp2MKkYhqQNAf5plotQTju", "object": "chat.completion", "created": 1744903576, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, widely used for managing inflammatory pain via cyclooxygenase inhibition but associated with gastrointestinal mucosal irritation and increased risk of bleeding, could elevate the likelihood of vaginal bleeding when co-administered with an agent that enhances synaptic serotonin and norepinephrine by transporter inhibition for depressive disorders?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 704, "completion_tokens": 66, "total_tokens": 770, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd86bc08190a4b84430f86d5379", "custom_id": "Ziprasidone-Desloratadine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "205945684b274aa9b9a167067096058c", "body": {"id": "chatcmpl-BNLQ2qm4abiiX4WR5jlTc4QZqF8qF", "object": "chat.completion", "created": 1744903578, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nGiven a combination therapy scenario involving a second-generation atypical antipsychotic used for managing schizophrenia or bipolar disorder (noted for modulating serotonergic and dopaminergic pathways) and a tricyclic H1 inverse agonist indicated for allergy treatment, which drug is more likely to cause an increase in heart rate when the two are administered together?\n\nAnswer: Ziprasidone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 574, "completion_tokens": 79, "total_tokens": 653, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dd87e048190b2cb2a74c657b479", "custom_id": "indometacin-Salmeterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "195a2af346f861812715696e9a026b7b", "body": {"id": "chatcmpl-BNLQ33asZp8RNTrBd4CDyIOaAN84v", "object": "chat.completion", "created": 1744903579, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient experiences back ache as a result of the pharmacological interaction between an NSAID that inhibits prostaglandin production to reduce inflammation and a LABA used for long-term asthma management, which medication is considered the object of this adverse effect in their interaction?\n\nAnswer: Salmeterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 564, "completion_tokens": 61, "total_tokens": 625, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dd894148190a783caf6fa7b4bdf", "custom_id": "Lamotrigine-Salmeterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8aeaee21db3ee538e981ac3f7457fcbd", "body": {"id": "chatcmpl-BNLQ5g5i1ZLz7Dsxdt7lXHiNRNTCW", "object": "chat.completion", "created": 1744903581, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient being treated with both a phenyltriazine anticonvulsant for epilepsy and mood stabilization, and a long-acting \u03b22 adrenergic receptor agonist for asthma or COPD, which agent is specifically associated with the potential for erythema when the two are used together?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 628, "completion_tokens": 69, "total_tokens": 697, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd8a740819086476f9548882060", "custom_id": "Gemfibrozil-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8b14da674f58deb6fea560f98f166ac6", "body": {"id": "chatcmpl-BNLQ6Hvybt1FkaEbNoPuU31zuXH6J", "object": "chat.completion", "created": 1744903582, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, the one used for abnormal blood lipid levels that works by decreasing the breakdown of lipids in fat cells, or the one that functions as a selective inhibitor of phosphodiesterase type 5 to potentiate nitric oxide-mediated vasodilation, is associated with erythema when taken together with the other?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 667, "completion_tokens": 70, "total_tokens": 737, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd8b85881909824053fed41ee46", "custom_id": "alendronic acid-Pimecrolimus-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "de0a9096ed11206d09c70b611041ec3c", "body": {"id": "chatcmpl-BNLQ8zXHxMXWPrVZlDU0RE13jQ4UF", "object": "chat.completion", "created": 1744903584, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when used in the treatment of osteoporosis or Paget's disease and commonly co-administered with vitamin D and calcium, has been reported to be associated with cases of nasopharyngitis when administered alongside a topical calcineurin inhibitor used for eczema?\n\nAnswer: alendronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 475, "completion_tokens": 62, "total_tokens": 537, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd8c9248190a157e8cd15a62eea", "custom_id": "nevirapine-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "611553a2fb2fca955b3184d468339a11", "body": {"id": "chatcmpl-BNLQ9cIsm7Bre7U4EJa2xHMrY2VUP", "object": "chat.completion", "created": 1744903585, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, the anticholinergic agent used primarily to manage overactive bladder symptoms and known for side effects like xerostomia and thermoregulatory dysfunction, is associated with an emesis-related drug interaction when taken together with an HIV-1 treatment that blocks reverse transcriptase?\n\nAnswer: oxybutynin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 66, "total_tokens": 751, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dd8da80819098f7cfd5b7104240", "custom_id": "Aciclovir-Doxazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "772d8e6ee82b19b9a82f6d663c1452ae", "body": {"id": "chatcmpl-BNLQA3s4BWw31aCqLyqkvjqsUZdp1", "object": "chat.completion", "created": 1744903586, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to treat herpesvirus infections and known for potential nephrotoxicity and thrombocytopenia, may cause gastric inflammation when administered in conjunction with a selective \u03b11-adrenergic blocker commonly prescribed for benign prostatic hyperplasia and hypertension?\n\nAnswer: Aciclovir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 595, "completion_tokens": 61, "total_tokens": 656, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd8ed748190b74a60ad00b9a5b9", "custom_id": "Diazepam-Duloxetine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "cac0d2b7f196ae50463450aee4dbb8a4", "body": {"id": "chatcmpl-BNLQBunHJ8mZgO8EdCeAUmwlX6PTJ", "object": "chat.completion", "created": 1744903587, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for modulating synaptic reuptake mechanisms of serotonin and norepinephrine to treat neuropathic pain and major depressive disorder, is associated with gastric inflammation when used in combination with a benzodiazepine anxiolytic that acts via potentiation of GABAergic neurotransmission?\n\nAnswer: Duloxetine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 789, "completion_tokens": 67, "total_tokens": 856, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd900c08190b13e18184427b517", "custom_id": "Famotidine-Ticlopidine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "12c15ff34d2486b6537f6e1ac54c58d3", "body": {"id": "chatcmpl-BNLQCfD9erSC6mhMfHviwinN42jNN", "object": "chat.completion", "created": 1744903588, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient who is taking a medication to reduce stomach acid by blocking histamine H2 receptors and another drug that is an ADP receptor inhibitor used to lower the risk of thrombotic strokes, which of these two agents is reported to be associated with the occurrence of extrasystoles ventricular when administered together?\n\nAnswer: Ticlopidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 584, "completion_tokens": 70, "total_tokens": 654, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dd9134c819093d7e28e8ec08898", "custom_id": "Alprazolam-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "51198857d883df548009881f5cf71474", "body": {"id": "chatcmpl-BNLQEbZOpykYeeSF6YjSN8SKeDzc0", "object": "chat.completion", "created": 1744903590, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with a high-affinity triazolobenzodiazepine anxiolytic that acts on the GABA_A receptor causing CNS depression and potential somnolence, may increase the risk of apoplexy due to its alpha-1 blocking action resulting in lowered blood pressure?\n\nAnswer: Terazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 629, "completion_tokens": 71, "total_tokens": 700, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd925fc8190a15e53740443eac3", "custom_id": "Amlodipine-Cinacalcet-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5409ed22b015873e6e17cf466164320c", "body": {"id": "chatcmpl-BNLQF9zTrsDvetMWFeu2KyAaYbpqF", "object": "chat.completion", "created": 1744903591, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered alongside an orally dosed dihydropyridine calcium channel antagonist known for its vasodilatory effects and use in hypertension and angina, is associated with the occurrence of abnormal EEGs as part of their drug-drug interaction?\n\nAnswer: Cinacalcet", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 566, "completion_tokens": 60, "total_tokens": 626, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dd93a2c81909dc9d87f17130cae", "custom_id": "Candesartan-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1598d792474339f5e19633a19d10803d", "body": {"id": "chatcmpl-BNLQGjnWmVP6enVjzCkVhJqmlOJhx", "object": "chat.completion", "created": 1744903592, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, the one used to treat high blood pressure and heart failure as a potent AT-1 receptor antagonist, is associated with causing gastric inflammation when used with the nitrogen-containing bisphosphonate prescribed to prevent osteoporosis?\n\nAnswer: Candesartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 392, "completion_tokens": 52, "total_tokens": 444, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd94d4c81909fc6f65fb0478f69", "custom_id": "alendronic acid-Salmeterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bc8a72b569f1880ace2a59e86f48fda9", "body": {"id": "chatcmpl-BNLQIFtC905UFPOqkFHU1XILzpChn", "object": "chat.completion", "created": 1744903594, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to treat osteoporosis and Paget's disease of bone, has been associated with an increased risk of cholecystitis when taken alongside a long-acting \u03b22 adrenergic receptor agonist used for asthma and COPD?\n\nAnswer: alendronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 590, "completion_tokens": 58, "total_tokens": 648, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dd95ec88190a3e9568f506f5b6a", "custom_id": "alendronic acid-Alprazolam-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "03b4075e67d79c8aa455fc56f9be0269", "body": {"id": "chatcmpl-BNLQJZ7qWMLmjc052bepBGQSypBix", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient develops cholecystitis due to a drug-drug interaction between a bisphosphonate used for osteoporosis and a potent anxiolytic benzodiazepine, which of the two drugs is most directly implicated as contributing to the development of cholecystitis in the context of their interaction?\n\nAnswer: Alprazolam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 635, "completion_tokens": 72, "total_tokens": 707, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd9723c8190a99219bd7455c49a", "custom_id": "Fentanyl-Nimodipine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d7d5fb9bffa6e065ceda92a5a53c0e58", "body": {"id": "chatcmpl-BNLQKSHCv3XidurPdhRKhmvuloqs9", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a synthetic opioid analgesic with high \u03bc-opioid receptor affinity and significant risk of respiratory depression and overdose, can induce a muscle disorder when administered concomitantly with a calcium channel blocker used to prevent vasospasm following subarachnoid hemorrhage?\n\nAnswer: Fentanyl", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 604, "completion_tokens": 62, "total_tokens": 666, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd986148190be84bdd4b20c1c87", "custom_id": "Aciclovir-Citalopram-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1cc18c0ec68a274a124515ba2b4cfe43", "body": {"id": "chatcmpl-BNLPown7R9bnOXMfyGUrSSov6hjva", "object": "chat.completion", "created": 1744903564, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where an antiviral guanosine analogue that inhibits viral DNA polymerase is co-administered with a selective serotonin reuptake inhibitor utilized in major depressive and anxiety disorders, which drug in this combination is associated with a risk of developing methaemoglobinaemia as part of their drug-drug interaction?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 678, "completion_tokens": 74, "total_tokens": 752, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd99aa88190879a497bd77923c3", "custom_id": "Lidocaine-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "282ec61f38344bc4b1b1369514f7bcc6", "body": {"id": "chatcmpl-BNLPp5ktDeEJsUqOVtXOdVXrIGr6g", "object": "chat.completion", "created": 1744903565, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a nitrogen-containing bisphosphonate used to prevent osteoporosis, has been shown in drug-drug interaction studies to have a relationship with a classic amino amide local anesthetic and class Ib antiarrhythmic agent specifically in the context of trigeminal neuralgia management?\n\nAnswer: Pamidronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 592, "completion_tokens": 67, "total_tokens": 659, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd9aee08190ac4524b8251a75c1", "custom_id": "Triazolam-Exemestane-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1628c4ecf4dcf49051c9451a82ed9dca", "body": {"id": "chatcmpl-BNLPrlwBdAEGLUANaWYHD9UKrK1PU", "object": "chat.completion", "created": 1744903567, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used as an aromatase inhibitor to treat hormone-receptor-positive breast cancer, may be associated with the risk of developing cholecystitis when administered with a benzodiazepine tranquilizer primarily used for severe insomnia?\n\nAnswer: Exemestane", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 540, "completion_tokens": 57, "total_tokens": 597, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd9c13c81909ac2b825e527639d", "custom_id": "Efavirenz-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c199bc238315bb2807bfced74ed43521", "body": {"id": "chatcmpl-BNLPsscAxjaxws2DYxQweqLqp63jX", "object": "chat.completion", "created": 1744903568, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich of the following medications\u2014one primarily used as an antimuscarinic agent to treat overactive bladder and known for adverse effects like dry mouth and thermoregulation issues, and the other a non-nucleoside reverse transcriptase inhibitor used for HIV therapy\u2014has its use associated with an increased risk of constipation when taken together?\n\nAnswer: oxybutynin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 706, "completion_tokens": 76, "total_tokens": 782, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd9d4208190ab7dcca95d7f36ea", "custom_id": "Amlodipine-Dexpramipexole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9742afc552eaa1a73cfcc507581e75c7", "body": {"id": "chatcmpl-BNLPtjCGVHnXxsVBHYcM6vQUMY9To", "object": "chat.completion", "created": 1744903569, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA certain investigational oral medicine under development for eosinophilic asthma, noted for its eosinophil-lowering properties in multiple clinical trials, may cause adenopathy when taken concomitantly with a long-acting calcium channel antagonist widely prescribed for hypertension and angina management due to its vasodilatory actions. Which drug is most likely to cause adenopathy in this interaction?\n\nAnswer: Dexpramipexole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 521, "completion_tokens": 87, "total_tokens": 608, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dd9e6108190a967c1ca55e91c2b", "custom_id": "Amlodipine-Thalidomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "888875ff0a9725cdbdc03e21299e4bdf", "body": {"id": "chatcmpl-BNLPvVyuULzzA6UUGhBP48DZefBRe", "object": "chat.completion", "created": 1744903571, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its immunomodulatory properties and use in hematological malignancies, has been reported to cause erythema when co-administered with a long-acting calcium channel blocker primarily used for hypertension and angina?\n\nAnswer: Thalidomide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 661, "completion_tokens": 56, "total_tokens": 717, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dd9f72081908a3868873de8b079", "custom_id": "Naproxen-Temazepam-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b8d3ede05716d354f565172cb5a4bff8", "body": {"id": "chatcmpl-BNLPwcs6zVlolK9gFxtliu3NYawSE", "object": "chat.completion", "created": 1744903572, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when considered in conjunction with a benzodiazepine hypnotic used primarily for severe insomnia, is associated with a reported interaction specifically involving acne as an adverse effect?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 740, "completion_tokens": 43, "total_tokens": 783, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dda08f88190a50213b4cad29e65", "custom_id": "Diazepam-Formoterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9690eec9bda0acf2a141c2e75c62745f", "body": {"id": "chatcmpl-BNLPx1VdiKXcPaHGqPuCmszG0lx0C", "object": "chat.completion", "created": 1744903573, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly used for long-term control of asthma and COPD due to its bronchodilatory effects, is associated with weight loss when co-administered with a benzodiazepine anxiolytic known for its risk of dependence and sedative properties?\nAnswer: Formoterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 789, "completion_tokens": 60, "total_tokens": 849, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dda1c5481909dc4744a76c6603f", "custom_id": "Ranitidine-gadoversetamide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4a259ddf23bb2e21d510f0bbe85105c6", "body": {"id": "chatcmpl-BNLPzAooI8lhZwXOCu4jyJGrnoUdN", "object": "chat.completion", "created": 1744903575, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered in combination with an MRI contrast agent used for imaging the brain, spine, and liver, is associated with causing a bulging interaction effect?\n\nAnswer: Ranitidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 541, "completion_tokens": 41, "total_tokens": 582, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dda33d88190a399dff7e06c57d3", "custom_id": "Naproxen-Lamotrigine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "94930cd6ad24430867b3d575ebf9ba94", "body": {"id": "chatcmpl-BNLQ0HQG0Wy27nYgEbEYE2rIeyc6i", "object": "chat.completion", "created": 1744903576, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of bipolar disorder and epilepsy, who is being treated with a medication known for modulating voltage-sensitive sodium channels to prevent both seizures and mood episodes, develops an abnormal EEG after starting a course of a nonselective cyclooxygenase inhibitor for inflammatory pain. Which medication is most likely to be associated with the observed abnormal EEG in this interaction?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 708, "completion_tokens": 82, "total_tokens": 790, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dda496c8190b42c3fddd5cd5431", "custom_id": "Carvedilol-Dexpramipexole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1606e2f5a46c5484fe0e068b2693b088", "body": {"id": "chatcmpl-BNLQ1TQOfkpXN1pZZHp2gnqYkaJkU", "object": "chat.completion", "created": 1744903577, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nConsidering one drug commonly used to manage hypertension and heart failure through nonselective beta- and alpha-1 adrenergic blockade, and another investigational oral agent developed primarily for eosinophilic asthma through significant blood eosinophil reduction, which drug interacts with the other to cause gastric inflammation?\n\nAnswer: Carvedilol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 577, "completion_tokens": 69, "total_tokens": 646, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dda5ee48190b3e012cfaaa8c9c9", "custom_id": "phenytoin-Dapsone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d72d4769a5642c6e28211c3fae6fe217", "body": {"id": "chatcmpl-BNLQ22813bzVtEUOCkcqoyNvOIPyV", "object": "chat.completion", "created": 1744903578, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient receiving both a voltage-gated sodium channel inhibitor for tonic-clonic and focal seizures and a sulfone-class bacteriostatic used for leprosy and pneumocystis pneumonia prophylaxis, which agent is associated as the precipitating factor in cases of intracranial hemorrhage observed in the context of their co-administration?\n\nAnswer: Dapsone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 750, "completion_tokens": 77, "total_tokens": 827, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dda71b88190a8946af9877dadd5", "custom_id": "Celecoxib-Propofol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e603a1a4381b700ebd555e8c70f3fd1d", "body": {"id": "chatcmpl-BNLQ4c2v77c0OJivGUdW7FeH0ihrK", "object": "chat.completion", "created": 1744903580, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a selective cyclooxygenase-2 inhibitor used for arthritis and pain management is associated with the occurrence of jaundice (icterus) when combined with a lipid-based intravenous anesthetic that acts on GABA_A receptors, which drug is the one related to causing or being linked to icterus in this interaction?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 748, "completion_tokens": 76, "total_tokens": 824, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dda83808190a26b5b58beb850fe", "custom_id": "Gabapentin-Lamivudine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c1e0afd6195b1577938b51abfd7165f3", "body": {"id": "chatcmpl-BNLQ5VIIm8JqCVuKFhUKE1Q7dB4Ck", "object": "chat.completion", "created": 1744903581, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn patients treated for neuropathic pain or partial seizures with a drug that binds the \u03b12\u03b4-1 subunit of voltage-gated calcium channels, which medication, when co-administered, is associated with causing adenopathy?\n\nAnswer: Lamivudine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 703, "completion_tokens": 56, "total_tokens": 759, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dda9ac481908919af005efe4cde", "custom_id": "Norfloxacin-Sorafenib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d7d1065dfbc1ee8a284584a7cfb4a3de", "body": {"id": "chatcmpl-BNLQ7MfPzBmi1htXC5VcefabaLuC9", "object": "chat.completion", "created": 1744903583, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used as a kinase inhibitor for advanced cancers, may cause confusion when administered along with a fluoroquinolone antibiotic indicated for urinary tract infections and associated with tendon ruptures?\n\nAnswer: Sorafenib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 432, "completion_tokens": 45, "total_tokens": 477, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddaadd48190bc2021589186513e", "custom_id": "Candesartan-Famotidine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c2ee8cbd4af87e4255ed5351057323df", "body": {"id": "chatcmpl-BNLQ8j6TVFEW1NbcGiSEtlwmrisVn", "object": "chat.completion", "created": 1744903584, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for high blood pressure and heart failure with a potent cascading prodrug angiotensin receptor blocker develops excessive thirst after starting a histamine H2 receptor antagonist used for reducing stomach acid. According to their documented drug-drug interaction, which medication is most likely the second agent introduced?\n\nAnswer: Famotidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 508, "completion_tokens": 67, "total_tokens": 575, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddabe8481908a66bb1cc65955e4", "custom_id": "Rofecoxib-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8a77061421e29990a3a9d865065903e9", "body": {"id": "chatcmpl-BNLQ9KeGNT9AdsU5YklMxo3MJJMRA", "object": "chat.completion", "created": 1744903585, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its COX-2 selectivity and historical use in arthritic conditions before withdrawal due to cardiovascular concerns, has been documented to be associated with lymph node abnormalities when interacting with a sedative hypnotic that enhances GABAA receptor activity for insomnia?\n\nAnswer: Rofecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 758, "completion_tokens": 64, "total_tokens": 822, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddad0dc81909951babb443af439", "custom_id": "Modafinil-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ca25db8b1f848aa4bcb0b18169c4b116", "body": {"id": "chatcmpl-BNLQBbo9RdcsawFcmH4WTRYTNwDUf", "object": "chat.completion", "created": 1744903587, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with a nitrogen-containing bisphosphonate used to prevent osteoporosis, has the potential to contribute to elevated blood pressure due to its CNS stimulant and wakefulness-promoting properties?\n\nAnswer: Modafinil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 466, "completion_tokens": 50, "total_tokens": 516, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddae2248190862aa27787702eb4", "custom_id": "Fluorouracil-Indapamide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "38cebb12fad84ce2ac7319dfbd02fc46", "body": {"id": "chatcmpl-BNLQCZMpOjpLNlOQgUh0DP5jVujo8", "object": "chat.completion", "created": 1744903588, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a pyrimidine analog antimetabolite used in the treatment of various carcinomas is combined with a thiazide-like sulfonamide diuretic prescribed for hypertension, which drug is associated with the development of cellulitis as an adverse effect related to their interaction?\n\nAnswer: Indapamide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 66, "total_tokens": 751, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddaf54c81909b5d3768c6c4986b", "custom_id": "Carvedilol-Pilocarpine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c7af69d6280b2ce30148a8b69c375ffc", "body": {"id": "chatcmpl-BNLQDdEliytzApk74Aqrl8R2vrGNs", "object": "chat.completion", "created": 1744903589, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the nonselective beta-adrenergic blocker with alpha-1 antagonistic properties commonly prescribed for heart failure and hypertension, and the muscarinic agonist employed for acute glaucoma and xerostomia, which drug is associated as the object in a knowledge graph relationship where the other drug is implicated in causing fracture nonunion involving it?\n\nAnswer: Pilocarpine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 679, "completion_tokens": 77, "total_tokens": 756, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddb0920819098ab31bac641cbf4", "custom_id": "Ondansetron-Telmisartan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ff74820fcec87dfda4b0fc01c1067e32", "body": {"id": "chatcmpl-BNLQFy8LVTUPPgIPFRo6lldDijace", "object": "chat.completion", "created": 1744903591, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nGiven one drug used to control nausea through selective serotonin 5-HT3 receptor antagonism with no significant dopaminergic action, and another prescribed for hypertension by inhibiting angiotensin II AT1 receptors but known to carry risks of renal impairment and teratogenicity, which of these two agents, according to knowledge-graph data, is described as being apoplectic in relation to the other?\n\nAnswer: Ondansetron", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 649, "completion_tokens": 89, "total_tokens": 738, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddb1a608190b6a8f42aed7b4a82", "custom_id": "Celecoxib-Pirbuterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "628a3e95b1400cb076dc3da6723610dc", "body": {"id": "chatcmpl-BNLQGcYy3IkmlX4PrEpXBWTOBCVCd", "object": "chat.completion", "created": 1744903592, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its selective COX-2 inhibition and commonly used to manage various forms of arthritis and pain, can experience a loss of weight as an interaction when co-administered with a short-acting \u03b22 adrenoreceptor agonist prescribed for asthma relief?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 584, "completion_tokens": 64, "total_tokens": 648, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddb2b988190bd982143c496dd72", "custom_id": "Furosemide-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "30b9303d12a8437782d1b59c51d68c64", "body": {"id": "chatcmpl-BNLQHVyxCWoV3KRHChCjuZfNoqS77", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario involving the co-administration of a potent loop diuretic\u2014used to treat edema via inhibition of the Na-K-2Cl symporter and known for potential nephrotoxicity\u2014and a vinca alkaloid chemotherapy agent that disrupts microtubule formation but can cause peripheral neuropathy and is only administered intravenously, which drug has been reported in the literature to have an interaction with the other involving amyloidosis?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 714, "completion_tokens": 98, "total_tokens": 812, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddb3fb081908b35d862fd621136", "custom_id": "Carvedilol-Famotidine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6a495320dbdb3384a0298b1669f887cc", "body": {"id": "chatcmpl-BNLQJlyw2Kgf9cSYPtdF6cbTf2j8W", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with chronic heart failure with reduced ejection fraction (HFrEF) managed on a nonselective beta-adrenergic blocker and alpha-1 adrenergic antagonist, or a patient being treated for gastric acid disorders with a histamine H2 antagonist, is found to have worsening cardiomyopathy as a result of a drug interaction. Based on this interaction, which drug is associated as the cause or contributor to the development or exacerbation of cardiomyopathy when used concomitantly?\n\nAnswer: Famotidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 628, "completion_tokens": 108, "total_tokens": 736, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddb50888190a52255aca879805e", "custom_id": "Candesartan-Thalidomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "168ff257a0308f8db106c4bf06f8c14e", "body": {"id": "chatcmpl-BNLQLhKaSn3VBsFBbov04oxFJVnDR", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a patient being treated for high blood pressure or heart failure with a potent angiotensin receptor blocker is experiencing back ache, which additional drug, commonly used for hematological malignancies and notorious for its teratogenic risks, is the one associated with this adverse event when combined with the first agent?\n\nAnswer: Thalidomide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 596, "completion_tokens": 72, "total_tokens": 668, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011ddb61b08190b934d9bdf6bb7ff8", "custom_id": "Gabapentin-Ziprasidone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "22f5534ec08c7e90be83737e88e7cb7b", "body": {"id": "chatcmpl-BNLPpdFuY277hkk5UfivB6bkJDjLM", "object": "chat.completion", "created": 1744903565, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the prototypical gabapentinoid used for neuropathic pain and a second-generation antipsychotic efficacious in bipolar disorder and schizophrenia with a relatively favorable weight profile, which agent is more likely to be associated with loss of weight when considering their reported drug-drug interaction?\n\nAnswer: Ziprasidone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 725, "completion_tokens": 67, "total_tokens": 792, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddb72f08190b00e2fcc80de12e6", "custom_id": "Citalopram-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "50b21d9855e8f91261597c9f591b53db", "body": {"id": "chatcmpl-BNLPq1aW2MRV5GTeXhTTpMjAwBtJs", "object": "chat.completion", "created": 1744903566, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its role as an alpha-1 blocker in the management of prostatic hyperplasia and hypertension, has been associated with cases of gastric inflammation when used in combination with a selective serotonin reuptake inhibitor that modulates serotonergic neurotransmission and is notable for potential QT interval prolongation?\n\nAnswer: Terazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 680, "completion_tokens": 69, "total_tokens": 749, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddb85c08190a2c9692ad5550f18", "custom_id": "Zolpidem-solifenacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "794d12ad438777967f1dc1dba3aa5da7", "body": {"id": "chatcmpl-BNLPrtYFwVtmGMYn1pyq3BPpfBVgL", "object": "chat.completion", "created": 1744903567, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with an oral antimuscarinic used for overactive bladder and neurogenic detrusor overactivity, has been associated with a reported loss of weight as an interaction effect?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 706, "completion_tokens": 52, "total_tokens": 758, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddb966c81908be15be85a18584a", "custom_id": "Rofecoxib-Torasemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "738d1882cf7075c28de6530245e9c9b7", "body": {"id": "chatcmpl-BNLPtxiOOs53LeZQnXlEN1x2lxJK5", "object": "chat.completion", "created": 1744903569, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly administered for edema due to heart, kidney, or liver insufficiency and acting by diminishing renal sodium reabsorption, when used concurrently with a COX-2-selective NSAID formerly marketed for arthritic conditions but withdrawn due to cardiovascular risk, is implicated in a drug-drug interaction where the NSAID may increase the risk of cholecystitis?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 659, "completion_tokens": 84, "total_tokens": 743, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddba9508190bc239840dc5173bd", "custom_id": "Celecoxib-Desloratadine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c58112675df8df2f5341d76daf492bdc", "body": {"id": "chatcmpl-BNLPuCH1wgV8HQ8LNoJS7bezxCsW4", "object": "chat.completion", "created": 1744903570, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly prescribed for the treatment of arthritis-related pain and inflammation and known for selectively inhibiting cyclooxygenase-2, has been implicated in a drug-drug interaction with an H1 inverse agonist used for allergy treatment resulting in an increased risk of cholecystitis?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 602, "completion_tokens": 67, "total_tokens": 669, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddbbb0c8190b5a97c4a22797492", "custom_id": "Methylphenidate-Salmeterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "cd3e76ae0362e190fd41934d188f86a5", "body": {"id": "chatcmpl-BNLPvIpDDpGbFUhABXGOAwW8ANY33", "object": "chat.completion", "created": 1744903571, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly administered to manage ADHD and narcolepsy through the inhibition of dopamine and norepinephrine reuptake, is associated with the risk of weight loss when used concomitantly with a long-acting \u03b22 adrenergic agonist indicated for chronic respiratory diseases?\n\nAnswer: Methylphenidate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 652, "completion_tokens": 66, "total_tokens": 718, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddbce64819085bd7f85a89d3cc5", "custom_id": "Metoprolol-Perphenazine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7dd730d8f0ac44f3c5ec78a7aabdab62", "body": {"id": "chatcmpl-BNLPxEIeXpaWro2YtgW9sAgJ2C0ZM", "object": "chat.completion", "created": 1744903573, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered with a typical antipsychotic that is a medium-potency D2 antagonist, may increase the risk for insulin-dependent diabetes mellitus due to a pharmacological interaction?\n\nAnswer: Metoprolol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 538, "completion_tokens": 47, "total_tokens": 585, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddbdfb48190a6b37f3c3f2f8bc1", "custom_id": "Lamotrigine-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f17f9f7ffd303fe6f3406418da48eaa0", "body": {"id": "chatcmpl-BNLPyMVv8tdN914mu1AnKK1AgXymd", "object": "chat.completion", "created": 1744903574, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered, has been identified as being associated with the development of cholecystitis in patients concurrently taking an anticholinergic agent primarily indicated for overactive bladder treatment due to its potent antimuscarinic effects?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 707, "completion_tokens": 57, "total_tokens": 764, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddbf0e481909017bad1b504250f", "custom_id": "acetazolamide-Celecoxib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b41e172508be13764232b89a8c0ea6c3", "body": {"id": "chatcmpl-BNLPzb5xVvhXJaktWhXgZCCiM7Lpe", "object": "chat.completion", "created": 1744903575, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a carbonic anhydrase inhibitor indicated for glaucoma and acute mountain sickness, is related via drug-drug interactions to a nonsteroidal anti-inflammatory agent commonly prescribed for arthritis pain?\n\nAnswer: acetazolamide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 745, "completion_tokens": 48, "total_tokens": 793, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddc03a081908b6da338add6130c", "custom_id": "Naproxen-Torasemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1cb3c2ccbe646bfcbb8b64ac72400383", "body": {"id": "chatcmpl-BNLQ0rI3o4YfP8J247ZtrzeDNwThX", "object": "chat.completion", "created": 1744903576, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of heart failure is prescribed a medication that decreases sodium reabsorption by the kidneys and is known for side effects such as increased urination and low blood potassium. If this patient develops back ache as a result of a drug-drug interaction with a nonsteroidal anti-inflammatory agent commonly used for chronic inflammatory conditions, which medication is most likely to be directly associated with causing the back ache in this interaction?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 689, "completion_tokens": 94, "total_tokens": 783, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddc15408190a1702684b6efdd63", "custom_id": "Famotidine-Lamotrigine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b7ba197626232185150b783298341865", "body": {"id": "chatcmpl-BNLQ2PKgeBBWtfyy9BB38IOeGfcrr", "object": "chat.completion", "created": 1744903578, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the medication commonly used to decrease stomach acid production and the anticonvulsant agent often indicated for epilepsy and bipolar disorder, which one is specifically associated with adenopathy when considered in terms of their drug-drug interaction?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 623, "completion_tokens": 53, "total_tokens": 676, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddc2864819093d75ade66fc5623", "custom_id": "Cetirizine-desvenlafaxine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "dabf30a3553e22986880aaa846bbc193", "body": {"id": "chatcmpl-BNLQ3Woi34VP6KN6mn2GTjqAeAGMn", "object": "chat.completion", "created": 1744903579, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBased on the pharmacodynamic properties of an oral second-generation antihistaminergic agent commonly prescribed for allergic conditions and a potent serotonin-norepinephrine reuptake inhibitor indicated for major depressive disorder, which of the two drugs is associated, in the context of their interaction, with the manifestation of erythema nodosum according to the knowledge-graph relationship provided?\n\nAnswer: desvenlafaxine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 718, "completion_tokens": 83, "total_tokens": 801, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011ddc39dc8190a19e282cdf7af0ef", "custom_id": "Duloxetine-desvenlafaxine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ebef0956418821700c04a56ab87f7717", "body": {"id": "chatcmpl-BNLQ5TPQmcfnLFi9iozxmg8xFJaaN", "object": "chat.completion", "created": 1744903581, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nConsidering two SNRI antidepressants, one of which is notably employed for both neuropathic pain and major depressive disorder and the other for major depressive disorder with its approval status differing between the United States and Europe, which drug is identified in their interaction as being associated with the condition adenopathy when taken together?\n\nAnswer: desvenlafaxine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 702, "completion_tokens": 71, "total_tokens": 773, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddc4ac081908d6702dc56568456", "custom_id": "Celecoxib-Midodrine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "13ee30219c8df38c179d926678c68efe", "body": {"id": "chatcmpl-BNLQ6QKZ3vnk6DIJcGaor8m5U51eO", "object": "chat.completion", "created": 1744903582, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient treated concurrently with a selective COX-2 inhibiting NSAID for arthritis and an antihypotensive agent that is a prodrug for an \u03b11-adrenergic receptor agonist, which drug is more likely to precipitate an allergic dermatitis due to their pharmacologic interaction?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 679, "completion_tokens": 68, "total_tokens": 747, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddc641c81908fbf90af14d0cdba", "custom_id": "Amlodipine-Furosemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3cb255a657dc5c1d617fde17941a0453", "body": {"id": "chatcmpl-BNLQ8JqKjZUx3loi4PXEF6okRRjzG", "object": "chat.completion", "created": 1744903584, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its inhibition of the Na-K-2Cl symporter in the loop of Henle and frequent monitoring requirements for electrolytes, is associated with metabolic encephalopathy when interacting with a long-acting calcium channel antagonist?\n\nAnswer: Furosemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 655, "completion_tokens": 57, "total_tokens": 712, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011ddc78a0819097c1f5fff6f2bd3a", "custom_id": "oxybutynin-Zaleplon-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b6fc82b1ab5410742034db3eec5fc169", "body": {"id": "chatcmpl-BNLQ90XVykguPYjpG0ijTQl9MYlSI", "object": "chat.completion", "created": 1744903585, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its antimuscarinic effects in managing overactive bladder symptoms, is implicated in an interaction leading to apoplexy when combined with a nonbenzodiazepine sedative-hypnotic of the pyrazolopyrimidine class used for treating insomnia?\n\nAnswer: oxybutynin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 564, "completion_tokens": 66, "total_tokens": 630, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddc8a98819092154dc006b893b7", "custom_id": "Celecoxib-tolcapone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e83ce947c23df7d58ed7c2761d61811a", "body": {"id": "chatcmpl-BNLQAqeiyDIqRVEOoTtLWvXzxnDIS", "object": "chat.completion", "created": 1744903586, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, either a selective cyclooxygenase-2 inhibiting NSAID commonly prescribed for various inflammatory conditions, or a nitrocatechol-type COMT inhibitor used in Parkinson's disease management, has been explored alongside the other for potential therapeutic effect in the treatment of trigeminal neuralgia?\n\nAnswer: tolcapone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 699, "completion_tokens": 68, "total_tokens": 767, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddc9c9481909d8bb9b5240024c0", "custom_id": "Temozolomide-Thalidomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "01024d86f009f1fd1db6d2a4c12db513", "body": {"id": "chatcmpl-BNLQBQ7rWxMi5Kd9M1xPkVBqhfGSt", "object": "chat.completion", "created": 1744903587, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, among a cytotoxic alkylating agent used for high-grade gliomas and an immunomodulatory agent notorious for its teratogenicity and employed in multiple myeloma and leprosy complications, is associated with causing gastric inflammation when interacting with the other?\n\nAnswer: Thalidomide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 711, "completion_tokens": 64, "total_tokens": 775, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddcae84819092bd28cb2f2e27f6", "custom_id": "Haloperidol-indometacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9c5f35c60d80da561a0d807701406abd", "body": {"id": "chatcmpl-BNLQDXE9EYrKDEzdp7qGYJRY0LrxC", "object": "chat.completion", "created": 1744903589, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBased on their mechanisms and known uses, which of these two medications\u2014one primarily antagonizing central dopamine receptors for psychotic disorders, and the other inhibiting cyclooxygenase to reduce pain and inflammation\u2014has been associated with cases of erythema multiforme when used alongside its counterpart?\n\nAnswer: indometacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 635, "completion_tokens": 67, "total_tokens": 702, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddcc0288190a07c1e9b9596bc30", "custom_id": "Amlodipine-Ziprasidone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0b22877553f95b8137a9ece803f6c515", "body": {"id": "chatcmpl-BNLQEGXfDQdK69UJEkVZ7B409QUIE", "object": "chat.completion", "created": 1744903590, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient being treated for hypertension with a long-acting dihydropyridine calcium channel blocker known for its vasodilatory effects, and for schizophrenia or bipolar disorder with an atypical antipsychotic characterized by serotonergic and dopaminergic modulation and a relatively lower likelihood of weight gain, which medication in this combination is specifically associated with a drug-drug interaction leading to loss of weight?\n\nAnswer: Ziprasidone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 651, "completion_tokens": 89, "total_tokens": 740, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011ddcd1988190900b6e56a600f8fb", "custom_id": "Citalopram-Thalidomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f938cd5926f4bba6922e849d7c279b36", "body": {"id": "chatcmpl-BNLQFkv9l23gFBhOGkb9REH78DJVA", "object": "chat.completion", "created": 1744903591, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where an orally administered selective serotonin reuptake inhibitor indicated for major depressive disorder is co-prescribed with an immunomodulatory agent notable for its revitalized use in treating hematological malignancies and notorious teratogenicity, which medication is implicated as potentially inducing metabolic encephalopathy when interacting with the other?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 772, "completion_tokens": 74, "total_tokens": 846, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddce38881908742047bdb07006d", "custom_id": "Norfloxacin-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "022f9df12e6a957e0c53d759f940c8cf", "body": {"id": "chatcmpl-BNLQHEbt0yqsSUI2ifakiNCMGx6i9", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, the fluoroquinolone antibiotic used for urinary and gynecological infections and associated with rare but serious tendon problems, is reported to cause folate deficiency when interacting with the nonbenzodiazepine hypnotic agent prescribed for insomnia?\n\nAnswer: Norfloxacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 668, "completion_tokens": 57, "total_tokens": 725, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddcf6b08190be9ac784e9233688", "custom_id": "Naproxen-Furosemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "035ef2fbf23394575a9f0e9dd9d44e3d", "body": {"id": "chatcmpl-BNLQI3c7c0Wi8y719sKALWSERgAU0", "object": "chat.completion", "created": 1744903594, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, used to manage edema by enhancing natriuresis and diuresis, is reported to interact with a nonsteroidal anti-inflammatory medication commonly prescribed for pain and inflammatory disorders, in the context of managing adenomyosis?\n\nAnswer: Furosemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 751, "completion_tokens": 57, "total_tokens": 808, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddd09a8819095b449f3d5af4aba", "custom_id": "Fentanyl-Labetalol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "59a0c7c2accffa101a84d6748a54aa71", "body": {"id": "chatcmpl-BNLQJt83dsAvJ7F6Dvd3FiiTyPbxC", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its exceptional potency in managing severe pain through \u03bc-opioid receptor activation, is more likely to be administered to a patient suffering from a back injury when compared to another drug primarily used for blood pressure control and adrenergic blockade?\n\nAnswer: Fentanyl", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 59, "total_tokens": 750, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011ddd1d648190a1a7b9a68bbe5a0c", "custom_id": "Temazepam-Cinacalcet-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ad2080b13a99a6c52f58521871c37f7b", "body": {"id": "chatcmpl-BNLQLYTKOObHrRVyYzwtmzRvyjv2v", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly prescribed for severe insomnia and acting as a positive allosteric modulator of the GABA-A receptor, can cause constipation when used in combination with a calcimimetic agent that activates calcium-sensing receptors?\n\nAnswer: Temazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 650, "completion_tokens": 54, "total_tokens": 704, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddd32f08190893b5a3874214694", "custom_id": "Ranitidine-Dobutamine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5d024660c070c8c3affefd14b43119d2", "body": {"id": "chatcmpl-BNLPwdSRuJ67wRisdCNs69ptTHDbM", "object": "chat.completion", "created": 1744903572, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nAmong a histamine H2 antagonist with historical use in acid-related disorders but withdrawn due to carcinogenic concerns, and a \u03b21-adrenergic agonist used intravenously to boost cardiac contractility during heart failure or shock, which drug is implicated in the occurrence of apoplexy when considered in interaction with the other?\n\nAnswer: Ranitidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 684, "completion_tokens": 73, "total_tokens": 757, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddd4800819081c849e777870ad1", "custom_id": "Ofloxacin-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c84e8a3933711634944233081f6bd4a4", "body": {"id": "chatcmpl-BNLPyjLHfok1D9fIloiTfWqMZyF4X", "object": "chat.completion", "created": 1744903574, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient undergoing treatment for chronic myelogenous leukemia and gastrointestinal stromal tumors with an ATP-competitive small molecule tyrosine kinase inhibitor begins to experience unexplained weight gain when co-administered with a DNA synthesis inhibitor primarily used for bacterial infections such as pneumonia and urinary tract infections. Based on their described interaction, which medication is most likely associated with the observed weight gain?\n\nAnswer: Imatinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 699, "completion_tokens": 83, "total_tokens": 782, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddd5ed881908ff25694d98818ee", "custom_id": "alendronic acid-Sumatriptan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0231031e475a6b147a807a2feb05b213", "body": {"id": "chatcmpl-BNLQ3YShCZPth07kvlw5UvmavTTzx", "object": "chat.completion", "created": 1744903579, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its role as a bisphosphonate in osteoporosis treatment, is associated with the risk of developing cholecystitis when used concomitantly with the triptan-class antimigraine agent that targets serotonin receptors?\n\nAnswer: alendronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 648, "completion_tokens": 57, "total_tokens": 705, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddd729c8190b7ebecc7a384d56b", "custom_id": "alendronic acid-Ibuprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "de7f863e4f10c0dbf133ec8ebc5861d1", "body": {"id": "chatcmpl-BNLQ5QE7NVxqCjqD7VDiJ6de03F5n", "object": "chat.completion", "created": 1744903581, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly used to reduce inflammation and pain by inhibiting cyclooxygenase activity, may increase the risk of gastric inflammation when used in combination with a bisphosphonate therapy prescribed for osteoporosis and Paget's disease of bone?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 653, "completion_tokens": 55, "total_tokens": 708, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddd859481908f165dabcdc6f077", "custom_id": "Naproxen-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "202fe18c386f83f6d9da06e96577c1a5", "body": {"id": "chatcmpl-BNLQ6eItUP5WpNw68BWBgqHWk5qLo", "object": "chat.completion", "created": 1744903582, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly used to manage pain and inflammation or to alleviate symptoms of rheumatic diseases, has the potential to cause gastric inflammation when administered concurrently with a drug that acts as an alpha-1 adrenergic blocker for hypertension and benign prostatic hyperplasia?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 667, "completion_tokens": 60, "total_tokens": 727, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddd99a481909f9b5f02b0ac946b", "custom_id": "Furosemide-Oxaprozin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "863b853438bac4f4ef0194e37de3520e", "body": {"id": "chatcmpl-BNLQ7xokZHC22y1ZlNWDfL3RrjvDM", "object": "chat.completion", "created": 1744903583, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a potent loop diuretic used to manage edema and hypertension is co-administered with a propionic acid derivative nonsteroidal anti-inflammatory drug indicated for arthritis, which medication in this combination is most likely to cause gastric inflammation through their interaction?\n\nAnswer: Oxaprozin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 601, "completion_tokens": 59, "total_tokens": 660, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dddac18819091efff2f60ca3713", "custom_id": "Naproxen-Amoxapine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fa118dc6f3b08fc4e9e43d74bb782eea", "body": {"id": "chatcmpl-BNLQ8cZGybSTzkg4XyJ6ujIyC0htZ", "object": "chat.completion", "created": 1744903584, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of pharmacological interactions, which drug\u2014used for inflammatory diseases by inhibiting cyclooxygenase enzymes\u2014has been associated with affecting a condition involving increased intraocular pressure when administered concurrently with a tricyclic antidepressant approved in the 1980s?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 578, "completion_tokens": 62, "total_tokens": 640, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dddbfcc8190969f8b28b5143a73", "custom_id": "Etiracetam-Ziprasidone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "86ce2ccf34c8d9389913b483d4da219f", "body": {"id": "chatcmpl-BNLQAAStR9txwXMQXtP1F0NJS5n7K", "object": "chat.completion", "created": 1744903586, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly prescribed to manage schizophrenia and bipolar disorder and known for affecting serotonergic and dopaminergic neurotransmitter pathways, has been shown to have an abnormal electroencephalogram (EEG) interaction with a racetam-family compound that served as the basis for a major antiepileptic medication?\n\nAnswer: Ziprasidone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 544, "completion_tokens": 70, "total_tokens": 614, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dddd2908190b0a90ad0b0ac107f", "custom_id": "Celecoxib-Chloroquine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "aac9eb53cbc1cbd4a815f59895d3dbac", "body": {"id": "chatcmpl-BNLQB7p55xqjewi5iyIXpQwahqQXn", "object": "chat.completion", "created": 1744903587, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA selective cyclooxygenase-2 inhibitor used for pain and inflammation may precipitate angiitis when combined with a 4-aminoquinoline antimalarial known for disrupting Plasmodium intraerythrocytic stages; which agent in this scenario is the one causing the angiitis?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 764, "completion_tokens": 68, "total_tokens": 832, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddde4a08190bbea71fee17f336d", "custom_id": "Ranitidine-Rosiglitazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f13eeeb2582109b963dfa630e342ffb0", "body": {"id": "chatcmpl-BNLQC8RbhAerELYg5K1sOHsykD9j1", "object": "chat.completion", "created": 1744903588, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich of the two drugs, one acting as an H2 receptor antagonist withdrawn for carcinogenic concerns and the other a PPAR\u03b3 agonist implicated in myocardial infarction risk, is associated with provoking cholecystitis when used concurrently with the other?\n\nAnswer: Ranitidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 704, "completion_tokens": 59, "total_tokens": 763, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dddfd548190965da9eb56d03a71", "custom_id": "acetazolamide-Famotidine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bf95ad245f66432c8e6b5bc317462b13", "body": {"id": "chatcmpl-BNLQEcdeRWKkwNl6faOOKkuxVI0QP", "object": "chat.completion", "created": 1744903590, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient co-administered a carbonic anhydrase inhibitor commonly prescribed for glaucoma, altitude sickness, and epilepsy, and a histamine H2 receptor antagonist used to reduce stomach acid, which drug is linked to causing back ache when used in combination, according to known drug-drug interaction profiles?\n\nAnswer: Famotidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 640, "completion_tokens": 69, "total_tokens": 709, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dde10448190b966c490afed7c33", "custom_id": "Ketorolac-Ticlopidine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "13a223b33762bd23818bf4e04baddfee", "body": {"id": "chatcmpl-BNLQFI4XS078dAxupX5ycRSy8Ni24", "object": "chat.completion", "created": 1744903591, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its potent inhibition of prostaglandin synthesis and use in short-term management of moderate to severe nociceptive pain, is associated with an increased risk of apoplexy when administered concomitantly with an antiplatelet agent that inhibits the ADP receptor to prevent thrombotic strokes?\n\nAnswer: Ketorolac", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 706, "completion_tokens": 72, "total_tokens": 778, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dde21c88190a75788549e4ede0b", "custom_id": "Famotidine-Fosphenytoin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f0fec2fc0c8ec2138ff4a1533b70aff2", "body": {"id": "chatcmpl-BNLQHfkBfCt7kRM3zy7rq1gEhtKCb", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a histamine H2 receptor antagonist used to decrease stomach acid production is combined with a water-soluble prodrug administered for acute convulsive status epilepticus, which of these two drugs is more likely to be associated with erythema in this interaction?\n\nAnswer: Fosphenytoin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 504, "completion_tokens": 62, "total_tokens": 566, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dde31988190946b7c2d4cf90165", "custom_id": "Ranitidine-Sibutramine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4ad5dd66911db4a89268e34904678068", "body": {"id": "chatcmpl-BNLQIGJqL5hETVTXTTecRfRm4GSBf", "object": "chat.completion", "created": 1744903594, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with an SNRI anti-obesity agent formerly withdrawn due to cardiovascular risk, is associated with increased gastric inflammation, potentially complicating management of acid-related gastrointestinal conditions?\n\nAnswer: Ranitidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 696, "completion_tokens": 48, "total_tokens": 744, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dde428c8190a74a12917eb68e5f", "custom_id": "Furosemide-Salmeterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "13fe1127c58d2e98fdaaa226ff4bd064", "body": {"id": "chatcmpl-BNLQJqaQRFGJkQiPETPmuRsPwWSkn", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA diuretic that acts by inhibiting the Na-K-2Cl symporter in the loop of Henle and is used to manage edema and hypertension is distinguished from a long-acting \u03b22 adrenergic agonist intended for asthma and COPD; according to their known drug-drug interaction, which of these two agents is indicated in clinical scenarios involving right heart failure?\n\nAnswer: Furosemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 669, "completion_tokens": 84, "total_tokens": 753, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dde55cc819091e576edb46e59d2", "custom_id": "Metronidazole-Pimecrolimus-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5a996e349f5f730859177aa966d22076", "body": {"id": "chatcmpl-BNLQKCnQjy9muyAt5sWKZT4NbNxea", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient receiving a nitroimidazole antimicrobial agent that is often administered for anaerobic infections and a topical calcineurin inhibitor for eczema develops adenopathy as a potential adverse effect stemming from a drug-drug interaction. Which drug is more likely to be associated with the causation of this lymph node enlargement in this context?\n\nAnswer: Metronidazole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 532, "completion_tokens": 73, "total_tokens": 605, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dde68948190891e7646cb149652", "custom_id": "Rofecoxib-Triazolam-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9e6a13ce8381c7a1978406c2c7b7ee7a", "body": {"id": "chatcmpl-BNLQMSaYqXIENpWI6I2D0DWnzv2zw", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered with a central nervous system depressant triazolobenzodiazepine used for severe insomnia, has been associated with the risk of developing cholecystitis as an adverse interaction?\n\nAnswer: Rofecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 644, "completion_tokens": 53, "total_tokens": 697, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dde7e98819087f503657e1342a3", "custom_id": "acetazolamide-Diazepam-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a827af7286a916ce0f1d08ca89786ec5", "body": {"id": "chatcmpl-BNLQNU2blV93pIh4nBPWLNRJhK71z", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, characterized as a benzodiazepine and primarily prescribed for anxiety and seizure management, may have its pain-alleviating effects influenced through interaction with a carbonic anhydrase inhibitor that is commonly used for glaucoma and altitude sickness?\n\nAnswer: Diazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 777, "completion_tokens": 55, "total_tokens": 832, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dde913081909541bfba7cb2f8b0", "custom_id": "Methylphenidate-Sorafenib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1c987d14394907608863e24c078cac83", "body": {"id": "chatcmpl-BNLQOB3guniWAyROk94ljvokw7hrx", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient diagnosed with hepatocellular carcinoma currently managed by a kinase inhibitor indicated for certain advanced cancers experiences apoplexy, which concurrent prescription drug\u2014classified as a central nervous system stimulant primarily used in ADHD and narcolepsy\u2014could be implicated in the interaction?\n\nAnswer: Methylphenidate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 535, "completion_tokens": 63, "total_tokens": 598, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddea5b8819098cef1999da88765", "custom_id": "Citalopram-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "69a8bf4b3d2cf287cb98cd090e72fbd9", "body": {"id": "chatcmpl-BNLQQmTIFXcqbhW4Y9oKlzAdjTWnG", "object": "chat.completion", "created": 1744903602, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when considered in an interaction where adenopathy (lymph node enlargement) is a reported association between a chiral bicyclic phthalane derivative SSRI used for major depressive disorder and a nonbenzodiazepine Z-drug sleep aid acting as a GABAA receptor modulator, serves as the agent primarily prescribed for the short-term management of insomnia?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 803, "completion_tokens": 83, "total_tokens": 886, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddeb9dc81908f24c6ad370554f8", "custom_id": "Efavirenz-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b3265edfd2be314eafac41ab5942f04a", "body": {"id": "chatcmpl-BNLQRi1Vg6C50eNa6sMtTvx9m6Dfi", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its allosteric inhibition of HIV-1 reverse transcriptase and use in antiretroviral therapy, is associated with an interaction that can lead to elevated cholesterol levels when administered with an agent used for hypertension and heart failure through ACE inhibition?\n\nAnswer: Efavirenz", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 669, "completion_tokens": 61, "total_tokens": 730, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011ddecab481909fa729b583487a30", "custom_id": "indometacin-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a68d496e88ef135696be8ffc8ae3e73b", "body": {"id": "chatcmpl-BNLQSNXwtVpT6m0lcfiyge5v2tEDs", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, either a nonsteroidal anti-inflammatory used for pain and inflammation or an anticholinergic agent indicated for overactive bladder, is the agent that induces apoplexy in the other according to their documented interaction?\n\nAnswer: indometacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 54, "total_tokens": 696, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011ddedda88190ad8b218471b7de16", "custom_id": "Celecoxib-Palonosetron-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2fe005fcd95dba83d96cd5d265ab7c5c", "body": {"id": "chatcmpl-BNLQToDScDgnEbfgUZcuoKoojN9PU", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when combined with a 5-HT3 antagonist used for chemotherapy-induced nausea and vomiting, has been associated with an increased risk of cellulitis, despite its primary indication as a selective COX-2 inhibitor for inflammation and pain management?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 673, "completion_tokens": 58, "total_tokens": 731, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddeede48190a7530f1c728d3363", "custom_id": "Carvedilol-Ibuprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c246a505bfaf35909960afed796698e1", "body": {"id": "chatcmpl-BNLQVXNks2YYj1D6VnVM4b0Da0qLZ", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, utilized for conditions such as dysmenorrhea and inflammatory arthropathies by targeting prostaglandin synthesis, has been associated with a risk of cholecystitis when interacting with a nonselective beta-blocker also exhibiting alpha-1 antagonism?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 696, "completion_tokens": 62, "total_tokens": 758, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011ddefec08190bbc21a2c1850bddf", "custom_id": "Candesartan-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "da3672d3bc9f83a86f764ab5992c145f", "body": {"id": "chatcmpl-BNLQW0vubemRcVPIYrzghlp1Kj1eQ", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for being metabolized as a cascading prodrug with high potency in AT-1 receptor antagonism, is associated with weight gain when used alongside a long-acting ACE inhibitor that increases sodium excretion and plasma renin activity?\n\nAnswer: Candesartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 551, "completion_tokens": 57, "total_tokens": 608, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddf10c88190beb554db7a845739", "custom_id": "Methylphenidate-Ofloxacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a30e5a8c82480fd58713369dd274fc0a", "body": {"id": "chatcmpl-BNLPz53ILmollrBgwlz1GGH7Ex5gh", "object": "chat.completion", "created": 1744903575, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient concurrently receiving a DNA synthesis inhibitor from the fluoroquinolone class, which is notable for side effects such as tendinopathy and CNS disturbances, which co-administered medication\u2014known for augmenting synaptic monoamines and widely prescribed for ADHD\u2014would have its toxicity classified as \u201cnot otherwise specified\u201d due to this interaction?\n\nAnswer: Methylphenidate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 676, "completion_tokens": 79, "total_tokens": 755, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddf24f08190b45e2334193e8136", "custom_id": "Rofecoxib-Etiracetam-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fe74b19ee3cde594eac20f31c0c9294d", "body": {"id": "chatcmpl-BNLQ1g2unZEUIFQG0BDzuhnvYld0t", "object": "chat.completion", "created": 1744903577, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with a racemic nootropic compound whose active enantiomer is used to treat epilepsy, is associated with an increased risk of exertional dyspnea\u2014a side effect relevant to its profile as a COX-2 selective inhibitor with known cardiovascular complications?\n\nAnswer: Rofecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 520, "completion_tokens": 68, "total_tokens": 588, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddf386081909bbfde18d48499a2", "custom_id": "Lidocaine-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "733a15bea4e9e0e75547b505d1851404", "body": {"id": "chatcmpl-BNLQ33oNa0PhfCOu8sbb6O0gVMuKh", "object": "chat.completion", "created": 1744903579, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its disruption of microtubule assembly to arrest metaphase in cancer cells and associated with profound neurotoxicity and risk of fatality upon improper administration, may have its risk of liver enlargement increased when used concurrently with a medication that blocks voltage-gated sodium channels for cardiac arrhythmia and local anesthesia?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 755, "completion_tokens": 74, "total_tokens": 829, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddf4b44819087410d2f92b35f8d", "custom_id": "Minoxidil-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "eb3a785f11c620602af6cf1052f235f4", "body": {"id": "chatcmpl-BNLQ57UlYK0FfC7dv0xdrzp95ggr3", "object": "chat.completion", "created": 1744903581, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, an ACE inhibitor that lowers blood pressure by suppressing aldosterone biosynthesis and promoting sodium excretion after hepatic activation, has been associated with thrombocytopenia when used alongside a vasodilator commonly prescribed for both hypertension and hair loss?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 515, "completion_tokens": 59, "total_tokens": 574, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddf5d98819086fcb6adc97e50b5", "custom_id": "Amlodipine-Pyridostigmine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0041470bc655ecfe4233ac8ba15eb2c1", "body": {"id": "chatcmpl-BNLQ6NebNm8Lbbtk18priz3SNGXBC", "object": "chat.completion", "created": 1744903582, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich of the following drugs, one being a dihydropyridine calcium channel blocker mainly used for hypertension and angina, and the other an acetylcholinesterase inhibitor primarily treating myasthenia gravis and neurogenic bladder, is documented to have an interaction with the other that involves causing a loss of weight?\n\nAnswer: Amlodipine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 652, "completion_tokens": 75, "total_tokens": 727, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddf6f448190aab9ff552790ade1", "custom_id": "Cetirizine-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d997a29377dd9fc67a4d1181c3391a84", "body": {"id": "chatcmpl-BNLQ0TUApNLgG2weeGBCm8DUh4fpa", "object": "chat.completion", "created": 1744903576, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when taken concomitantly with a second-generation peripheral H1 antihistamine used for allergic rhinitis and urticaria, has the potential to cause a sinus headache as part of their drug-drug interaction profile?\n\nAnswer: Imatinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 753, "completion_tokens": 54, "total_tokens": 807, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddf81cc8190a0ecbd8d6c0ba5d7", "custom_id": "alendronic acid-Indapamide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "482f1c0ba08d0bffc42e6c6a7d616da9", "body": {"id": "chatcmpl-BNLQ8T8LZOuqzQCthUd7TpowiCM7W", "object": "chat.completion", "created": 1744903584, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly used to treat osteoporosis and Paget's disease by decreasing the activity of bone-resorbing cells, is associated with an increased risk of rectal hemorrhage when taken together with a thiazide-like sulfonamide diuretic primarily used for hypertension and heart failure?\n\nAnswer: alendronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 638, "completion_tokens": 67, "total_tokens": 705, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddf95f48190a2b9f75ae56d5104", "custom_id": "Methylphenidate-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b23a8902635f3427d521cbcd6c4be855", "body": {"id": "chatcmpl-BNLQ9snjohAufdjYhoxFdiE55oxVj", "object": "chat.completion", "created": 1744903585, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its use in treating symptoms of an enlarged prostate and high blood pressure by acting as an alpha-1 blocker, could theoretically counteract the sympathomimetic cardiovascular effects (such as tachycardia) of a central nervous system stimulant associated with executive function enhancement, potentially reducing the stimulant-induced risk of angina if both drugs are used together?\n\nAnswer: Terazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 645, "completion_tokens": 82, "total_tokens": 727, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddfa8a8819099e57531bfe423f4", "custom_id": "mitomycin C-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "08a3a32e70574469f3e5d6c3f14604e2", "body": {"id": "chatcmpl-BNLQ1R5UX9XFIcIPFcVvG0y4oYDfa", "object": "chat.completion", "created": 1744903577, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the chemotherapeutic agent known for its antitumor activity and the vinca alkaloid that inhibits mitosis through microtubule disruption, which drug is associated with the onset of myelodysplasia when given in combination with the other?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 491, "completion_tokens": 59, "total_tokens": 550, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddfba3c8190bf718174a8cb3697", "custom_id": "Diazepam-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ea90e5261692e27d186063616953bca7", "body": {"id": "chatcmpl-BNLQAfcz9EdNynay5cu2ek6Jw1kUD", "object": "chat.completion", "created": 1744903586, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its anxiolytic effects via potentiation of GABAergic neurotransmission and risk of CNS depression, may experience micturition urgency when administered concurrently with an ACE inhibitor that is a prodrug requiring hepatic activation for antihypertensive effects?\n\nAnswer: Diazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 767, "completion_tokens": 61, "total_tokens": 828, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ddfcbe08190a7e08a841d8e3e3a", "custom_id": "Cetirizine-Pyridostigmine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2ffa36e60e4cfd7ff2244cb6e06a9b68", "body": {"id": "chatcmpl-BNLQCVgFv07usa07fsa30fbdDRnez", "object": "chat.completion", "created": 1744903588, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nGiven two medications, one being a peripheral-selective second-generation antihistamine used extensively for allergic conditions with minimal central nervous system effects, and the other a quaternary acetylcholinesterase inhibitor integral to myasthenia gravis management by increasing synaptic acetylcholine, which of these drugs is the \"object\" in a knowledge-graph relationship where the \"subject\" drug is associated with causing a bleeding interaction with it?\n\nAnswer: Pyridostigmine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 743, "completion_tokens": 98, "total_tokens": 841, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ddfdd5c8190bc0a3828a92f32bc", "custom_id": "Methylphenidate-Ziprasidone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ae36d1d32e314e5c77bdd13957c01806", "body": {"id": "chatcmpl-BNLQ2zeg4VKKvBVnYPbVZMU5o1NIx", "object": "chat.completion", "created": 1744903578, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly utilized for the management of schizophrenia and bipolar disorder and associated with a lower risk of weight gain among atypical antipsychotics, has been implicated in an increased risk of cholecystitis when co-administered with a central nervous system stimulant often prescribed for ADHD and narcolepsy?\n\nAnswer: Ziprasidone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 730, "completion_tokens": 72, "total_tokens": 802, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ddfef7081908f92cbe66359b1d6", "custom_id": "Celecoxib-chlortalidone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0f1efd438ad2062337435442f86d204a", "body": {"id": "chatcmpl-BNLQD56Tff9Jr7mk8DHcTe5YHPu9H", "object": "chat.completion", "created": 1744903589, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a selective COX-2 inhibiting NSAID with reduced gastrointestinal adverse effects and potential thrombotic risk is administered alongside a thiazide-like diuretic used for long-acting antihypertensive control, which agent, based on their drug-drug interaction, could exacerbate the risk of apoplexy (stroke) when co-administered with the other?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 791, "completion_tokens": 88, "total_tokens": 879, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de001fc8190b49a08771eca4303", "custom_id": "Aciclovir-Ganciclovir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "99ef26d71294c7ac476a88b205b71f95", "body": {"id": "chatcmpl-BNLQ3kZ76apZORWljBKqtmxHmRDr2", "object": "chat.completion", "created": 1744903579, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich antiviral agent, commonly employed for CMV prophylaxis post-transplantation by inhibiting viral DNA polymerase, could be implicated in the development of right heart failure when co-administered with another antiviral drug patented in 1980 for CMV treatment?\n\nAnswer: Aciclovir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 464, "completion_tokens": 61, "total_tokens": 525, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de013308190b22e1147a976fb29", "custom_id": "Ketoprofen-Lamivudine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "df0681c4faf8639896703ca14a139a11", "body": {"id": "chatcmpl-BNLQF7UZc8AZecKcbc3lHFaPzLSgl", "object": "chat.completion", "created": 1744903591, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, one acting as a nonsteroidal anti-inflammatory agent inhibiting prostaglandin production, is associated with causing sleep disturbances when used concurrently with a nucleoside reverse transcriptase inhibitor effective against HIV and hepatitis B?\n\nAnswer: Ketoprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 532, "completion_tokens": 55, "total_tokens": 587, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de025d88190bfdd04286dc6d293", "custom_id": "Risedronic acid-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "20e941c18bea8d79328a05ce3502e15c", "body": {"id": "chatcmpl-BNLQ5xtQr2M36WzOq7hVOQ8nk95Z8", "object": "chat.completion", "created": 1744903581, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly prescribed for the short-term treatment of insomnia via modulation of GABAA receptors and known for neuropsychiatric side effects, is associated with the development of erythema when used in combination with a bisphosphonate used to treat osteoporosis and Paget's disease?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 610, "completion_tokens": 67, "total_tokens": 677, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de0360481908a1368c0f3bff8c2", "custom_id": "Famotidine-Pirbuterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "acf0960d1bd513acee60f58e1f484418", "body": {"id": "chatcmpl-BNLQG0sb6KEOn2xtLmfgJwjXggRj3", "object": "chat.completion", "created": 1744903592, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when used in combination with a short-acting \u03b22 adrenoreceptor agonist administered via a breath-activated inhaler for asthma, is associated with an elevated cholesterol interaction risk?\n\nAnswer: Famotidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 480, "completion_tokens": 48, "total_tokens": 528, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de048408190961382925312d3f6", "custom_id": "Duloxetine-Acamprosate-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a1ae4eb3ea32b2f5cf983795c68620b0", "body": {"id": "chatcmpl-BNLQ6Rll5mPFKcjYtcgLA0stRnWrN", "object": "chat.completion", "created": 1744903582, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly prescribed for managing symptoms of major depressive disorder and neuropathic pain by inhibiting the reuptake of both serotonin and norepinephrine, is more likely to contribute to nausea when used together with a compound that helps mitigate alcohol withdrawal symptoms?\n\nAnswer: Duloxetine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 649, "completion_tokens": 59, "total_tokens": 708, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de05b0c8190a614d7d2d07eee5e", "custom_id": "Temazepam-Megestrol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b3144dd3ec406f7f3cb1e036a0caa5cb", "body": {"id": "chatcmpl-BNLQHQXIYHAp5k778IURg1QK7nRp1", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known as a benzodiazepine hypnotic primarily prescribed for severe insomnia and acting via GABA-A receptor allosteric modulation, is linked through cholecystitis as an interaction to a progestin of the 17\u03b1-hydroxyprogesterone group used for disease-related weight loss and hormone-sensitive cancers?\n\nAnswer: Temazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 592, "completion_tokens": 76, "total_tokens": 668, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de06f548190b17d372198966152", "custom_id": "Candesartan-Duloxetine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "94f9f61da2e783d6733f56e76dc8ddaf", "body": {"id": "chatcmpl-BNLQ7XbBMk1AaTRmhI1FJKA6mXSwc", "object": "chat.completion", "created": 1744903583, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its potent AT-1 receptor antagonism and prodrug metabolism, may lead to gastric inflammation when interacting with an agent commonly used for major depressive disorder and generalized anxiety disorder?\n\nAnswer: Candesartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 576, "completion_tokens": 47, "total_tokens": 623, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de081c88190ba97d3f884350f5a", "custom_id": "Sildenafil-Zaleplon-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c3dd1a0ccde947f3f8fda4a9cb5ee518", "body": {"id": "chatcmpl-BNLQJ1vSkY5cuUomsYO065qdMpGE3", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, one acting as a phosphodiesterase type 5 inhibitor for pulmonary arterial hypertension and erectile dysfunction, or the other as a nonbenzodiazepine hypnotic for insomnia, could interact with the other to increase the risk of apoplexy when used concomitantly?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 548, "completion_tokens": 63, "total_tokens": 611, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de0981c81909b73d9388c078996", "custom_id": "Risedronic acid-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d73144e6c3cb8c0e51c42b58ebf86e28", "body": {"id": "chatcmpl-BNLQ9IUhHRMiTN5QacLEhUiQ0Vo4m", "object": "chat.completion", "created": 1744903585, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a bisphosphonate prescribed for osteoporosis is co-administered with an ATP-competitive small molecule inhibitor pivotal for treating chronic leukemias, which agent is associated with an increased risk of sinus headache when both are part of a drug-drug interaction?\n\nAnswer: Imatinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 578, "completion_tokens": 63, "total_tokens": 641, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de0acd48190a4a115e9de97d7b5", "custom_id": "Furosemide-Telithromycin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2108d9c478e3671a9b62a2cc4af911d0", "body": {"id": "chatcmpl-BNLQKvqh6GiIS8foL6pMBx9Lzh6V2", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient taking a potent loop diuretic known for causing electrolyte imbalances, who begins therapy with a semi-synthetic ketolide antibiotic approved primarily for mild to moderate community-acquired pneumonia, develops rectal hemorrhage. Based on the interaction between these two drugs, which medication is most likely associated with this adverse event?\n\nAnswer: Telithromycin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 663, "completion_tokens": 73, "total_tokens": 736, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de0c3508190a7e2aec3811be4f4", "custom_id": "Citalopram-nevirapine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a2dd68a525e85fa201da5e0e34c1b04d", "body": {"id": "chatcmpl-BNLQAsZOmq6JbJwexxrvr5aydoRDi", "object": "chat.completion", "created": 1744903586, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when used in combination with a chiral bicyclic SSRI primarily employed for depressive and anxiety disorders, has been associated with causing loss of weight?\n\nAnswer: nevirapine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 702, "completion_tokens": 41, "total_tokens": 743, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de0d55c8190adb212fec84cc10a", "custom_id": "Bumetanide-Fenofibrate-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "202acc8131431efc3b777905396900ca", "body": {"id": "chatcmpl-BNLQLza7uX06JsemYS75Itik8CsQM", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a patient treated for edema due to congestive heart failure is concurrently administered a lipid-modifying agent that acts via PPAR\u03b1 agonism, which therapy is implicated in increasing the risk of hepatic neoplasia according to known drug-drug interaction data?\n\nAnswer: Fenofibrate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 732, "completion_tokens": 62, "total_tokens": 794, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de0e7348190bc869837ba326ef7", "custom_id": "folinic acid-Thalidomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b7977d37dc8a0339fc361eb982c3428d", "body": {"id": "chatcmpl-BNLQBJ7rfBoM5uBAy5SYIO59yc3Yr", "object": "chat.completion", "created": 1744903587, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to reduce the toxic effects of methotrexate and often given in combination with fluorouracil for colorectal cancer, has been reported to cause skin eruptions when coadministered with an orally administered immunomodulatory drug that historically caused catastrophic fetal birth defects?\n\nAnswer: folinic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 65, "total_tokens": 752, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de0fa988190a4aaeea1a13d2438", "custom_id": "Diazepam-Ibuprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7980540d4419e6d62094894e16a0a24d", "body": {"id": "chatcmpl-BNLQNCIeqpotkW8fPBLwsZetCwwdF", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for potentiating GABAergic neurotransmission as an anxiolytic and used for conditions such as status epilepticus and alcohol withdrawal, may be affected by increased gastric inflammation when co-administered with a nonsteroidal anti-inflammatory drug that inhibits prostaglandin synthesis?\n\nAnswer: Diazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 789, "completion_tokens": 67, "total_tokens": 856, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de10c288190bd84d4911c39a4b3", "custom_id": "Naproxen-Palonosetron-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "42ef6ed5019ac4f05f4d8799db0dcd9b", "body": {"id": "chatcmpl-BNLQC7xmM2relcceo9Gu1x3cL4n6M", "object": "chat.completion", "created": 1744903588, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly prescribed for relieving pain and inflammation through cyclooxygenase inhibition and known for potential gastrointestinal and cardiovascular side effects, is associated in clinical knowledge graphs with adenopathy when used concurrently with a selective 5-HT3 antagonist employed for chemotherapy-induced nausea and vomiting?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 653, "completion_tokens": 63, "total_tokens": 716, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de121dc8190990b441dd065496d", "custom_id": "Alprazolam-Formoterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "16ff33add0a84f29a0c081ea5ba5824e", "body": {"id": "chatcmpl-BNLQOFncmo3a3jIm627CgqLngDJaO", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its selective bronchodilatory action via \u03b22-adrenergic receptor agonism and used in chronic respiratory disease management, is associated with inducing weight loss when taken in combination with a benzodiazepine anxiolytic that modulates the GABA_A receptor?\n\nAnswer: Formoterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 700, "completion_tokens": 66, "total_tokens": 766, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de136f081909ecfe6c143011eb7", "custom_id": "Fentanyl-Trimethoprim-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7e1746c2c685c068fac6c6d06b805a19", "body": {"id": "chatcmpl-BNLQDwLcG2ykn8Xf3d4D1gMYKiUb6", "object": "chat.completion", "created": 1744903589, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for blocking bacterial folate metabolism to treat conditions such as bladder and ear infections, has been reported to cause articulation difficulties (dysarthria) when taken in conjunction with the highly potent opioid agonist used for severe pain management?\n\nAnswer: Trimethoprim", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 59, "total_tokens": 746, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de14dac8190886ba2a83bfb2ef6", "custom_id": "Citalopram-Midodrine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8f76146ebab5f56eca46c6770d60385d", "body": {"id": "chatcmpl-BNLQP3SgsLMSrTP3Qt00neDx4getE", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, widely used to manage orthostatic hypotension through \u03b11-adrenergic receptor agonism but capable of causing side effects such as hypertension and urinary retention, may increase the risk of haematoma when co-administered with a selective serotonin reuptake inhibitor metabolized hepatically and known for potential serotonergic and cardiac adverse effects?\n\nAnswer: Midodrine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 672, "completion_tokens": 79, "total_tokens": 751, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de15f908190a84a3a07be2043f5", "custom_id": "Duloxetine-solifenacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2c7fdfff588d1200ba33aa7e1a28d85a", "body": {"id": "chatcmpl-BNLQFNTQFfOeeeo9JFyTb5y6ZHAC9", "object": "chat.completion", "created": 1744903591, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with an oral medication used to treat overactive bladder by decreasing bladder contractions, is associated with a loss of weight as a pharmacological interaction?\n\nAnswer: Duloxetine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 651, "completion_tokens": 43, "total_tokens": 694, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de171488190a5d9be2bfff6226d", "custom_id": "Rofecoxib-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ba24ed1e458bd5a8f42adb0f76d84eaa", "body": {"id": "chatcmpl-BNLQRPpGNZuSWWHcXPybxONOUG9An", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known as a tyrosine kinase inhibitor crucial for treating various leukemias and gastrointestinal tumors, may provoke an eruption when used concurrently with a COX-2-selective NSAID that was withdrawn due to cardiovascular risks but has orphan drug status for hemophilic arthropathy?\n\nAnswer: Imatinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 727, "completion_tokens": 67, "total_tokens": 794, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de183448190938fb35ba4f1a0db", "custom_id": "Diazepam-Ketoprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "58744f43752cbeffa8768fba8c899d5c", "body": {"id": "chatcmpl-BNLQGKZVBCba4O7hnsy7eSHneAQif", "object": "chat.completion", "created": 1744903592, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used concurrently with a propionic acid class NSAID that inhibits prostaglandin production and is indicated for analgesic and antipyretic purposes, may increase the risk of cholecystitis due to a drug-drug interaction?\n\nAnswer: Diazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 615, "completion_tokens": 59, "total_tokens": 674, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de197c48190a1adb9f765d9ad67", "custom_id": "Diazepam-Temozolomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "10374090d875c665fa7806fd2cf5a634", "body": {"id": "chatcmpl-BNLQSH8tjZnMUmJZS7HEcl8jqrdmC", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in patients already receiving a benzodiazepine anxiolytic that enhances GABA_A receptor activity and is associated with CNS and respiratory depression, may increase the risk of toxicity for the benzodiazepine through mechanisms related to myelosuppression or potential pharmacodynamic interactions?\n\nAnswer: Temozolomide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 760, "completion_tokens": 69, "total_tokens": 829, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de1ab208190a8f9db228ad993e4", "custom_id": "Naproxen-Pyridostigmine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "91dae7cdcaa0597fe86b16d64e9eef78", "body": {"id": "chatcmpl-BNLQH5BIDKSaWkRR0hI3gMLkWU7wW", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient taking a nonsteroidal anti-inflammatory drug that non-selectively inhibits COX enzymes to treat inflammatory conditions develops erythema after starting a quaternary ammonium acetylcholinesterase inhibitor used primarily in myasthenia gravis management; which of these two drugs is most likely associated with erythema due to their drug-drug interaction?\n\nAnswer: Pyridostigmine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 750, "completion_tokens": 83, "total_tokens": 833, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de1bebc81908e079dc1b0ce17b1", "custom_id": "Temozolomide-Trimethoprim-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "05d1ec9b97c741eb249f88db1cc5840b", "body": {"id": "chatcmpl-BNLQUsGAdPcY3h4IiQH0o2lEJDSR4", "object": "chat.completion", "created": 1744903606, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient undergoing treatment for high-grade gliomas with a cytotoxic alkylating agent known for causing myelosuppression and DNA methylation\u2014especially when combined with agents such as PARP inhibitors\u2014which drug's administration may result in an increased body temperature when co-administered with an antibiotic that blocks bacterial folate metabolism and is commonly used for bladder infections?\n\nAnswer: Temozolomide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 83, "total_tokens": 725, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de1cf708190af0de9cfc3addad6", "custom_id": "Oxaprozin-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d868e98da7759a178d6fec4a7dd535a3", "body": {"id": "chatcmpl-BNLQIKfYkbBhgCTYALIIlzlzwCxf8", "object": "chat.completion", "created": 1744903594, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with a phosphodiesterase type 5 inhibitor that potentiates nitric oxide-mediated vasodilation, may increase the risk of gastric inflammation due to its classification as a nonsteroidal anti-inflammatory agent used for arthritis management?\n\nAnswer: Oxaprozin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 584, "completion_tokens": 61, "total_tokens": 645, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de1e2bc81909ed03afa53dfe7a6", "custom_id": "Citalopram-Darunavir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3329f5c04a85221179035ec0b60281a8", "body": {"id": "chatcmpl-BNLQVPda0zaTqSQPm72kNJfu2wP1l", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient receiving a chiral bicyclic phthalane derivative that selectively inhibits the serotonin reuptake transporter for psychiatric indications develops allergic dermatitis when co-administered with an antiretroviral protease inhibitor commonly combined with pharmacokinetic enhancers for HIV therapy; which of these two agents is most likely to be primarily associated with the onset of allergic dermatitis in this interaction as described?\n\nAnswer: Darunavir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 715, "completion_tokens": 85, "total_tokens": 800, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de1f5ac819089b4e87441e8cda4", "custom_id": "Famotidine-melphalan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b099e45b9ef4f59796fda823d2a3a81d", "body": {"id": "chatcmpl-BNLQKnJaWU0uhKztYkpfL5sWhB3vi", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a chemotherapy agent that interferes with DNA and RNA synthesis, is associated with cholecystitis when used alongside a histamine H2 receptor antagonist that decreases stomach acid production?\n\nAnswer: melphalan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 588, "completion_tokens": 47, "total_tokens": 635, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de20bb08190b7974984c95e65b2", "custom_id": "Rofecoxib-Balsalazide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "da6c4694fc9cccf29da6db321dc0fc63", "body": {"id": "chatcmpl-BNLQXhlZQEB27arkubZ1A6t5LGUhy", "object": "chat.completion", "created": 1744903609, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, a COX-2-selective NSAID formerly used for pain and arthritic conditions but withdrawn from the market due to cardiovascular risk, is associated with an interaction relating to atelectasis when co-administered with an anti-inflammatory agent that delivers 5-ASA specifically to the large intestine for ulcerative colitis treatment?\n\nAnswer: Rofecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 78, "total_tokens": 720, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de220bc81909510bb9c05d457c2", "custom_id": "Tramadol-Almotriptan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d152631f587d60736f4edc7da59bcfcc", "body": {"id": "chatcmpl-BNLQLTuomzLoxFtPYAk5lu0smIg7C", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, characterized as a triptan agent for migraine headaches and developed by Almirall, is associated with weight loss as a drug-drug interaction when taken with an atypical analgesic combining opioid and monoaminergic mechanisms?\n\nAnswer: Almotriptan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 511, "completion_tokens": 55, "total_tokens": 566, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de2351c8190b8093d32fc3461f0", "custom_id": "Rofecoxib-Telmisartan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "61aefc2db1f31d4d2efdb7e7cb18896d", "body": {"id": "chatcmpl-BNLQYr75dVN5jgLYUxGDaHyFtGXVB", "object": "chat.completion", "created": 1744903610, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its angiotensin II receptor antagonism in blood pressure management, may have an increased risk of cholecystitis when co-administered with an NSAID previously withdrawn due to cardiovascular risks?\n\nAnswer: Telmisartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 651, "completion_tokens": 53, "total_tokens": 704, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de254808190b518e97eff2c1639", "custom_id": "Triazolam-Rosiglitazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c4970bfb3b405de1e94312a49a6f01e5", "body": {"id": "chatcmpl-BNLQMDKDv2YqWxOEpAam6tW5AZejL", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for enhancing insulin sensitivity as a PPAR\u03b3 agonist but with a contentious history due to cardiovascular risk concerns, has been found to potentially interact with a central nervous system depressant benzodiazepine derivative by increasing the risk of pneumonia when administered concurrently?\n\nAnswer: Rosiglitazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 617, "completion_tokens": 64, "total_tokens": 681, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de26898819093245a779e02fde5", "custom_id": "Naproxen-Dapsone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "67331e7d7e48743e550e99c28f2852b3", "body": {"id": "chatcmpl-BNLQNzB8Pgae6jQRWPfKUe8tTKWxc", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its antimicrobial action and use in leprosy, when co-administered with a nonsteroidal anti-inflammatory agent, has been associated with the increased risk of adenopathy as part of their interaction?\n\nAnswer: Dapsone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 768, "completion_tokens": 54, "total_tokens": 822, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de27b8481908960fdb780b27d41", "custom_id": "Metronidazole-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bf3f066a9452781179634091f3ca6548", "body": {"id": "chatcmpl-BNLQOcODAI4mcdV4DWgplSS62toTj", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with a broad-spectrum nitroimidazole antimicrobial known for treating anaerobic and protozoal infections, is associated with a risk of toxicity that warrants careful monitoring of adverse effects such as pronounced hypotension or severe side effects like priapism?\n\nAnswer: Terazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 64, "total_tokens": 706, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de295848190abfcf2955562a412", "custom_id": "Diazepam-Moexipril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f5eb5928622a5e371ed103c258500be0", "body": {"id": "chatcmpl-BNLQPINWQGR750qjvavNbNLwy1o7U", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when taken in combination with a medication that is a prototypical benzodiazepine anxiolytic acting primarily via potentiation of GABA_A receptor activity, has been associated with the development of insulin dependent diabetes mellitus as a drug-drug interaction?\n\nAnswer: Moexipril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 655, "completion_tokens": 62, "total_tokens": 717, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de2a90881908bc3e4d746c15165", "custom_id": "Methylphenidate-Megestrol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "367a8991b06c4ac288cbb8f830e0a49a", "body": {"id": "chatcmpl-BNLQRvN4FbXJvPw6l5yl6iQTBLAnJ", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for treating disease-related weight loss and certain cancers, may have its propensity to cause gastric inflammation increased when co-administered with a central nervous system stimulant used for ADHD and narcolepsy?\n\nAnswer: Megestrol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 585, "completion_tokens": 50, "total_tokens": 635, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de2bedc8190b79bad674946b473", "custom_id": "Citalopram-Gemfibrozil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "dd3b9f4605531f5c26551a1fbbb9676b", "body": {"id": "chatcmpl-BNLQSC8ObcmxJVPUl9nbEh9H6NzGA", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient receiving a chiral bicyclic phthalane derivative SSRI, primarily metabolized by hepatic CYP2C19, CYP3A4, and CYP2D6, and prescribed for psychiatric disorders such as major depressive disorder, develops metabolic encephalopathy following the addition of a fibrate medication used to treat abnormal blood lipid levels. Which medication is the SSRI implicated in this interaction?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 701, "completion_tokens": 88, "total_tokens": 789, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de2d05c819085dcbdb84ae506f7", "custom_id": "Lamotrigine-Oxaprozin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "436b576c104eea162ff5ff46d1affd23", "body": {"id": "chatcmpl-BNLQTHALkVEKTBOZhBO68kbXYuFFl", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, an NSAID propionic acid derivative indicated for osteoarthritis and rheumatoid arthritis, is known to cause bulging when co-administered with a phenyltriazine anticonvulsant used for epilepsy and bipolar disorder?\n\nAnswer: Oxaprozin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 558, "completion_tokens": 55, "total_tokens": 613, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de2e68c8190983b39e348d21ec4", "custom_id": "Citalopram-Palonosetron-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d29acebd498a3fdd94b2f850947a1cb5", "body": {"id": "chatcmpl-BNLQ1OVbgKeJDPyg6scKtaVcCVa72", "object": "chat.completion", "created": 1744903577, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical context where a selective serotonin reuptake inhibitor primarily used for mood disorders is co-administered with a 5-HT3 antagonist indicated for the prevention of chemotherapy-induced nausea and vomiting, which drug is associated as the subject in a knowledge-graph triple describing failure to thrive as an interaction outcome with the other?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 667, "completion_tokens": 75, "total_tokens": 742, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de2f9e081908515b74d79d05011", "custom_id": "Metronidazole-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a5df95c694798a53db8f38e30f205214", "body": {"id": "chatcmpl-BNLQ22l3RnLCtIdOzpk2ScVfGMRKw", "object": "chat.completion", "created": 1744903578, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its nonbenzodiazepine hypnotic action in the treatment of insomnia, may have its gastric tolerability affected due to the potential for gastric inflammation when administered concurrently with a nitroimidazole antimicrobial agent?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 766, "completion_tokens": 55, "total_tokens": 821, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de30e2c81909500a705b27dd6b2", "custom_id": "Tramadol-Telmisartan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "87f3017ccc6998a61ccdf86192d438e2", "body": {"id": "chatcmpl-BNLQ36Pc7nUuPwpfvdeyF3hOww5oy", "object": "chat.completion", "created": 1744903579, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in combination with an angiotensin II receptor antagonist for hypertension that reduces vasoconstriction and systemic vascular resistance, is implicated in the development or exacerbation of cholecystitis due to its opioid-like effects on gastrointestinal motility?\n\nAnswer: Tramadol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 645, "completion_tokens": 61, "total_tokens": 706, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de323588190ac739a4cce740cb0", "custom_id": "Cetirizine-Dipyridamole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bebed142750e5bbe259c12a475c2be82", "body": {"id": "chatcmpl-BNLQ4zKzPw26i8qeyJZHx35Oo43H3", "object": "chat.completion", "created": 1744903580, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly employed for allergic rhinitis and differentiated from first-generation H1 antihistamines by its reduced central nervous system penetration and lower sedative potential, is associated with an increased risk of apoplexy when co-administered with an antiplatelet agent that acts as a nucleoside transport and PDE3 inhibitor used to inhibit blood clot formation?\n\nAnswer: Cetirizine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 555, "completion_tokens": 82, "total_tokens": 637, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de33a948190b33db3c452975f29", "custom_id": "Methylphenidate-Trazodone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2ba1626bbda363eca6d5defd6aa7d0ee", "body": {"id": "chatcmpl-BNLQ6fom7fBeaf5AngU5wq9LIH1DA", "object": "chat.completion", "created": 1744903582, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient co-administered a medication that acts as a CNS stimulant for ADHD by inhibiting presynaptic dopamine and norepinephrine transporters, and another medication used to treat depression and insomnia as a serotonin antagonist and reuptake inhibitor (SARI), which drug is more likely to be associated with causing back ache when the two interact?\n\nAnswer: Trazodone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 640, "completion_tokens": 79, "total_tokens": 719, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de3520c819089cc98f98b24616a", "custom_id": "Duloxetine-Darunavir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2c137fd78a2c122f0ce9fceb0dc3839c", "body": {"id": "chatcmpl-BNLQ7D9WwtWP4vVadh5xnYNOC53sK", "object": "chat.completion", "created": 1744903583, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with an antiretroviral protease inhibitor commonly used in HIV therapy that requires pharmacokinetic boosting, is associated with an increased risk of narcolepsy as a drug-drug interaction?\n\nAnswer: Duloxetine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 685, "completion_tokens": 53, "total_tokens": 738, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de3650c8190a635bf8655050484", "custom_id": "Aciclovir-Trimethoprim-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2477caabe25e172c78dfa55961916a89", "body": {"id": "chatcmpl-BNLQ8yNpmG0qNsLCOW2l4mBGhqApg", "object": "chat.completion", "created": 1744903584, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient experiencing abdominal pain in the upper region after co-administration of an antiviral guanosine analogue used for herpesvirus infections and an antibiotic that blocks bacterial folate metabolism by inhibiting dihydrofolate reductase, which medication is most likely the cause of this adverse reaction?\n\nAnswer: Trimethoprim", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 599, "completion_tokens": 67, "total_tokens": 666, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de3796c81909c19d7609128fc07", "custom_id": "Ondansetron-Salmeterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "aeb45bb901c4f8ae5c88a56a71c79e23", "body": {"id": "chatcmpl-BNLQAgRBGgW531NMh5Pup87VrXrzY", "object": "chat.completion", "created": 1744903586, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, prescribed to alleviate nausea associated with chemotherapy and notable for its lack of dopaminergic and muscarinic receptor activity as well as its tendency to cause QT interval prolongation, has been found to have a cholecystitis-related interaction with a long-acting \u03b22 agonist used to control asthma and COPD symptoms?\n\nAnswer: Ondansetron", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 75, "total_tokens": 717, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de38cfc8190a3eff99a1d4931c7", "custom_id": "Fentanyl-Trazodone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "288a432e21ab95391c26021dd0fd0c5f", "body": {"id": "chatcmpl-BNLQBxsl5nC1HJw71wxf9qar5qnt8", "object": "chat.completion", "created": 1744903587, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA synthetic opioid analgesic that is highly potent and carries a risk of severe respiratory depression is often chosen for severe pain management following a traumatic musculoskeletal event, such as a vertebral fracture, whereas a serotonin antagonist and reuptake inhibitor typically prescribed for depression and insomnia may not be suited for such acute analgesic needs. Based on their pharmacological profiles, which drug is more likely to be used to manage pain resulting from a back injury?\n\nAnswer: Fentanyl", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 656, "completion_tokens": 96, "total_tokens": 752, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de3a1788190ae95dab755f3122a", "custom_id": "Metolazone-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "759fc5865863dd954cfa2ef8ee66c2f9", "body": {"id": "chatcmpl-BNLQDZziRH7sUXWhMeeskhWfC35OF", "object": "chat.completion", "created": 1744903589, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a thiazide-like diuretic used to treat congestive heart failure and high blood pressure, is reported to have an adenopathy interaction with a nitrogen-containing bisphosphonate used to prevent osteoporosis?\n\nAnswer: Metolazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 445, "completion_tokens": 53, "total_tokens": 498, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de3b26081909d741f71e1300d60", "custom_id": "Cetirizine-Salmeterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fdc78ed6df617c2121a007572ef5dd76", "body": {"id": "chatcmpl-BNLQEc1cZkppnybooNJiUOouF7H3t", "object": "chat.completion", "created": 1744903590, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used primarily for allergy management with a notable, although reduced, risk of somnolence compared to first-generation agents, is associated with the risk of cholecystitis when taken in combination with a long-acting \u03b22 adrenergic receptor agonist used in asthma and COPD?\n\nAnswer: Cetirizine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 668, "completion_tokens": 69, "total_tokens": 737, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de3c43c8190ae67c15f48cad596", "custom_id": "Ticlopidine-Tirofiban-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bf7c2d1229038b2d4ed6284a652fd5cb", "body": {"id": "chatcmpl-BNLQGjshyxo0vIsG7p1IAhbXnbR57", "object": "chat.completion", "created": 1744903592, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly used as a glycoprotein IIb/IIIa inhibitor antiplatelet agent and a small molecule inhibitor of the interaction between fibrinogen and platelet integrin receptors, is associated with thrombocytopenia as a drug-drug interaction when used with the thienopyridine ADP receptor inhibitor utilized to prevent thrombotic strokes in patients intolerant to aspirin?\n\nAnswer: Tirofiban", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 517, "completion_tokens": 89, "total_tokens": 606, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de3d68c8190ad2f60987067e9b2", "custom_id": "Gabapentin-Telithromycin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "31241175d79ec1d6d341ce53d554c9b9", "body": {"id": "chatcmpl-BNLQHl53HOj2UgxGv8E3ufyQ1R7pw", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its activity against community acquired pneumonia and its structural derivation from erythromycin, has been reported to cause back ache when used in combination with a prototypical gabapentinoid used for neuropathic pain?\n\nAnswer: Telithromycin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 640, "completion_tokens": 55, "total_tokens": 695, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de3e80881909b7905b6006d3e71", "custom_id": "Alprazolam-Fluorouracil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9aeec649b40894298b41d479d22e33bc", "body": {"id": "chatcmpl-BNLQJpa8SCzfmschk6Bqb47hVmScy", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of a patient receiving a GABA_A receptor-modulating anxiolytic for panic disorder and chemotherapy-induced emesis alongside a pyrimidine antimetabolite used to inhibit DNA synthesis in various malignancies, which agent is documented to be associated with episodes of rectal hemorrhage when co-administered?\n\nAnswer: Fluorouracil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 686, "completion_tokens": 74, "total_tokens": 760, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de3f98c81909145ecba62ad05de", "custom_id": "folinic acid-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f83bc6c4c845ec4091742c162a01bcd2", "body": {"id": "chatcmpl-BNLQKQkMJEzoZlVomL9XiQustM1iF", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to treat anemia and as an adjunct in certain cancer therapies, has been reported to cause abnormal ECG findings when administered with a nitrogen-containing bisphosphonate that prevents osteoporosis?\n\nAnswer: folinic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 482, "completion_tokens": 46, "total_tokens": 528, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de40b4481909a6e849252d6065b", "custom_id": "Fentanyl-Ketamine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "da5e4fbac21d2e9885c0ce0535dbc13d", "body": {"id": "chatcmpl-BNLQLGBvfNoRvcuVE7SpkFXwb2WBA", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nAmong a synthetic opioid with high potency and overdose risk, commonly used for severe pain, and a non-competitive NMDA antagonist known for inducing dissociative anesthesia while preserving respiratory function, which drug is reported to have an interaction with the other involving the complication of disseminated lupus erythematosus?\n\nAnswer: Fentanyl", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 718, "completion_tokens": 69, "total_tokens": 787, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de41e08819088d39e86a12de5f8", "custom_id": "Risedronic acid-Telmisartan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "24aad73a502ddec0008da1eecafe2033", "body": {"id": "chatcmpl-BNLQNvkP2vTpnkvqoBmWr7gLYq3aY", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient being treated for osteoporosis with a medication that slows bone breakdown experiences apoplexy when co-administered with an antihypertensive agent that antagonizes angiotensin II receptors, which drug is identified as the causative agent of apoplexy in this interaction?\n\nAnswer: Telmisartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 500, "completion_tokens": 64, "total_tokens": 564, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de4306c819089c3a842c26fc0dd", "custom_id": "Amlodipine-Dapsone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0655bb5bf97a379647d00302e15cf216", "body": {"id": "chatcmpl-BNLQOxrZvYCq9rGguAhjNHcg0ltMf", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, the long-acting calcium channel blocker primarily used to treat hypertension and angina, or the sulfone-class antimicrobial indicated for leprosy and dermatological conditions, has been associated with the occurrence of cholecystitis when administered in conjunction with the other?\n\nAnswer: Dapsone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 673, "completion_tokens": 63, "total_tokens": 736, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de445c081908bb2de9421d57c70", "custom_id": "Famotidine-Propofol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "79acc973fdc1fdf260ef1703fbc1fe2a", "body": {"id": "chatcmpl-BNLQPYrXHqJPPDTDFTc2uzBGgMzoP", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly used for reducing stomach acid production in conditions like GERD and peptic ulcers, has been associated with adenopathy when administered alongside an intravenous anesthetic notable for its rapid induction of unconsciousness and its formulation with soy and egg-based emulsifiers?\n\nAnswer: Famotidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 60, "total_tokens": 702, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de457bc8190baf44078691d2e31", "custom_id": "alendronic acid-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "95d80323b8ee069b7ec4c908497794af", "body": {"id": "chatcmpl-BNLQR59PgMdgN8J7z6sOkhvEldzi7", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, the one used to treat osteoporosis by decreasing bone breakdown or the tyrosine kinase inhibitor essential for certain leukemias, is associated with adenopathy as a drug-drug interaction effect when combined with the other?\n\nAnswer: Imatinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 675, "completion_tokens": 53, "total_tokens": 728, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de46c1881908c94fc08855608e1", "custom_id": "Citalopram-hydralazine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "19e5a896ffeff602060a01cc73da30fd", "body": {"id": "chatcmpl-BNLQSNCDCPSTgbKSyzncwvKRuOMjZ", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly employed to manage depressive or anxiety disorders by modulating serotonergic neurotransmission, is associated with an increased risk of muscle disorders when coadministered with a direct-acting vasodilator that lowers blood pressure by relaxing arteriolar smooth muscle?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 731, "completion_tokens": 62, "total_tokens": 793, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de47f18819086b6447dc5aecaa5", "custom_id": "Aciclovir-Dipyridamole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "06fadbbabfffc4d1de7b4f147b108d01", "body": {"id": "chatcmpl-BNLQTReUoxo5sx9iHpZuCB3fCs8KS", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its antiviral action against herpesviruses and a risk of gastrointestinal side effects, is reported to potentially cause skin eruptions when administered concomitantly with a nucleoside transport and PDE3 inhibitor that acts as an antiplatelet agent and vasodilator?\n\nAnswer: Aciclovir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 470, "completion_tokens": 66, "total_tokens": 536, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de48f508190aebafe56b61fdf35", "custom_id": "Rosiglitazone-Bimatoprost-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b7408f81f814dd36a943ce4c5bd77bd2", "body": {"id": "chatcmpl-BNLQVb1wLXLwYNOcg9DybSAmLO1r5", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its role as a PPAR\u03b3 agonist utilized in glycemic control for Type 2 diabetes but associated with cardiovascular risk concerns, has a documented relationship with adenopathy when administered alongside an ophthalmic prostaglandin analog used in the management of high intraocular pressure?\n\nAnswer: Rosiglitazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 622, "completion_tokens": 69, "total_tokens": 691, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de4a04c819094013a98abbe3b38", "custom_id": "Metronidazole-Thalidomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "cad1b43ebdb96d0d19d40284b54ddefc", "body": {"id": "chatcmpl-BNLQWmJ21ERbWCAivHGdsxyo5vNnJ", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with an immunomodulatory agent known for its serious teratogenic effects and oncological uses, has been reported to induce metabolic encephalopathy as a neurological complication?\n\nAnswer: Metronidazole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 734, "completion_tokens": 50, "total_tokens": 784, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de4b4f08190bc0ca3cfcfdf143f", "custom_id": "acetazolamide-Propofol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "dbee0bd6c71efefba6828c5e98a80fb8", "body": {"id": "chatcmpl-BNLQXuRwFgdFFilsBwFL9Nk2EYzhT", "object": "chat.completion", "created": 1744903609, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a diuretic and carbonic anhydrase inhibitor used for glaucoma and altitude illness is administered alongside a rapid-acting intravenous anesthetic formulated with soy and egg-derived components, which medication in this pair has been associated with eliciting an allergic skin reaction such as dermatitis when co-administered with the other?\n\nAnswer: acetazolamide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 699, "completion_tokens": 75, "total_tokens": 774, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de4c7bc819093884d8dda716abe", "custom_id": "Metoprolol-Fulvestrant-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "91e6a01f52c7469f6501d7ba60b92ea1", "body": {"id": "chatcmpl-BNLQ3r2iU9pjAkBsLFfkK1zjCTd0D", "object": "chat.completion", "created": 1744903579, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient being treated with a cardioselective \u03b21-adrenergic receptor antagonist commonly used for hypertension and migraine prophylaxis, co-administration with an injectable selective estrogen receptor degrader indicated for metastatic breast cancer has been associated with an increased risk of upper abdominal pain. If a clinician is seeking to identify which medication's addition is most likely to be linked with this upper gastrointestinal adverse event in the context of their interaction, which drug would that be?\n\nAnswer: Fulvestrant", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 604, "completion_tokens": 100, "total_tokens": 704, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de4dd24819098e559bdb05dd79f", "custom_id": "Celecoxib-Fulvestrant-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fd128e605fbbb83f7c592245200ea439", "body": {"id": "chatcmpl-BNLQ44anZ8LfDxzl469WKdHxCXpK8", "object": "chat.completion", "created": 1744903580, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient undergoing treatment for hormone receptor-positive metastatic breast cancer with an agent that degrades estrogen receptors, sinus headache is most likely to occur as a result of interaction with which of the following: the selective cyclooxygenase-2 inhibitor prescribed for managing chronic joint pain, or the antiestrogenic injectable therapy?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 673, "completion_tokens": 72, "total_tokens": 745, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de4f04c819087df30b6164b1e8b", "custom_id": "Aciclovir-Ibuprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b27d070e7963921c6961d328b2e79f86", "body": {"id": "chatcmpl-BNLQ6BKlqZRrnrTFOgVrC37e9tCH2", "object": "chat.completion", "created": 1744903582, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with an antiviral guanosine analogue that inhibits viral DNA polymerase used in herpesvirus infections, is associated with an increased risk of cholecystitis due to their interaction?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 647, "completion_tokens": 51, "total_tokens": 698, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de506c481908b373cca180d5a78", "custom_id": "Metronidazole-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "791bae507f5c7c9d85467a6a25d1c02f", "body": {"id": "chatcmpl-BNLQ7hroIOFHNbDUHpVJzX4mKJ94v", "object": "chat.completion", "created": 1744903583, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in combination with an agent that disrupts microtubule assembly and is utilized in the treatment of leukemias and other malignancies, has been associated with an increased risk of causing acute respiratory distress syndrome as a result of their interaction?\n\nAnswer: Metronidazole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 695, "completion_tokens": 62, "total_tokens": 757, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de5198c819088a1de7946683e2c", "custom_id": "Megestrol-Sorafenib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d1179972820be4b273fd7fd554780915", "body": {"id": "chatcmpl-BNLQ9OHR78fJvtnS2dXOwJWgL5BgF", "object": "chat.completion", "created": 1744903585, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a progestin originally not used clinically but now indicated for disease-related weight loss and certain cancers, has been reported to cause adverse drug effects when administered with a kinase inhibitor used in advanced kidney and liver cancers?\n\nAnswer: Megestrol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 408, "completion_tokens": 53, "total_tokens": 461, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de52d4c81908dbf91b9ce38dfe5", "custom_id": "indometacin-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8320788fddd5294cedfc77daaf811cef", "body": {"id": "chatcmpl-BNLQA7xxdWcJ4ZOmFeP9V7DkQoJKn", "object": "chat.completion", "created": 1744903586, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in combination with another medication, is associated with an elevated erythrocyte sedimentation rate, a marker often used to assess inflammation, when co-administered with a nitrogen-containing bisphosphonate commonly used to prevent osteoporosis?\n\nAnswer: indometacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 451, "completion_tokens": 59, "total_tokens": 510, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de541e88190bc1b67b51247071f", "custom_id": "Bumetanide-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4c8628af7d3bfea899db6b266d9e4206", "body": {"id": "chatcmpl-BNLQBwjlbTa33WRp7SgOyUexwraDq", "object": "chat.completion", "created": 1744903587, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its loop diuretic action and use in managing edema due to heart failure, has been reported to interact with an anti-mitotic chemotherapeutic agent by potentially being associated with pneumonia as an adverse interaction?\n\nAnswer: Bumetanide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 698, "completion_tokens": 55, "total_tokens": 753, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de555dc8190b44fd3b3775c8823", "custom_id": "Doxazosin-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b0a4e50d92acb7aae57682a9777f786e", "body": {"id": "chatcmpl-BNLQC0rsPFUhbpbKA0njRsuOAanxn", "object": "chat.completion", "created": 1744903588, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to prevent osteoporosis, is associated with a risk of atelectasis when co-administered with a selective \u03b11-adrenergic blocker prescribed for hypertension and benign prostatic hyperplasia?\n\nAnswer: Pamidronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 485, "completion_tokens": 51, "total_tokens": 536, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de568fc819091cf32a0fbeb441f", "custom_id": "Methylphenidate-Erlotinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "dc870cb3f81670d39736379ccafafea5", "body": {"id": "chatcmpl-BNLQD7T82Bnx3SESFDW4zE8boDsIX", "object": "chat.completion", "created": 1744903589, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used primarily to treat cancers driven by EGFR mutations and associated with potential adverse effects such as rash and gastrointestinal symptoms, is involved in a drug-drug interaction with a CNS stimulant (used for ADHD and narcolepsy) specifically characterized by an increased risk of bacteraemia?\n\nAnswer: Erlotinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 676, "completion_tokens": 66, "total_tokens": 742, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de582a88190bb67ead4c0f527a3", "custom_id": "Paracetamol-Tirofiban-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "97ac4219d42da2ff100d25093de67cfb", "body": {"id": "chatcmpl-BNLQFGGIfGQSwbrTrcPJisQZCMDII", "object": "chat.completion", "created": 1744903591, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient receiving an analgesic and antipyretic that acts primarily through central COX inhibition develops thrombocytopenia after initiating therapy with a glycoprotein IIb/IIIa receptor antagonist, which agent is most likely to be the cause of the reduced platelet count due to the interaction?\n\nAnswer: Tirofiban", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 699, "completion_tokens": 70, "total_tokens": 769, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de597f48190b6bda46a23226b14", "custom_id": "Celecoxib-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2378206ad10a2ab09b321822687b4beb", "body": {"id": "chatcmpl-BNLQGP9VLVVR3kkgyCHVaj6HKOsWM", "object": "chat.completion", "created": 1744903592, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nGiven that one agent is a selective cyclooxygenase-2 (COX-2) inhibitor primarily used for its anti-inflammatory and analgesic effects, and the other is an ATP-competitive tyrosine kinase inhibitor pivotal in treating various malignancies such as chronic myelogenous leukemia, which of these drugs, when interacting with the other, has been associated with inducing adenopathy?\n\nAnswer: Imatinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 779, "completion_tokens": 85, "total_tokens": 864, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de5aa308190928a548094bb2687", "custom_id": "Ranitidine-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7f08ce2175c0c551c1d9e608f6a2ed90", "body": {"id": "chatcmpl-BNLQHmQOtQsuYsPtsxEWKgE1dbaEV", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient, without referencing specific drug names, is being treated with an agent that attenuates gastric acid secretion via H2 histamine receptor antagonism and is at risk for various oncogenic and gastrointestinal complications, which drug in an interaction with a nonbenzodiazepine hypnotic used for insomnia is associated as the subject in a relationship involving gastric inflammation?\n\nAnswer: Ranitidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 797, "completion_tokens": 80, "total_tokens": 877, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de5bc808190aa0aec25d1d6a5d3", "custom_id": "Dipyridamole-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9daa0ec88e5595726314d5a641ed8def", "body": {"id": "chatcmpl-BNLQI6CPXzhoN1JtpFk0LN5s1WkCY", "object": "chat.completion", "created": 1744903594, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when combined with a nucleoside transport and PDE3 inhibitor antiplatelet agent known for its clot inhibition and vasodilatory effects, is associated with a risk of weight gain according to drug interaction data?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 540, "completion_tokens": 51, "total_tokens": 591, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de5cfd88190a670d41418f5c078", "custom_id": "Ketoprofen-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bd3addde762a95f0569d6a60bbc9de60", "body": {"id": "chatcmpl-BNLQJw6MPoEF6cF15SLG6at3OKkT8", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, an NSAID that inhibits prostaglandin production or a nitrogen-containing bisphosphonate used to prevent osteoporosis, is associated with the risk of nasopharyngitis when taken together with the other drug?\n\nAnswer: Ketoprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 361, "completion_tokens": 52, "total_tokens": 413, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de5e28081909d340dd4ad791bb0", "custom_id": "Methylphenidate-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e96e02abbc5b6c99e7b9ed5ff098107a", "body": {"id": "chatcmpl-BNLQLb5sN112R1LAwvcXrg9vjhlD1", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, characterized by inhibition of presynaptic dopamine and norepinephrine transporters to manage attention disorders and narcolepsy, has been reported to induce a state of restlessness or increased agitation when used concurrently with a small molecule tyrosine kinase inhibitor crucial for treating certain leukemias and gastrointestinal tumors?\n\nAnswer: Methylphenidate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 738, "completion_tokens": 72, "total_tokens": 810, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de5f5b08190b7f5f32c2311dfdc", "custom_id": "Desloratadine-Darunavir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5b598cf8b0162818b581ed6bbe8dd6aa", "body": {"id": "chatcmpl-BNLQMzir0DNk5FRFKXWvDHeXhOeY3", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used alongside an antiretroviral protease inhibitor primarily utilized in the treatment of HIV/AIDS, has been associated with an increased risk of acute pancreatitis due to their interaction?\n\nAnswer: Desloratadine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 529, "completion_tokens": 48, "total_tokens": 577, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de6098c8190aabfb0799cf3299a", "custom_id": "Labetalol-Metoprolol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "de4d4489a57ec1061ef963531d0ba6f6", "body": {"id": "chatcmpl-BNLQNqb8pqO67pzvvMudbX6ZMSU6Y", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich of the following medications, one known to block both \u03b2- and \u03b1-adrenergic receptors and commonly prescribed for managing high blood pressure in pregnancy, is reported to have an interaction resulting in apoplexy when combined with a cardioselective \u03b21-adrenergic receptor antagonist used for angina, tachyarrhythmia, and migraine prophylaxis?\n\nAnswer: Labetalol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 645, "completion_tokens": 82, "total_tokens": 727, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de61b708190b1a7d63300f997c2", "custom_id": "Bumetanide-Torasemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "55c46ca9e8b271c0674c6598b32d946b", "body": {"id": "chatcmpl-BNLQPegFDqa8hr2KhKsde35PoLSKC", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nConsidering two loop diuretic medications, both included in the World Health Organization\u2019s List of Essential Medicines and primarily used to address fluid overload from cardiac, hepatic, or renal origins, which drug is more likely to be associated with the potential for weight gain as a result of their pharmacological interaction?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 670, "completion_tokens": 67, "total_tokens": 737, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de62ee88190ab439e5b84f8adbc", "custom_id": "Cimetidine-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "82b675e000140f5286dad3803cccacfe", "body": {"id": "chatcmpl-BNLQQ5wcJ2hrutAHgjyZZ9NRGKJIo", "object": "chat.completion", "created": 1744903602, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a nitrogen-containing bisphosphonate used to prevent osteoporosis, has been associated with the development of erythema when administered in conjunction with a histamine H2 receptor antagonist that inhibits stomach acid production?\n\nAnswer: Pamidronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 442, "completion_tokens": 52, "total_tokens": 494, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de640c881908ea2370f0ef1f26a", "custom_id": "indometacin-Torasemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bc335579a722ee2f1cabe59ae7e0ff4f", "body": {"id": "chatcmpl-BNLQRnj51HY3OOmHbe3et7nLHvjAd", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for inhibiting prostaglandin production to reduce inflammation, may blunt the blood pressure-lowering effects of a sulfonamide loop diuretic by causing an increase in arterial pressure when both are taken together?\n\nAnswer: indometacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 584, "completion_tokens": 54, "total_tokens": 638, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de65368819096796727f68ad0df", "custom_id": "Lamotrigine-Torasemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7efebb1666e44205c6de80c660c20ceb", "body": {"id": "chatcmpl-BNLQSzkIrJs7JAEdUHf4iFJ1pM2Fn", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used for conditions such as epilepsy and bipolar disorder and known to modulate excitatory neurotransmission via sodium and calcium channel inhibition, is associated with a loss of weight when administered together with a sulfonamide loop diuretic indicated for heart failure and fluid overload?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 644, "completion_tokens": 64, "total_tokens": 708, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de6680c8190a14cef5cc01d256e", "custom_id": "oxybutynin-Pirbuterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fd660140fa7d6672e13b8c2590cfbada", "body": {"id": "chatcmpl-BNLQT343QedHjPZzqbFJ352uIjVWj", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a patient is simultaneously administered an antimuscarinic agent commonly used for overactive bladder and a short-acting \u03b22 agonist supplied as a breath-activated metered-dose inhaler for asthma, which medication is most directly linked as the subject in a knowledge-graph triple indicating it induces apoplexy when combined with the other?\n\nAnswer: oxybutynin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 560, "completion_tokens": 80, "total_tokens": 640, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de67c54819087aa9ff94e2bb906", "custom_id": "Metoprolol-Bimatoprost-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "eae3e91a66c8b11642e52969fb98f049", "body": {"id": "chatcmpl-BNLQVpkrLJ22o6YRrAfYwTvyuaqDA", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA cardioselective \u03b21-adrenergic receptor antagonist with prominent use in hypertension and angina is known to exhibit exertional dyspnea as an interaction when co-administered with a prostaglandin analog that increases aqueous humor outflow for glaucoma; which of these two drugs is more likely to be associated with exertional dyspnea due to this interaction?\n\nAnswer: Metoprolol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 633, "completion_tokens": 84, "total_tokens": 717, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de68fb08190b03b29850aa4ee67", "custom_id": "Naproxen-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2d2d02b29131d87bebce44fa1d3632b1", "body": {"id": "chatcmpl-BNLQWTfXBHxckI2Tft3eHS2JwsLla", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, characterized by potent antimuscarinic activity for managing overactive bladder symptoms, is associated with an increased risk of cholecystitis when co-administered with a non-selective cyclooxygenase-inhibiting NSAID commonly used for pain and inflammatory conditions?\n\nAnswer: oxybutynin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 752, "completion_tokens": 66, "total_tokens": 818, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de6a4ac8190beb6f6efc482f3f4", "custom_id": "Cimetidine-Labetalol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a8cb311ab490919d860762269f6a9641", "body": {"id": "chatcmpl-BNLQYvLU57iv0Ht4I2YAs4ndIlzCL", "object": "chat.completion", "created": 1744903610, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to block \u03b2- and \u03b1-adrenergic receptors for treating high blood pressure, may have increased risk of back injury when taken together with the histamine H2 receptor antagonist prescribed for heartburn and peptic ulcers?\n\nAnswer: Labetalol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 583, "completion_tokens": 57, "total_tokens": 640, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de6b96c81908ef0939662dc7f19", "custom_id": "Cimetidine-hydroxychloroquine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2b2b0989a1c4503aaedb63376f2d8e8b", "body": {"id": "chatcmpl-BNLQCoqkf0xSu9zf0KZNY3T9azDhb", "object": "chat.completion", "created": 1744903588, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when co-administered with a histamine H2 receptor antagonist used for peptic ulcers and heartburn, is associated with an increased risk of vasculitic inflammation (angiitis)?\n\nAnswer: hydroxychloroquine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 640, "completion_tokens": 49, "total_tokens": 689, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de6cba881909b1682701e297966", "custom_id": "Gabapentin-hydroxychloroquine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9734ce6a3217ce8171d0b3bde142ec4d", "body": {"id": "chatcmpl-BNLQDuCmEIK7oXweINTUR9KmFs2EB", "object": "chat.completion", "created": 1744903589, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient concurrently using a medication that acts by binding the \u03b12\u03b4-1 subunit of voltage-gated calcium channels for neuropathic pain and seizures, and another agent with immunomodulatory effects often prescribed for autoimmune diseases and malaria, which drug is more likely to be associated with reports of erythema when the two are used together?\nAnswer: hydroxychloroquine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 729, "completion_tokens": 79, "total_tokens": 808, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de6df488190a8d54f9ba8590be7", "custom_id": "Doxazosin-Fluorouracil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "10d773b18b2d465b6e74e9f5ed7c77da", "body": {"id": "chatcmpl-BNLQEQlwcf5nEGyZKtUtcBiVfL6VQ", "object": "chat.completion", "created": 1744903590, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its role in treating various cancers by interfering with DNA synthesis, has been associated with inducing weight loss when used concurrently with a selective \u03b11-adrenergic blocker primarily prescribed for hypertension and benign prostatic hyperplasia?\n\nAnswer: Fluorouracil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 652, "completion_tokens": 58, "total_tokens": 710, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de6f1c4819091050e3a5c35f475", "custom_id": "Metolazone-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d0d9f259559ff9cb32346f879e506e0a", "body": {"id": "chatcmpl-BNLQFQAcikETGDCGCMJ30xGn6Z24B", "object": "chat.completion", "created": 1744903591, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used concurrently with the other described medication, may lead to an increased risk of toxicity not otherwise specified, raising concerns for adverse reactions due to their pharmacological interaction?\n\nAnswer: Metolazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 628, "completion_tokens": 45, "total_tokens": 673, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de7054c8190a137c1b0898eede0", "custom_id": "Celecoxib-Zaleplon-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6c1ca78cda4209562d03d35ed84ae41c", "body": {"id": "chatcmpl-BNLQG71f59o2HRkpTjmgsfrhhLFkG", "object": "chat.completion", "created": 1744903592, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a patient is being treated for chronic inflammatory joint pain with a selective cyclooxygenase-2 inhibitor that may carry risks of cardiovascular and gastrointestinal side effects, and this patient is also prescribed a nonbenzodiazepine sedative-hypnotic from the pyrazolopyrimidine class for insomnia, which of these medications is most likely to be implicated if the patient develops erythema as a manifestation of a drug-drug interaction?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 589, "completion_tokens": 100, "total_tokens": 689, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de71c38819092b9b01ebf1a9943", "custom_id": "acetazolamide-Citalopram-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fe87e5cced3cb8f129373435bd4d864a", "body": {"id": "chatcmpl-BNLQIcFbOv3usTZSN86Tnj8WGvUDX", "object": "chat.completion", "created": 1744903594, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in conjunction with the other agent that modulates serotonergic neurotransmission as a selective serotonin reuptake inhibitor (SSRI) for depressive and anxiety-related conditions, has been associated with the occurrence of back ache as an adverse event arising from their interaction?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 738, "completion_tokens": 64, "total_tokens": 802, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de72e688190a6430a0406e7f083", "custom_id": "Gabapentin-Ketorolac-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3c7a94047d505e69ae8a8d3df38890bf", "body": {"id": "chatcmpl-BNLQKbciwaq0YJvc9LoBCyf4RaKzR", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a patient with neuropathic pain managed with a ligand of voltage-gated calcium channels is also receiving short-term therapy with an analgesic that inhibits prostaglandin synthesis via COX-1 and COX-2 blockade, which agent from this combination is mechanistically linked to potentially exacerbating a condition characterized by ectopic endometrial tissue within the uterine musculature (adenomyosis) due to its effects on uterine prostaglandin balance?\n\nAnswer: Ketorolac", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 773, "completion_tokens": 106, "total_tokens": 879, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de7433c81909fd7c345bb8a3339", "custom_id": "Sildenafil-Acamprosate-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "57a61ecadc7081722476ece22416a434", "body": {"id": "chatcmpl-BNLQLkMXzMc2OAxKd2ZigLxszgPwS", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when interacting with a medication that stabilizes brain signaling to reduce alcohol withdrawal cravings, is associated with a loss of weight as a drug-drug interaction outcome?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 647, "completion_tokens": 40, "total_tokens": 687, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de75f6481909b09410c9b7ae1ed", "custom_id": "Naproxen-Zaleplon-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1f631bf35b1544b83a7771bf6526ed87", "body": {"id": "chatcmpl-BNLQMsFbStJv3eweXL9HzqOboodNN", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for reducing pain and inflammation by inhibiting cyclooxygenase enzymes, has been reported to be associated with the side effect of edema when used in combination with a sedative-hypnotic agent of the pyrazolopyrimidine class?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 567, "completion_tokens": 61, "total_tokens": 628, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de7729c81908836d509aea792a7", "custom_id": "Carvedilol-Tirofiban-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fbc4d44d14fbf36ec4dd77da96a1eb5a", "body": {"id": "chatcmpl-BNLQO83cRXTdOgT93RaxGDvOcIUfp", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient is being treated with a nonselective beta-adrenergic blocker that is well-established in managing hypertension and HFrEF and subsequently develops thrombocytopenia when initiated on a small molecule glycoprotein IIb/IIIa inhibitor antiplatelet agent, which drug is most likely responsible for the thrombocytopenia due to this interaction?\n\nAnswer: Tirofiban", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 563, "completion_tokens": 83, "total_tokens": 646, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de7852c8190bd7e704bf9921292", "custom_id": "Cetirizine-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "121424a7b3b25f8139fce2f06b09e289", "body": {"id": "chatcmpl-BNLQPNSaJfWtkSU8Ba1zgqaYs6HQQ", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario involving a peripherally selective second-generation H1 antihistaminergic agent commonly prescribed for allergic conditions and a vinca alkaloid that disrupts microtubule formation for oncologic use, which of these drugs is associated as the object in a knowledge graph triple indicating risk of thrombophlebitis when interacting with the other?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 713, "completion_tokens": 80, "total_tokens": 793, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de7965881909a0b14a7b2904c3a", "custom_id": "Lamotrigine-Zaleplon-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "391826ade5ad88f44da00338d8980bd2", "body": {"id": "chatcmpl-BNLQRuGnGyoW5hcvtNYYyUnBVJt3K", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBased on their respective pharmacological actions\u2014one being a phenyltriazine anticonvulsant and mood stabilizer used for seizure and bipolar disorder management, and the other a sedative-hypnotic nonbenzodiazepine for insomnia\u2014 which drug is identified as the agent that, when interacting with the other, is associated with the risk of inducing apoplexy according to their documented drug-drug interaction?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 523, "completion_tokens": 93, "total_tokens": 616, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de7b7e88190aa724ca66a1105fd", "custom_id": "Celecoxib-Ibuprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7f81329f48194cf1940e618a56b6cb31", "body": {"id": "chatcmpl-BNLQSzticdhsQJpYAoFrHu1PfeyCP", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, the selective COX-2 inhibitor used for osteoarthritis and colorectal adenoma prevention or the nonselective NSAID included in the WHO's List of Essential Medicines, is more likely to cause gastric inflammation due to its effect on prostaglandin synthesis?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 757, "completion_tokens": 61, "total_tokens": 818, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de7ca5881909e51edd089aa28b2", "custom_id": "Ketorolac-Oxaprozin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "de70a48e49f7b0fddbc1d09a49a01cba", "body": {"id": "chatcmpl-BNLQTItsC0sqeYB8to2Kn8yo861cI", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used for moderate to severe nociceptive pain and known for robust inhibition of prostaglandin synthesis, may contribute to gastric inflammation when used in combination with a propionic acid derivative NSAID indicated for arthritis?\n\nAnswer: Ketorolac", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 645, "completion_tokens": 53, "total_tokens": 698, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de7da2c8190ace7ff20f77f7059", "custom_id": "phenytoin-Propofol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a35cfdf90f8022636059dac46d468a5e", "body": {"id": "chatcmpl-BNLQV8kJGzdc9cAy4yDWcyS5nVJVm", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its essential role in inducing and maintaining general anesthesia via GABA_A receptor agonism and commonly formulated as a milky intravenous emulsion, may demonstrate abnormal EEG effects when co-administered with an agent that inhibits voltage-gated sodium channels used as first-line therapy for tonic-clonic and focal seizures?\n\nAnswer: Propofol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 705, "completion_tokens": 73, "total_tokens": 778, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de7edc48190b4d342a26f9a8d9d", "custom_id": "Modafinil-Bimatoprost-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "106fc3533ae0cf0faef4e40dad100192", "body": {"id": "chatcmpl-BNLQWukAlLfR3MdVUPY2sVa3LsVWC", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient is experiencing increased nighttime urination as a result of a drug combination involving a CNS stimulant and eugeroic agent primarily used for sleep disorders, and a prostaglandin analog indicated for increased intraocular pressure, which drug is most likely the direct cause of nocturia in this interaction according to their reported relationship?\n\nAnswer: Modafinil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 593, "completion_tokens": 74, "total_tokens": 667, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de7fe4c8190913864dfb2202722", "custom_id": "Fentanyl-Ketorolac-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5707519d27bd62b41ae6b65f7754fb92", "body": {"id": "chatcmpl-BNLQXPyUNxYFAl9C3nYokLyXOpUi5", "object": "chat.completion", "created": 1744903609, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known as a potent opioid agonist that is often utilized for severe pain management in oncologic and post-operative contexts, is associated with adenopathy when used in conjunction with a nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and carries significant gastrointestinal and renal risk?\n\nAnswer: Fentanyl", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 792, "completion_tokens": 67, "total_tokens": 859, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de80e24819085330e99923bd09f", "custom_id": "Fentanyl-Aminophylline-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "403a0ba354652200dbadc9edbef2aead", "body": {"id": "chatcmpl-BNLQZLgHoPtKweRTFcJfInlun9Qi4", "object": "chat.completion", "created": 1744903611, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a synthetic opioid with high \u03bc-opioid receptor affinity and significant overdose risk is administered alongside a nonselective adenosine receptor antagonist and bronchodilator commonly used for airway obstruction, which drug is more likely to be associated with the development of thrombocytopenia due to this interaction?\n\nAnswer: Aminophylline", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 601, "completion_tokens": 71, "total_tokens": 672, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de81ff0819090c6287a743bea18", "custom_id": "Ibuprofen-Propofol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7d95d2b6717828e461a9135250f97260", "body": {"id": "chatcmpl-BNLQbAa1kdLlpn9CUmvVh6Au8waOz", "object": "chat.completion", "created": 1744903613, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question: Which drug, recognized for its ability to potentiate inhibitory neurotransmission via GABA_A receptor agonism and frequently administered as a milky intravenous emulsion for anesthesia induction, has been associated with the emergence of dysarthria when used in the context of concomitant therapy with an NSAID employed for acute pain and inflammation?\n\nAnswer: Propofol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 710, "completion_tokens": 72, "total_tokens": 782, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de832188190b8704920d50e383f", "custom_id": "Fentanyl-Dexpramipexole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8e160a6e40fafd913180c008464a337a", "body": {"id": "chatcmpl-BNLQcPZ3KKjYM7lMSlNFnrEXhopqW", "object": "chat.completion", "created": 1744903614, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its role as an investigational oral agent that reduces blood eosinophil counts in asthma, has been associated with gastric inflammation when combined with a potent synthetic opioid analgesic widely used for severe pain management?\n\nAnswer: Dexpramipexole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 616, "completion_tokens": 57, "total_tokens": 673, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de844408190a368b6cf680f7dfe", "custom_id": "Amlodipine-Exemestane-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3e045d4909f931843aca66c06130453b", "body": {"id": "chatcmpl-BNLQdVJK8CdwtB3G7U2UEHl8LfAbc", "object": "chat.completion", "created": 1744903615, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, recognized globally for its antihypertensive properties due to calcium channel blockade, is associated with inducing pain when used concurrently with an aromatase inhibitor prescribed for hormone-receptor-positive breast cancer?\n\nAnswer: Amlodipine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 519, "completion_tokens": 51, "total_tokens": 570, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de854ec81908bde652cce0b2b9f", "custom_id": "Alprazolam-Ciclopirox-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f1316b626a2cee51b71bb73e34b593c9", "body": {"id": "chatcmpl-BNLQeC05nuTbfayIY3o5kB63FZ0Gh", "object": "chat.completion", "created": 1744903616, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its action as a high-affinity triazolobenzodiazepine used to manage anxiety disorders, is associated with a decrease in arterial pressure when co-administered with an antifungal agent often prescribed for moderate onychomycosis and seborrheic dermatitis?\n\nAnswer: Alprazolam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 529, "completion_tokens": 69, "total_tokens": 598, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de86750819093aecf7cdf03fce4", "custom_id": "Desloratadine-Telithromycin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0c48977d98a2dbf52c3dd475d59f2a25", "body": {"id": "chatcmpl-BNLQgjvQx2GXIfywdtTU7bM87EEDR", "object": "chat.completion", "created": 1744903618, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient being treated for allergies with a tricyclic H1 inverse agonist that is an active metabolite of loratadine, the addition of a semi-synthetic erythromycin derivative with a ketogroup replacing the cladinose sugar may lead to an increased risk of developing a sinus headache. Which drug is associated with this heightened side effect when combined with the second drug?\n\nAnswer: Desloratadine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 489, "completion_tokens": 86, "total_tokens": 575, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de879588190a5829e9e2877beee", "custom_id": "Risedronic acid-Trazodone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a6d957cd0742110ef79d8ae04db6b028", "body": {"id": "chatcmpl-BNLQhQniaJiH4VfLLdttpjUqIiOQH", "object": "chat.completion", "created": 1744903619, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when involved in a drug-drug interaction with a bisphosphonate used for osteoporosis and Paget's disease, could potentially be associated with failure to thrive as an outcome?\n\nAnswer: Trazodone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 480, "completion_tokens": 47, "total_tokens": 527, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de88d5c8190b9ddaaa1376eaa5b", "custom_id": "Naproxen-Pirbuterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b539383f4aa96b51f565ef654961353c", "body": {"id": "chatcmpl-BNLQiCCWJDn9quAe28GSkSu589td4", "object": "chat.completion", "created": 1744903620, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its bronchodilating action as a short-acting \u03b22 adrenoreceptor agonist used in asthma treatment, is associated with weight loss when interacting with a nonsteroidal anti-inflammatory drug that inhibits COX enzymes and is contraindicated in renal impairment?\n\nAnswer: Pirbuterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 564, "completion_tokens": 65, "total_tokens": 629, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de8a1d48190bbe09d4e007a8e2d", "custom_id": "Duloxetine-Desloratadine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "36d48f4bcd0237c9e661e2e2ef841690", "body": {"id": "chatcmpl-BNLQGkOnbbDJnXMKuqZhvNHzMQQBJ", "object": "chat.completion", "created": 1744903592, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly used for allergic conditions due to its tricyclic H1 inverse agonist activity, is associated with gastric inflammation when administered alongside a serotonin\u2013norepinephrine reuptake inhibitor indicated for depression and neuropathic pain?\n\nAnswer: Desloratadine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 563, "completion_tokens": 58, "total_tokens": 621, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de8b87c8190920ba23022c16d5c", "custom_id": "Alfuzosin-Benazepril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "da447318e0eea539a55b93e08e8fc4a2", "body": {"id": "chatcmpl-BNLQHWNSxRT9X5RT2LIT0hmNBuROD", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, an ACE inhibitor used for the management of hypertension, heart failure, and diabetic nephropathy, may experience decreased libido when used in combination with an \u03b11 blocker prescribed for benign prostatic hyperplasia due to their interaction?\n\nAnswer: Benazepril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 560, "completion_tokens": 56, "total_tokens": 616, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de8cbd081908b77ac9e7428de13", "custom_id": "Amlodipine-Ganciclovir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7445c339556f6bf28c0b6089c4c1d75b", "body": {"id": "chatcmpl-BNLQIhVI5oaS8Ti8X20XNO5rQsV0b", "object": "chat.completion", "created": 1744903594, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for treating cytomegalovirus infections, has been associated with the occurrence of angiitis when used in combination with a dihydropyridine-type long-acting calcium channel antagonist?\n\nAnswer: Ganciclovir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 458, "completion_tokens": 50, "total_tokens": 508, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de8e1488190bb78ec331b9de938", "custom_id": "Chloroquine-hydroxychloroquine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f009e15101cf042730c472fe92c885bf", "body": {"id": "chatcmpl-BNLQJONOgUFQUDRgsuLhFxiQFRxxQ", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich antimalarial agent, distinguished by its historic inclusion on the World Health Organization\u2019s essential medicines list and primary use in disrupting Plasmodium haem biocrystallization, has been associated with loss of weight when administered together with a 4-aminoquinoline drug that additionally treats hereditary porphyrias?\n\nAnswer: Chloroquine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 742, "completion_tokens": 70, "total_tokens": 812, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de902588190a5549c0cb1740fa8", "custom_id": "acetazolamide-Dexpramipexole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ad9d1044645447bb38470e6d6b7fe4a7", "body": {"id": "chatcmpl-BNLQKl5rURfuLcagkF3eFOFuKPmVk", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its use in neurological and ophthalmic conditions, can cause hypoventilation when used in combination with an investigational agent for eosinophilic asthma?\n\nAnswer: acetazolamide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 592, "completion_tokens": 44, "total_tokens": 636, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de9142c8190891ddc449bbd5bbe", "custom_id": "Citalopram-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b9b4976814d6657d911ea237b3af278d", "body": {"id": "chatcmpl-BNLQLopUJ2O03egWCSu4VNe5n0dNv", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly indicated for overactive bladder due to its antimuscarinic effects, may be associated with cholecystitis when combined with a selective serotonin reuptake inhibitor frequently prescribed for major depressive disorder and known to interact via hepatic metabolism involving CYP enzymes?\n\nAnswer: oxybutynin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 765, "completion_tokens": 63, "total_tokens": 828, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de92aec819085b3aa466e3c7847", "custom_id": "Desloratadine-solifenacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1c706c077f23b63469e18213fae71f17", "body": {"id": "chatcmpl-BNLQNm9Y1YlRtzYFV2Sj65pEn1qed", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich of the following drugs, one a tricyclic H1 inverse agonist used for allergies and an active metabolite of loratadine, and the other an oral antimuscarinic agent used to reduce bladder contractions in conditions like overactive bladder, is associated with bursitis as part of its interaction with the other?\n\nAnswer: Desloratadine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 495, "completion_tokens": 74, "total_tokens": 569, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de93d788190a631d1da648de7f8", "custom_id": "Ofloxacin-Torasemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bfff92f4af95603ace628914f81e1e79", "body": {"id": "chatcmpl-BNLQOOD6QQMyj8PZi0W17dnLWt94Z", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, the fluoroquinolone antibiotic known for targeting DNA gyrase and used in a range of bacterial infections including those treated per WHO essential medicines, is associated with cholecystitis when used in combination with a sulfonamide loop diuretic indicated for fluid overload due to heart, kidney, or liver failure?\n\nAnswer: Ofloxacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 632, "completion_tokens": 73, "total_tokens": 705, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011de94ea88190b8c9554671e005d7", "custom_id": "alendronic acid-Dipyridamole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "62fd9c38082961d421918b28e916e6ad", "body": {"id": "chatcmpl-BNLQQSl16RUj1o3WsU4gIA7hG5s9a", "object": "chat.completion", "created": 1744903602, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient receiving a bisphosphonate used to treat osteoporosis and a nucleoside transport/PDE3 inhibitor antiplatelet drug, which medication is associated with causing erythema in the context of their interaction?\n\nAnswer: Dipyridamole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 478, "completion_tokens": 55, "total_tokens": 533, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de961ec81909f3eea97cd1b3032", "custom_id": "Temazepam-Trazodone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a5855a260f23eae2cff4c74738d7e887", "body": {"id": "chatcmpl-BNLQRhYHYh3MIzPDGKlCgxB2lPc4j", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for modulating GABA-A receptors to produce hypnotic effects and often reserved for refractory insomnia, is at risk of causing gastric inflammation when administered concomitantly with an antidepressant that acts as a serotonin antagonist and reuptake inhibitor?\n\nAnswer: Temazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 647, "completion_tokens": 59, "total_tokens": 706, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de976148190b90a7faeb9f494d7", "custom_id": "Furosemide-gadoversetamide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e95f0112bee1500d109e2022d2c4a838", "body": {"id": "chatcmpl-BNLQSnRESsAVLbtgvU60gNcKLRYrQ", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn patients with a history of potent loop diuretic use to manage edema and hypertension, which drug among the two described should cause greater concern when considering the risk of scleroderma-like skin changes if used concomitantly with a gadolinium-based MRI contrast agent?\n\nAnswer: Furosemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 533, "completion_tokens": 64, "total_tokens": 597, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011de989488190b519b1a3ea57c5fe", "custom_id": "Ketoprofen-Telithromycin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8ee2422b41fcf13c15049e9f3e2a2713", "body": {"id": "chatcmpl-BNLQTVabSrCKTQPCJzRYy1tdsBKrc", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for being the first ketolide antibiotic used to treat community-acquired pneumonia, has been associated with thrombocytopenia when interacting with a nonsteroidal anti-inflammatory drug that inhibits prostaglandin production?\n\nAnswer: Telithromycin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 472, "completion_tokens": 55, "total_tokens": 527, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de99e648190bded2242d168c203", "custom_id": "Candesartan-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "acfbfaebb1290905cf8dfda6797fcb86", "body": {"id": "chatcmpl-BNLQVt1QxeWAbRqGymNDBej2lDoQV", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nConsidering one medication used principally to treat hypertension through antagonism of AT-1 receptors and another that selectively inhibits phosphodiesterase type 5 to enhance nitric oxide-mediated vasodilation, which drug has been reported to experience an increase in erythrocyte sedimentation rate when co-administered with the other?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 580, "completion_tokens": 69, "total_tokens": 649, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de9afd88190ac5733b60188bd39", "custom_id": "Isoniazid-Emtricitabine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bb6cef3872c85cc271f9a570dc51d272", "body": {"id": "chatcmpl-BNLQWQYZoJt6kLpY7EAKIe59equbj", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly prescribed for tuberculosis and usable in combination with rifampicin and ethambutol or as a monotherapy for latent infections, has been observed to potentially cause an enlargement of the liver when co-administered with a nucleoside reverse-transcriptase inhibitor integral to HIV antiretroviral regimens?\n\nAnswer: Isoniazid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 587, "completion_tokens": 74, "total_tokens": 661, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de9c230819081c9fa7a98a31d33", "custom_id": "Celecoxib-Oxaprozin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7f7ec27545a4c22b455999d141cf7279", "body": {"id": "chatcmpl-BNLQX2G2vpMHoMU0ZKXuZEX5qZmhj", "object": "chat.completion", "created": 1744903609, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of NSAID therapy for conditions such as osteoarthritis and rheumatoid arthritis, which medication, known for selective COX-2 inhibition, is associated with the risk of adenopathy when co-administered with a propionic acid derivative NSAID commonly used for inflammation and joint pain?\n\nAnswer: Celecoxib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 623, "completion_tokens": 66, "total_tokens": 689, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011de9d4748190a5b3c7146ede4dd1", "custom_id": "Ibuprofen-Repaglinide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6ef064bd0421985096f51be6f4c92820", "body": {"id": "chatcmpl-BNLQYfQdta4m5PYzJ4KTAbfEPFoYv", "object": "chat.completion", "created": 1744903610, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, characterized by attenuation of cyclooxygenase activity and indicated for pain and inflammation, is associated with the risk of causing renal abscess when co-administered with an antidiabetic agent that promotes pancreatic insulin release?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 633, "completion_tokens": 53, "total_tokens": 686, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de9e79c8190885411f0c5897312", "custom_id": "Ibuprofen-Adapalene-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "71d9bce6bdc8cc4968946f35aae7e6b2", "body": {"id": "chatcmpl-BNLQaBI7NfUu9zN4YpBFgzCkU2WSb", "object": "chat.completion", "created": 1744903612, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in combination with a third-generation topical retinoid primarily indicated for acne, is associated with implications for periodontitis due to its inhibition of prostaglandin synthesis and potential effects on inflammatory pathways?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 671, "completion_tokens": 52, "total_tokens": 723, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011de9f9f48190b04283e2fcf11214", "custom_id": "Rofecoxib-Thalidomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b6c47960ca2f9e27b63fd3859207d6c3", "body": {"id": "chatcmpl-BNLQbpg6wkhJS7HKyZFwkOvnV5Gzq", "object": "chat.completion", "created": 1744903613, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its selective cyclooxygenase-2 inhibition and primarily indicated for arthritic conditions before its withdrawal due to cardiovascular safety concerns, is associated with the development of erythema when used in combination with another drug infamous for its teratogenicity and use in cancer and leprosy-related complications?\n\nAnswer: Thalidomide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 726, "completion_tokens": 73, "total_tokens": 799, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dea0bfc81908a983f83a31f2f50", "custom_id": "Fentanyl-Ticlopidine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "196a778f0f5b5ee975ecd0091bc4136c", "body": {"id": "chatcmpl-BNLQcl8zpM498LEqogI9ajBBPZZPs", "object": "chat.completion", "created": 1744903614, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for reducing thrombotic stroke risk as an ADP receptor inhibitor, may experience a physical form alteration such as bulging when concurrently administered with a synthetic piperidine opioid agonist highly potent at \u03bc-opioid receptors?\n\nAnswer: Ticlopidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 662, "completion_tokens": 57, "total_tokens": 719, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dea1e7081909e521afd6654d4bb", "custom_id": "Ibuprofen-Midodrine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3d7a7af5789f4864ac6ddb3a849202ea", "body": {"id": "chatcmpl-BNLQdcvd22QyGMVv5tcNasNUDo52r", "object": "chat.completion", "created": 1744903615, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA medication that selectively stimulates \u03b11-adrenergic receptors to counteract orthostatic hypotension and may cause paresthesia, itching, and chills is reported to have an interaction with a nonsteroidal anti-inflammatory drug commonly used for pain and inflammation, resulting in an increased risk of dry skin. Which medication, the \u03b11-adrenergic agonist or the NSAID, is more likely to cause dry skin when these two drugs are used together?\n\nAnswer: Midodrine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 641, "completion_tokens": 102, "total_tokens": 743, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dea2fe48190b1f466168fd774d9", "custom_id": "Carvedilol-Ranolazine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a0e35e3077020e842515bef30f42f694", "body": {"id": "chatcmpl-BNLQfIrrVmLf8dXQ0GBQ9cE66W3tQ", "object": "chat.completion", "created": 1744903617, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to treat chest pain unresponsive to other therapies and associated with potential QT prolongation, is linked to an upper respiratory infection interaction when administered with a nonselective beta-adrenergic blocker indicated for HFrEF and hypertension?\n\nAnswer: Ranolazine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 613, "completion_tokens": 58, "total_tokens": 671, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dea41a08190954a9e567a969577", "custom_id": "Fentanyl-Adapalene-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "66abe110b9abfc5e1a6957254ae62fc9", "body": {"id": "chatcmpl-BNLQgJrLvzLesqTK9bgClsJkAXK4O", "object": "chat.completion", "created": 1744903618, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly used topically for acne and noted for its chemical stability and lower irritation profile, is associated with an interaction involving the development or exacerbation of periodontitis when used concomitantly with an exceptionally potent synthetic opioid analgesic?\n\nAnswer: Adapalene", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 686, "completion_tokens": 57, "total_tokens": 743, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68011dea54b08190850475498224a566", "custom_id": "alendronic acid-Pyridostigmine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7707549695150d7444d75d584b56ee8f", "body": {"id": "chatcmpl-BNLQhEjTgXIvrRNanmHOdFQv5irLE", "object": "chat.completion", "created": 1744903619, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, the bisphosphonate used for osteoporosis that decreases bone breakdown or the acetylcholinesterase inhibitor used for myasthenia gravis, is associated with an increased risk of gastric inflammation when coadministered with the other?\n\nAnswer: alendronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 666, "completion_tokens": 59, "total_tokens": 725, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dea67308190abde649d17b723ae", "custom_id": "Ciclopirox-hydroxychloroquine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "91f6425c0bac19fc86876543551283d6", "body": {"id": "chatcmpl-BNLQjEXNnfnaOzxFzK69eabd9BWyj", "object": "chat.completion", "created": 1744903621, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly indicated for malaria prophylaxis and the management of autoimmune diseases such as lupus erythematosus, is associated with the risk of adenopathy when administrated concurrently with a topical antifungal used for onychomycosis and seborrheic dermatitis?\n\nAnswer: hydroxychloroquine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 561, "completion_tokens": 64, "total_tokens": 625, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dea7a3081909273ace5d44253e2", "custom_id": "Ofloxacin-thiotepa-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bc87a104f31046a5d7f482c22213ab1a", "body": {"id": "chatcmpl-BNLQk0BvVgS3rt9dWetaFLoJbVGGj", "object": "chat.completion", "created": 1744903622, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBased on their pharmacological properties, which drug, when administered concurrently with an organophosphorus anti-cancer agent used in chemotherapy protocols, has been associated with causing splenomegaly as a potential drug-drug interaction?\n\nAnswer: Ofloxacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 503, "completion_tokens": 53, "total_tokens": 556, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dea9cb4819098a63467ef1103e4", "custom_id": "Alprazolam-Doxazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7b40c1c8aabf04d3678b4753fc909b37", "body": {"id": "chatcmpl-BNLQGyOt2hnOGJLNvFtvzLnXmj3Lf", "object": "chat.completion", "created": 1744903592, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when combined with a selective \u03b11-adrenergic blocker used for conditions like benign prostatic hyperplasia and hypertension, is implicated in an interaction associated with myelodysplasia due to its action as a potent anxiolytic acting on the GABA_A receptor?\n\nAnswer: Alprazolam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 650, "completion_tokens": 65, "total_tokens": 715, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011deabf5c8190a2334e1b81918a33", "custom_id": "Amlodipine-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d6d25f1d814f7dfbfb36011041e81626", "body": {"id": "chatcmpl-BNLQIeY9xgLQGSkZr1jfKmwx4ej3P", "object": "chat.completion", "created": 1744903594, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich agent, known for disrupting microtubule assembly in cancer therapy and associated with neurotoxic side effects, may experience an increased white blood cell count when co-administered with a dihydropyridine calcium channel blocker used to treat hypertension?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 622, "completion_tokens": 59, "total_tokens": 681, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dead22c819095581e468f1fec69", "custom_id": "Cimetidine-Palonosetron-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a8d8d15131c4cfedafd878ba6a2e7a8e", "body": {"id": "chatcmpl-BNLQJ4QPqSWUOssBzZyEYG5nmnHja", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, either the histamine H2 receptor antagonist used to inhibit stomach acid production or the 5-HT3 antagonist used to prevent chemotherapy-induced nausea and vomiting, is associated with erythema multiforme when interacting with the other?\n\nAnswer: Cimetidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 546, "completion_tokens": 57, "total_tokens": 603, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011deae63c8190a6c928c0fb34b49f", "custom_id": "Diazepam-Fenofibrate-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b978f0470ac44837432c6615f7f54b90", "body": {"id": "chatcmpl-BNLQK51zD3dQg9YdnvICgCQd68ZDa", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the case of co-administration, which drug\u2014used in the management of anxiety and seizures by enhancing GABA_A receptor activity\u2014is susceptible to developing metabolic encephalopathy when taken alongside a fibrate that activates PPAR\u03b1 to modify lipid profiles?\n\nAnswer: Diazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 801, "completion_tokens": 57, "total_tokens": 858, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011deaf80481908701065a9c74b7a7", "custom_id": "Naproxen-Ketoprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "33907d3f2f9acef4f394da2c1675e4c9", "body": {"id": "chatcmpl-BNLQLALmK98bxS0vFsMJptD6ikMXt", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, among a nonsteroidal anti-inflammatory agent commonly prescribed for conditions like rheumatoid arthritis and a propionic acid-derived NSAID patented in 1967, is associated with causing cholecystitis when interacting with the other?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 563, "completion_tokens": 56, "total_tokens": 619, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011deb09d48190a40c89274fe55fee", "custom_id": "Lamotrigine-Pilocarpine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4ea368a4e3e1e4bed31579dfd5c850bf", "body": {"id": "chatcmpl-BNLQMhG6HxzHIC4RaacJa5kIHv0ER", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used as a muscarinic agonist to facilitate aqueous humor outflow in glaucoma and also for xerostomia, when combined with a phenyltriazine anticonvulsant that inhibits excitatory neurotransmitter release, is associated with increased agitation due to their interaction?\n\nAnswer: Pilocarpine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 673, "completion_tokens": 66, "total_tokens": 739, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011deb1c148190b1af0c7ed5f38b92", "custom_id": "Citalopram-Ranolazine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f494b0b467685b3b7ef68a7e3a4d5111", "body": {"id": "chatcmpl-BNLQOmpWXRXxGZxcXDNPYDdhacNRM", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient receiving pharmacotherapy for major depressive disorder with a selective serotonin reuptake inhibitor that modulates serotonergic neurotransmission, poses a risk for developing bursitis when co-administered with an antianginal medication whose precise mechanism is unclear but is often reserved for cases unresponsive to first-line agents. Which of these two medications is implicated as the primary agent in this drug-drug interaction?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 666, "completion_tokens": 88, "total_tokens": 754, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011deb30948190999c14efd4c4944b", "custom_id": "Metronidazole-Duloxetine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b6e6b4e927657edccbe0c1c7e097ea2e", "body": {"id": "chatcmpl-BNLQPbUIZVRDxukSQRmHt1gPjIYYA", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of infectious diseases requiring a nitroimidazole antimicrobial with anaerobic and antiprotozoal activity and another patient receiving a serotonin\u2013norepinephrine reuptake inhibitor for mood or pain disorders both present with sudden-onset excessive daytime sleepiness. Based on the reported drug-drug interaction relating to narcolepsy, which patient\u2019s medication is more likely implicated as the interacting partner?\n\nAnswer: Duloxetine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 712, "completion_tokens": 90, "total_tokens": 802, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011deb426481909546ec346ab83b61", "custom_id": "Sibutramine-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9aeebc5a78126dd49dfea6044e16eed8", "body": {"id": "chatcmpl-BNLQRIilVoB1FGToMSZiC8C62jNqi", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich substance, known for modulating serotonin and norepinephrine reuptake to exert appetite-suppressing effects but withdrawn from several global markets due to cardiovascular risks, is associated with weight loss when used alongside a frequently prescribed nonbenzodiazepine hypnotic indicated for insomnia?\n\nAnswer: Sibutramine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 725, "completion_tokens": 64, "total_tokens": 789, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011deb544481909aac8b9533cff68f", "custom_id": "Tramadol-Exemestane-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d96d0b88abc8990fd8f684c1cedda939", "body": {"id": "chatcmpl-BNLQSrlJUlnRMW7udyB73ZJQVB9P6", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered concurrently with an aromatase inhibitor used for hormone-receptor-positive breast cancer, is associated with a potential for causing pneumonia as a drug-drug interaction?\n\nAnswer: Tramadol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 579, "completion_tokens": 44, "total_tokens": 623, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011deb70e48190ab9f4d2988b87234", "custom_id": "Diazepam-Doxazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a6570c386d3cd167617c4c84acccfec4", "body": {"id": "chatcmpl-BNLQTiIVonXLhPYPPtuw5DzRdrHOW", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its utility in conditions like benign prostatic hyperplasia and hypertension and acting as a selective \u03b11-adrenergic blocker, can be associated with the risk of right heart failure when co-administered with a prototypical benzodiazepine anxiolytic?\n\nAnswer: Doxazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 737, "completion_tokens": 67, "total_tokens": 804, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011deb834081909e5fdfafbc5a1c68", "custom_id": "acetazolamide-Lidocaine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "540fb73e9632c2b4c085d7767a51b2e4", "body": {"id": "chatcmpl-BNLQVkQ7HU76sqOdC1q2PH3XwccIG", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly used as a carbonic anhydrase inhibitor for the treatment of glaucoma and altitude sickness, is documented to cause exophthalmos when interacting with an amino amide local anesthetic renowned for its antiarrhythmic and anesthetic properties?\n\nAnswer: acetazolamide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 765, "completion_tokens": 61, "total_tokens": 826, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011deba0e081908c92177de0c0114e", "custom_id": "Fluorouracil-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "63dcbb74fcbb8f54fa507adbbef3566a", "body": {"id": "chatcmpl-BNLQWIAqj7kLltl67li6DCJ2vjCp4", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a chemotherapy regimen involving both a pyrimidine analog antimetabolite used for various carcinomas and dermatological conditions, and a vinca alkaloid mitotic inhibitor essential for leukemias and lymphomas, which of these two agents is indicated as contributing to bleeding when interacting with the other according to clinical knowledge-graph data?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 682, "completion_tokens": 76, "total_tokens": 758, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011debb4988190abff3a7864c742b5", "custom_id": "Fentanyl-desvenlafaxine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "14ecc44a8841cb5ac067d3f1bc818fa5", "body": {"id": "chatcmpl-BNLQYce5b22zYwDwSrNYDDVNlfhCx", "object": "chat.completion", "created": 1744903610, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in combination with an exceptionally potent synthetic opioid that poses high risk for rapid-onset central nervous system depression and is widely implicated in overdose scenarios, could contribute to nervous tension as part of their pharmacodynamic interaction?\n\nAnswer: desvenlafaxine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 718, "completion_tokens": 56, "total_tokens": 774, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011debc898819093a9329b06784acb", "custom_id": "Risedronic acid-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8fa72d0ba282bec611b56f3f762efc7e", "body": {"id": "chatcmpl-BNLQZOM8rYuEWyFucq6eFaiSuhk0i", "object": "chat.completion", "created": 1744903611, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with a bisphosphonate used to prevent bone breakdown in osteoporosis and Paget's disease, is associated with an increased risk of causing gastric inflammation?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 533, "completion_tokens": 47, "total_tokens": 580, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011debdbf0819083b68a6e00b541c4", "custom_id": "Candesartan-Amiloride-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3de2d6819d529c779883fa5cf72b9397", "body": {"id": "chatcmpl-BNLQauO8Ld6eWJNdlZzM9LNNxKy4d", "object": "chat.completion", "created": 1744903612, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of treating hypertension, which drug\u2014one that is an angiotensin receptor blocker with potent AT-1 antagonistic activity and is administered as a cascading prodrug\u2014has been associated with the adverse effect of back ache when combined with the potassium-sparing diuretic that inhibits epithelial sodium channels?\n\nAnswer: Candesartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 502, "completion_tokens": 70, "total_tokens": 572, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011debec748190ae6ca6d7a01a412b", "custom_id": "Cetirizine-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "12c1d30dccea6b1241388068d754ae81", "body": {"id": "chatcmpl-BNLQcsxzMPOGXiuyqhPiBlPSlfKkN", "object": "chat.completion", "created": 1744903614, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, characterized by its action as a second-generation selective H1 antihistaminergic agent with limited central nervous system effects and commonly prescribed for allergy management, has been associated with the development of erythema when used in combination with a selective PDE5 inhibitor used for erectile dysfunction and pulmonary arterial hypertension?\n\nAnswer: Cetirizine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 729, "completion_tokens": 70, "total_tokens": 799, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011debfdec8190a2871a4b157dffe0", "custom_id": "Benazepril-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3f51b15508488340d56746800e70369c", "body": {"id": "chatcmpl-BNLQdViFfVzFcZO7JX85xaXWILZsB", "object": "chat.completion", "created": 1744903615, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhen a patient taking an ACE inhibitor for hypertension\u2014known for risks such as nephrotoxicity, hyperkalemia, and sometimes prescribed in combination formulations\u2014experiences an interaction with an alpha-1 blocker also used for enlarged prostate, which of these drugs is the subject of an interaction characterized by apoplexy when administered with the other?\n\nAnswer: Benazepril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 592, "completion_tokens": 77, "total_tokens": 669, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dec0f008190993218b6744eb0d3", "custom_id": "nevirapine-Ofloxacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "26e2f61994fcd92d47ee7df05c635393", "body": {"id": "chatcmpl-BNLQeRNGK3SWeGLCQBmeTHT03Amr4", "object": "chat.completion", "created": 1744903616, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, used to treat and prevent HIV/AIDS and known as a non-nucleoside reverse transcriptase inhibitor, is linked via the knowledge graph to the medication typically prescribed for bacterial infections through an anogenital warts relationship?\n\nAnswer: nevirapine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 633, "completion_tokens": 56, "total_tokens": 689, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dec20088190909bbf94a6efcb14", "custom_id": "Gabapentin-Thalidomide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "88bfd00638d702be974090acb446977b", "body": {"id": "chatcmpl-BNLQgLT2xalji2zAve4XGVdVkFibU", "object": "chat.completion", "created": 1744903618, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient undergoing therapy for neuropathic pain with a drug that binds the \u03b12\u03b4-1 subunit of voltage-gated calcium channels develops cholecystitis after the introduction of an immunomodulatory agent, historically known for its teratogenicity in the treatment of multiple myeloma and leprosy complications. Based on the interaction between these agents, which drug is implicated as the precipitating cause of cholecystitis in this scenario?\n\nAnswer: Thalidomide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 736, "completion_tokens": 102, "total_tokens": 838, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dec311081908b1408ae7613a4f8", "custom_id": "Alfuzosin-Famotidine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "de705c6919950d03366daecb582c6e56", "body": {"id": "chatcmpl-BNLQh01esWfwjUDfO3uNS4h7jny4J", "object": "chat.completion", "created": 1744903619, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with benign prostatic hyperplasia is prescribed a medication that acts as an \u03b11-adrenergic receptor antagonist to make urination easier, and then begins taking a histamine H2 receptor antagonist for symptoms of peptic ulcer disease. Which of these two medications, when used together, is most associated with an increased risk of thrombocytopenia due to their drug-drug interaction?\n\nAnswer: Alfuzosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 550, "completion_tokens": 87, "total_tokens": 637, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dec42488190be095ba5e43fe8bb", "custom_id": "Famotidine-Repaglinide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2f6f463143624cb1db24a079a5bb0b6c", "body": {"id": "chatcmpl-BNLQj2OLyG2RsHFXu6xVSdoickgw3", "object": "chat.completion", "created": 1744903621, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question: In a patient being treated with a histamine H2 receptor antagonist for reducing stomach acid production and an antidiabetic meglitinide that promotes insulin release, which drug is specifically associated with causing erythema when used in combination with the other?\n\nAnswer: Famotidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 566, "completion_tokens": 57, "total_tokens": 623, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dec53648190a538fc5bafe48194", "custom_id": "Temazepam-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "32fd58bd7b7d0824c492a4fbabdc7c83", "body": {"id": "chatcmpl-BNLQkC2H61dQyojYhLv3bhvoZammR", "object": "chat.completion", "created": 1744903622, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich hypnotic agent, when used in combination with a nonbenzodiazepine imidazopyridine that acts as a GABA-A receptor positive allosteric modulator and is commonly prescribed as a Z-drug for insomnia, may contribute to the risk of gastric inflammation as described in their drug-drug interaction profile?\n\nAnswer: Temazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 777, "completion_tokens": 74, "total_tokens": 851, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dec64ac81908ecb3994822def26", "custom_id": "Alprazolam-Benazepril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "73e1e9a9bd68957e5d24a6e5db0f3648", "body": {"id": "chatcmpl-BNLQmIfoTFCSVBmgOox3t4Cc456CV", "object": "chat.completion", "created": 1744903624, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when used in combination with a triazolobenzodiazepine anxiolytic that modulates GABA_A receptors, is associated with an increased risk of gastric inflammation due to their interaction?\n\nAnswer: Benazepril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 644, "completion_tokens": 51, "total_tokens": 695, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dec79d0819095c1041b831150e6", "custom_id": "phenytoin-Fosphenytoin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5d43504a5e2e071e54eb997f023a371a", "body": {"id": "chatcmpl-BNLQnuzT4tXsV8V7Zmnmn3X5OjsNL", "object": "chat.completion", "created": 1744903625, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient experiences a drug hypersensitivity reaction upon receiving a water-soluble prodrug administered intravenously for acute convulsive status epilepticus, which related sodium channel inhibitor, commonly used for tonic-clonic and focal seizure disorders and requiring plasma monitoring, might they also need to avoid due to cross-reactivity?\n\nAnswer: phenytoin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 567, "completion_tokens": 71, "total_tokens": 638, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dec8ae881909e476bbb25664a6d", "custom_id": "Furosemide-hydralazine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a8ab3775df4f3d82db6e278006ff049a", "body": {"id": "chatcmpl-BNLQHYrLpPxSXVlWmv9IWO4FBeuYR", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nConsidering that one medication is a potent loop diuretic with rapid diuretic effects and the other is a direct-acting vasodilator effective in acute blood pressure management, which is associated with an increased risk of right bundle branch block when taken in conjunction with the other?\n\nAnswer: hydralazine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 717, "completion_tokens": 63, "total_tokens": 780, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dec9dcc81909200c122919fa5dc", "custom_id": "Famotidine-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3401c0bf61570f6cb529f9312fad312f", "body": {"id": "chatcmpl-BNLQJprVd7eziGQ9Evr753hSkUnme", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for inhibiting PDE5 to enhance cGMP-mediated vasodilation, may have its effectiveness influenced in the context of gastric inflammation when co-administered with a drug that reduces stomach acid production?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 650, "completion_tokens": 50, "total_tokens": 700, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011decb0a481908b554a6ae489cc45", "custom_id": "Amlodipine-Pamidronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d00aaa6d96d41b4834b014f5672af3ca", "body": {"id": "chatcmpl-BNLQK4dCTe9QXMfhxWP3JXJfmYK0W", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of a drug used to prevent osteoporosis and a long-acting calcium channel blocker indicated for hypertension, which medication is associated with causing erythema as a result of their drug-drug interaction?\n\nAnswer: Amlodipine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 456, "completion_tokens": 51, "total_tokens": 507, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011decc7bc8190a6873c2bf46c3160", "custom_id": "Famotidine-Fulvestrant-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "deb6d71721d221731716888662120959", "body": {"id": "chatcmpl-BNLQHwY7XzuPyFxoDP2xbqUkdBc8W", "object": "chat.completion", "created": 1744903593, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly prescribed for hormone receptor-positive metastatic breast cancer through intramuscular injection as a selective estrogen receptor degrader, may be associated with weight loss when used in combination with a medication that decreases stomach acid production by blocking histamine H2 receptors?\n\nAnswer: Fulvestrant", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 568, "completion_tokens": 60, "total_tokens": 628, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011decd9a08190b804d09dc96fd7ed", "custom_id": "Risedronic acid-mercaptopurine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7b47855560943069faa8c6062ad7887f", "body": {"id": "chatcmpl-BNLQLaHr8nl3LJSgc7UPvNnrpQwR7", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly administered for leukemia or inflammatory bowel disease due to its inhibition of purine nucleotide synthesis, may interact with a bisphosphonate osteoporosis treatment in a manner that increases the risk or severity of pain?\n\nAnswer: mercaptopurine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 554, "completion_tokens": 52, "total_tokens": 606, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011decef4481908bb4690c68983ad8", "custom_id": "Dofetilide-Bimatoprost-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1f6339e8c5d30f98e6ba9c66512f7966", "body": {"id": "chatcmpl-BNLQJM6WzKKrsqQevH8xs1ovKoWmf", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a medication used to decrease intraocular pressure in glaucoma by increasing the outflow of aqueous fluid, has been associated with a risk of phlebothrombosis when interacting with a class III antiarrhythmic agent?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 494, "completion_tokens": 56, "total_tokens": 550, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ded07008190b91da1ff75d636bb", "custom_id": "Ziprasidone-Acamprosate-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4f06bc5b34391537e92cde13940ddec6", "body": {"id": "chatcmpl-BNLQMN4Emsj6XI1IuU7KyB6MrTtFh", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA clinician is treating a patient for schizophrenia with a second-generation antipsychotic that modulates serotonergic and dopaminergic pathways and is noted for a lower risk of weight gain. If this patient is also prescribed a medication that helps reduce alcohol cravings and is known for causing diarrhea, but is associated with abnormal heart rhythms when combined with certain agents, which drug may contribute to arrhythmia risk in this combination\u2014 the antipsychotic, or the craving-reducing medication?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 662, "completion_tokens": 106, "total_tokens": 768, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ded1a5481909786228b2972116f", "custom_id": "Capecitabine-Erlotinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8ffb35e4050bd5d5d1c6221a2df7d78d", "body": {"id": "chatcmpl-BNLQKGaEVmVUhGqPLDVGmdCZ2EMQs", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in a patient also receiving an oral anticancer therapy commonly given for NSCLC with EGFR mutations, is linked as the potential precipitating agent for apoplexy according to known drug-drug interactions?\n\nAnswer: Capecitabine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 638, "completion_tokens": 54, "total_tokens": 692, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011ded2ed8819098ff68c2f670d27b", "custom_id": "indometacin-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4a3c6dc8d7e219afc5f65449cf4870cf", "body": {"id": "chatcmpl-BNLQO8J5v2uKdbMTcAve3sNQJ9uDr", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when taken concomitantly with an alpha-1 blocker used for enlarged prostate and high blood pressure, is associated with the occurrence of erythema?\n\nAnswer: indometacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 559, "completion_tokens": 41, "total_tokens": 600, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011ded43b88190a39e5fd5b8de6d18", "custom_id": "Fenofibrate-Modafinil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a45a9194262d4d01c387cf32f365f0b7", "body": {"id": "chatcmpl-BNLQLEmXpSqi0H9oYVDph4NqRn5fZ", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question: In a patient being treated for dyslipidemia characterized by elevated triglycerides using a PPAR\u03b1 agonist with potential risks of hepatotoxicity and cholelithiasis, which concurrently administered medication, primarily indicated for promoting wakefulness in narcolepsy and known to sometimes cause insomnia and headaches, is associated with the onset of gastric inflammation due to their interaction?\n\nAnswer: Modafinil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 660, "completion_tokens": 81, "total_tokens": 741, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ded57508190b8cd744ff508dc8b", "custom_id": "Cetirizine-hydroxychloroquine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7f87ce59a3704c46317fdda6b07fb579", "body": {"id": "chatcmpl-BNLQPJipt1hb7uiepT3BcoV38vk25", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question: In the context of their drug-drug interaction, which medication\u2014one primarily used for allergic conditions with minimal central nervous system effects, or the other, a 4-aminoquinoline antimalarial and immunomodulator\u2014has been associated with the development of cholecystitis when co-administered with the first?\n\nAnswer: hydroxychloroquine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 747, "completion_tokens": 75, "total_tokens": 822, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ded6b6c819088360ac41f601333", "custom_id": "Temazepam-mitomycin C-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "34497299e7ee42299858bfa7067abc9a", "body": {"id": "chatcmpl-BNLQM2nuW1tu7TVVK7N9JvYL5NOj9", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered in combination with a chemotherapeutic agent possessing antitumor properties, may lead to gastric inflammation due to its pharmacodynamic and safety profile that includes risks such as cognitive dysfunction, hypotension, and interactions with other CNS depressants?\n\nAnswer: Temazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 514, "completion_tokens": 59, "total_tokens": 573, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011ded7fd481908833ddaa85114f0a", "custom_id": "Tramadol-Trimethoprim-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "023cbe2cb5a70f0af193752f357cea4e", "body": {"id": "chatcmpl-BNLQQv5pqkSjSxrHvaz5Hn4Ji2NoN", "object": "chat.completion", "created": 1744903602, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for inhibiting dihydrofolate reductase to treat infections such as bladder and ear infections, may induce dysarthria when used concomitantly with an atypical analgesic that acts as both a \u03bc-opioid agonist and serotonin-norepinephrine reuptake inhibitor?\n\nAnswer: Trimethoprim", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 652, "completion_tokens": 71, "total_tokens": 723, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011ded93e48190baddce74141b9fa9", "custom_id": "Gabapentin-Moexipril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "da0eb34c6f972c47cc236940d83b227d", "body": {"id": "chatcmpl-BNLQOBw1DUUnQkuvvTrwgrajVIZJh", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, among those described as a commonly prescribed neuropathic pain and seizure agent versus an ACE inhibitor formerly used for hypertension and heart failure, has been linked in a drug-drug interaction to hepatic neoplasia when co-administered with the other?\n\nAnswer: Moexipril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 581, "completion_tokens": 61, "total_tokens": 642, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011deda7108190a3a023c5ad2eb6d3", "custom_id": "Lamivudine-Metoprolol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "223381cbec23a89746e0ef9911b57ad4", "body": {"id": "chatcmpl-BNLQPXNUr1DQch3Kf8MuoDr0Jk9kT", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a nucleoside reverse transcriptase inhibitor commonly used for HIV and hepatitis B therapy, is reported to be associated with the risk of developing dysarthria when used in combination with a cardioselective \u03b21-adrenergic receptor antagonist prescribed for cardiovascular conditions such as hypertension and angina pectoris?\n\nAnswer: Metoprolol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 676, "completion_tokens": 73, "total_tokens": 749, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dedba088190aa98451c6f044d26", "custom_id": "Methylphenidate-Pirbuterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "16f934d1b035ab4c3efc48189be775e6", "body": {"id": "chatcmpl-BNLQRuEQBqpxktcO6SBqWY63HjqkZ", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient receiving both a CNS stimulant medication commonly prescribed for ADHD that enhances synaptic dopamine and norepinephrine levels, and a short-acting \u03b22-adrenoreceptor agonist inhaler used for asthma relief, which of these two agents is more likely to be associated with weight gain as a result of their interaction?\n\nAnswer: Pirbuterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 543, "completion_tokens": 72, "total_tokens": 615, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dedcbc48190ada87b912a5ce34c", "custom_id": "Alfuzosin-Gemfibrozil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "427c2a9fa2d503516402798aed30159d", "body": {"id": "chatcmpl-BNLQQ1QHtzYqnllcgykQefSmJUNKr", "object": "chat.completion", "created": 1744903602, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to treat abnormal blood lipid levels, is associated with the risk of an enlarged spleen when taken in combination with an \u03b11 blocker prescribed for benign prostatic hyperplasia?\n\nAnswer: Gemfibrozil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 568, "completion_tokens": 47, "total_tokens": 615, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dedde208190872fcb4a97a84b18", "custom_id": "Candesartan-Cinacalcet-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c5bbcabe03becd408807f7389c7b5c0f", "body": {"id": "chatcmpl-BNLQTKY6UA0GwBEbgHu3uw0a9c9yx", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for high blood pressure and congestive heart failure is prescribed a highly potent angiotensin receptor blocker with a cascading prodrug metabolism. If this patient concurrently begins therapy with a calcimimetic agent used for parathyroid disorders and known for acting on the calcium-sensing receptor, which medication is associated with the onset of thrombocytopenia when combined with the other?\n\nAnswer: Candesartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 504, "completion_tokens": 86, "total_tokens": 590, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011dedf1348190a36a84370ff7de91", "custom_id": "Naproxen-hydroxychloroquine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2ded3ae63d9e11aa2245a67a7512ab21", "body": {"id": "chatcmpl-BNLQSizTG4EDFxirQyBuGbdoAv5tz", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, characterized by its immunomodulatory use in autoimmune diseases and historical but now discredited role in COVID-19 treatment, is associated with increased risk of gastric inflammation when combined with a nonsteroidal anti-inflammatory drug used for pain and inflammatory conditions?\n\nAnswer: hydroxychloroquine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 752, "completion_tokens": 61, "total_tokens": 813, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dee0420819085fef19b61efb587", "custom_id": "Citalopram-Riluzole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3c5726f543e2483a4a8c69d2b345658e", "body": {"id": "chatcmpl-BNLQUwVg6rEcaCspVzkvmrWwMaEuT", "object": "chat.completion", "created": 1744903606, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, employed in the treatment of amyotrophic lateral sclerosis and capable of prolonging survival by two to three months, is associated with deglutition disorder when used in combination with a selective serotonin reuptake inhibitor whose adverse effect profile includes serotonin toxicity and QT prolongation?\n\nAnswer: Riluzole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 580, "completion_tokens": 66, "total_tokens": 646, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dee16208190be24fea45c8dd33e", "custom_id": "folinic acid-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "eb5eed35b6ff8c8ce384e6286a867b40", "body": {"id": "chatcmpl-BNLQTlhUZlqA0KaY3cflchMMJM2gp", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in combination with a potent ACE inhibitor prodrug that requires hepatic activation and treats hypertension and heart failure, is associated with an increased risk of thrombocytopenia?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 645, "completion_tokens": 46, "total_tokens": 691, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dee2a0881908b331cac61813680", "custom_id": "Famotidine-hydroxychloroquine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "efd621808b40555d8833856a6aa432c4", "body": {"id": "chatcmpl-BNLQUVN3ktTVStpaTydr1Dvt1K1y7", "object": "chat.completion", "created": 1744903606, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used in the management of malaria and certain autoimmune disorders and associated with rare but severe toxicities including arrhythmias and retinopathy, has been linked to the development of adenopathy when administered in conjunction with a histamine H2 receptor antagonist that decreases stomach acid production?\n\nAnswer: hydroxychloroquine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 666, "completion_tokens": 66, "total_tokens": 732, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dee3b70819091eacca84b9a21c1", "custom_id": "Ibuprofen-Modafinil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c539511f122624378e65fb5783e92416", "body": {"id": "chatcmpl-BNLQV5JFIU519ew5aGneYuJuiOjsu", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, a nonsteroidal anti-inflammatory agent commonly used for pain and inflammation, may present with adenopathy when administered concomitantly with a central nervous system stimulant prescribed for wakefulness disorders?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 648, "completion_tokens": 47, "total_tokens": 695, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dee51e0819081ea39ccf5720d95", "custom_id": "Fentanyl-Metolazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "87d78749438ce5a72f2c0d25e766bc0d", "body": {"id": "chatcmpl-BNLQWWIJHUCJwEuB3z7i2ioNlu8Cg", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its thiazide-like diuretic action in managing hypertension and heart failure, is at risk of causing cholecystitis when combined with a potent synthetic opioid with high \u03bc-opioid receptor affinity?\n\nAnswer: Metolazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 646, "completion_tokens": 56, "total_tokens": 702, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dee65348190b8b4c1d41f3ae3c4", "custom_id": "Lamotrigine-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a062ddc26c1ed245fc6534779754d72b", "body": {"id": "chatcmpl-BNLQWPoqi95Cw79j5s24TdmXulvrM", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich of the following drugs, an anticonvulsant and mood stabilizer that inhibits excitatory neurotransmitter release, or a selective phosphodiesterase type 5 inhibitor used for vasodilation in erectile dysfunction and pulmonary arterial hypertension, is associated with rectal hemorrhage when used concomitantly with the other?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 692, "completion_tokens": 69, "total_tokens": 761, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011dee763c8190b787aa829350aa12", "custom_id": "Citalopram-Propofol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d85af15c19c624d33a4be6f2b10b01c7", "body": {"id": "chatcmpl-BNLQXK0lMsgN2zSTedVpt6nJKOxYa", "object": "chat.completion", "created": 1744903609, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical context where one agent is prescribed for major depressive or anxiety-related disorders and the other is utilized as a rapid-onset intravenous anesthetic, which drug, according to documented interactions, is implicated in the development of cataracts when co-administered with the other?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 740, "completion_tokens": 64, "total_tokens": 804, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011dee88688190937857b60f537317", "custom_id": "Diazepam-Gemfibrozil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "aa9090c51af828629c7c3bf841f8f412", "body": {"id": "chatcmpl-BNLQXqu6btFPqcjwCCzsBWUX9jpyb", "object": "chat.completion", "created": 1744903609, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when used in conjunction with a lipid-lowering fibrate associated with gastrointestinal side effects and risk of gallstones, has been specifically implicated in the occurrence of cholecystitis as a drug-drug interaction?\n\nAnswer: Diazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 740, "completion_tokens": 52, "total_tokens": 792, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011dee9b1881908ecafceb5e572473", "custom_id": "Naproxen-Capecitabine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1fe1893ced0581c9caee5debabb3a1ed", "body": {"id": "chatcmpl-BNLQZrZs5SfAQVMQRzmDFVJwp2u5g", "object": "chat.completion", "created": 1744903611, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn considering a scenario where a patient is being treated for inflammatory conditions with an agent that inhibits cyclooxygenase enzymes and is then prescribed a chemotherapy agent that acts as a prodrug of 5-fluorouracil, which medication is more likely to experience an interaction characterized by loss of weight according to clinical drug-drug interaction data?\n\nAnswer: Capecitabine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 697, "completion_tokens": 78, "total_tokens": 775, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011deeab9481909895eb0e449be609", "custom_id": "Gabapentin-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7bb673c7f54d29002747b9e1c1e4f564", "body": {"id": "chatcmpl-BNLQYXcx42xV35LFS7UKda4lFryw6", "object": "chat.completion", "created": 1744903610, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for attenuating synaptic glutamate release via high-affinity binding to neuronal calcium channels and commonly prescribed for neuropathic pain, is associated with causing gastric inflammation when administered alongside a selective phosphodiesterase type 5 inhibitor used for erectile dysfunction and pulmonary arterial hypertension?\n\nAnswer: Gabapentin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 712, "completion_tokens": 66, "total_tokens": 778, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011deec3408190bb1e1b5f530b7013", "custom_id": "alendronic acid-Moexipril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "bf1131e7518ce4445745e71404f42a4f", "body": {"id": "chatcmpl-BNLQaiozcLolqEhE6574TuFyOBv1C", "object": "chat.completion", "created": 1744903612, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, a bisphosphonate used to treat bone disorders or an ACE inhibitor used for hypertension, is more likely to cause gastric inflammation when used with the other?\n\nAnswer: alendronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 518, "completion_tokens": 43, "total_tokens": 561, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011deed5b48190a35401343cba5fde", "custom_id": "Risedronic acid-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0a883679bc21a0c0f891fbb3082f1c10", "body": {"id": "chatcmpl-BNLQZVXyO7YtbnIoUohi87gb2dTD0", "object": "chat.completion", "created": 1744903611, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich of the two medications\u2014one used primarily to treat or prevent osteoporosis by slowing bone breakdown, and the other an alpha-1 blocker addressing symptoms of an enlarged prostate and hypertension\u2014is associated with the possibility of causing adenopathy when used in combination with the other?\n\nAnswer: Terazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 485, "completion_tokens": 60, "total_tokens": 545, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011deee7c881909b80400e6fc553df", "custom_id": "Temazepam-Trimipramine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3e5ff17998b0b1ab6c18ef495c699da7", "body": {"id": "chatcmpl-BNLQb3ts1IJcsTG6FrlYpZM5evoXr", "object": "chat.completion", "created": 1744903613, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its use in treating depression and characterized by anticholinergic, antihistamine, and antiserotonergic activity, is at risk of causing constipation when used concurrently with a benzodiazepine hypnotic agent indicated for severe insomnia?\n\nAnswer: Trimipramine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 632, "completion_tokens": 61, "total_tokens": 693, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011deefaa481909adffd1d91c07fc0", "custom_id": "Ofloxacin-Darunavir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ddc28227932449ae70d5027812d372dc", "body": {"id": "chatcmpl-BNLQcLt1V3YXlTLwZUts0yA2oUTcA", "object": "chat.completion", "created": 1744903614, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of a patient being treated with a fluoroquinolone DNA synthesis inhibitor known for adverse effects like peripheral neuropathy and contraindication in pregnancy, as well as a protease inhibitor requiring pharmacokinetic boosting as part of HIV therapy, which medication is associated with causing an eruption when interacting with the other?\n\nAnswer: Darunavir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 643, "completion_tokens": 71, "total_tokens": 714, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011def0cb081908f718f9f1e6f2cbe", "custom_id": "Ketorolac-Ondansetron-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5c2caf6b8e493dd39a844f373209693b", "body": {"id": "chatcmpl-BNLQbcHUlCDhaKEFrJdgoxjJWP5le", "object": "chat.completion", "created": 1744903613, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its selective serotonin 5-HT3 receptor antagonism and prominent antiemetic use, has been associated with the risk of adenopathy when interacting with a potent nonsteroidal anti-inflammatory agent used for short-term pain control?\n\nAnswer: Ondansetron", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 763, "completion_tokens": 59, "total_tokens": 822, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011def20448190bc63e1712b19c642", "custom_id": "Amlodipine-Isoniazid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d734d338f503e593b64e49816dad48b7", "body": {"id": "chatcmpl-BNLQdAEsIV7YWZVHv2QJjboC6v1NE", "object": "chat.completion", "created": 1744903615, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly prescribed for tuberculosis and sometimes administered intramuscularly, is associated with angiitis when taken in combination with a dihydropyridine-type calcium channel blocker used for hypertension and angina?\n\nAnswer: Isoniazid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 522, "completion_tokens": 51, "total_tokens": 573, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011def316c81908599420b22ef862f", "custom_id": "Furosemide-Fulvestrant-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a7aa7c662565f2a2d9735c005de8f291", "body": {"id": "chatcmpl-BNLQcjmB6jEcv6pKOLWa7hmB9Vuoj", "object": "chat.completion", "created": 1744903614, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for inhibiting the Na-K-2Cl symporter in the kidney and commonly prescribed to manage edema and hypertension, is associated with an interaction in the form of gastric inflammation when co-administered with a selective estrogen receptor degrader used in hormone receptor-positive metastatic breast cancer?\n\nAnswer: Furosemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 651, "completion_tokens": 68, "total_tokens": 719, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011def439c81908feb4fc72d0e6158", "custom_id": "Diazepam-Desloratadine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "dfee97c5c4c8a0eb60bc7c17fb6401e8", "body": {"id": "chatcmpl-BNLQeqU98tD4hbXX4BiEYWPTIT6uN", "object": "chat.completion", "created": 1744903616, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly prescribed as an anxiolytic by enhancing GABAergic neurotransmission and associated with risks such as dependence and withdrawal syndrome, has been implicated in developing cholecystitis when co-administered with a tricyclic H1 inverse agonist used for allergy treatment?\n\nAnswer: Diazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 634, "completion_tokens": 65, "total_tokens": 699, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011def546c81908a49962ab4cc4045", "custom_id": "Metoprolol-Pirbuterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6958b5fa3ee61324bc705c759141f047", "body": {"id": "chatcmpl-BNLQejzSoP6WRyhje8mpL4KF6Ny11", "object": "chat.completion", "created": 1744903616, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used concurrently with a short-acting \u03b22-adrenoreceptor agonist indicated for asthma and administered as a breath-activated inhaler, has been associated with the adverse reaction of erythema due to its cardioselective \u03b21-adrenergic receptor antagonism and necessity for individualized dosing based on CYP2D6 metabolic variability?\n\nAnswer: Metoprolol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 515, "completion_tokens": 81, "total_tokens": 596, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011def6600819098c331de49971692", "custom_id": "Risedronic acid-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d5ec0d8c0186e424cc13fddc629e0563", "body": {"id": "chatcmpl-BNLQfd2dnYKuZV0hv1GxOAgVfDlpk", "object": "chat.completion", "created": 1744903617, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, characterized as a mitotic inhibitor derived from Catharanthus roseus and commonly used to treat various malignancies, is associated with weight gain when used in combination with a bisphosphonate prescribed for osteoporosis and Paget's disease?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 534, "completion_tokens": 57, "total_tokens": 591, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011def763481909b79deeff1be45e0", "custom_id": "Brimonidine-hydroxychloroquine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8783d929cab32d5edcba80e691a6b33f", "body": {"id": "chatcmpl-BNLQfZ8syLmZqDzSI409yCrT98RLl", "object": "chat.completion", "created": 1744903617, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, characterized by its ability to lower intraocular pressure via decreased aqueous humor production and increased uveoscleral outflow, is linked to weight loss when co-administered with a 4-aminoquinoline antimalarial agent used for malaria prophylaxis and autoimmune diseases?\n\nAnswer: Brimonidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 708, "completion_tokens": 66, "total_tokens": 774, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011def8a608190b2896d35dad0c18a", "custom_id": "Amlodipine-Erlotinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6a9368c213d8e1ecc73577920d299495", "body": {"id": "chatcmpl-BNLQIdljnBC3rBt0AORv0tsMLSNdQ", "object": "chat.completion", "created": 1744903594, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient receiving one drug that acts as a long-acting dihydropyridine calcium channel blocker indicated for hypertension and angina, and another drug that is an oral EGFR tyrosine kinase inhibitor used for advanced non-small cell lung and pancreatic cancers, which drug has been specifically associated with subarachnoid hemorrhage as an interaction risk when taken together?\n\nAnswer: Erlotinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 602, "completion_tokens": 82, "total_tokens": 684, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011def9bbc8190bb71b9cd00c8fa2c", "custom_id": "Naproxen-Norfloxacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f41aec80c8cb2e72b9a893f04bc4face", "body": {"id": "chatcmpl-BNLQhWAp2zfnHbCAykbC7ZdHhAHtK", "object": "chat.completion", "created": 1744903619, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for non-selectively inhibiting cyclooxygenase (COX) enzymes and commonly prescribed for pain and inflammatory conditions, shares a drug-drug interaction relationship related to atherosclerosis with a fluoroquinolone antibiotic used to treat urinary and gynecological infections that can rarely cause tendon rupture?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 631, "completion_tokens": 71, "total_tokens": 702, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011defacb081908b331adab6046936", "custom_id": "Candesartan-Ofloxacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1f6eeeb06a3fd91ba0beb328b7630ee6", "body": {"id": "chatcmpl-BNLQgmWUU7GQUyJ8Lu5mED2FkC7TQ", "object": "chat.completion", "created": 1744903618, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nGiven that one medication is a cascading prodrug angiotensin receptor blocker used mainly for hypertension and heart failure, and another is a fluoroquinolone antibiotic commonly indicated for bacterial infections, which of these two drugs is associated with causing gastric inflammation when administered together with the other?\n\nAnswer: Ofloxacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 535, "completion_tokens": 62, "total_tokens": 597, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011defc0408190a25c6b1a33e47bd2", "custom_id": "Ondansetron-Telithromycin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5429279e8fa60bf134c6d417de78e752", "body": {"id": "chatcmpl-BNLQJbqTACgmjvFugl12za5LoZAuK", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered in combination with a ketolide antibiotic indicated for mild to moderate community-acquired pneumonia, is associated with an increased risk of cholecystitis?\n\nAnswer: Ondansetron", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 633, "completion_tokens": 44, "total_tokens": 677, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011defd1c48190b5055778b818db1c", "custom_id": "Carvedilol-melphalan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0e0c5c9cdb3df4cef5b165c9f57231ce", "body": {"id": "chatcmpl-BNLQiSliLvPvKetCnC0RlGwXUK1wD", "object": "chat.completion", "created": 1744903620, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient being treated for multiple myeloma with an alkylating chemotherapy agent known to cause bone marrow suppression and risk of developing other cancers, which additional medication, a nonselective beta-adrenergic blocker also used for chronic heart failure, could increase the risk of thrombocytopenia when co-administered?\n\nAnswer: Carvedilol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 631, "completion_tokens": 75, "total_tokens": 706, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011defe55c8190af5db2160ba22f9e", "custom_id": "alendronic acid-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2e29606027954b2e1378e1499b8b461d", "body": {"id": "chatcmpl-BNLQhgJ4Spx6nVXz29C4NcijvxX9K", "object": "chat.completion", "created": 1744903619, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient being treated for osteoporosis with a medication that reduces bone breakdown via inhibition of bone-resorbing cell activity, and who is also receiving an antihypertensive prodrug that suppresses aldosterone and increases sodium excretion, which drug is reported to be associated with the development of erythema when the two are used together?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 630, "completion_tokens": 77, "total_tokens": 707, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011deff8788190832acf20d8884338", "custom_id": "Paracetamol-Disopyramide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3dd4bbbf4502ad04352a36ddcb8b7435", "body": {"id": "chatcmpl-BNLQj88f7Dfkq9tCmR1Pmkb92kmXZ", "object": "chat.completion", "created": 1744903621, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for use in ventricular tachycardia as a sodium channel blocker with anticholinergic effects and a high side effect burden, has been associated with erythema when administered alongside the centrally-acting analgesic and antipyretic agent primarily inhibiting COX enzymes in the CNS?\n\nAnswer: Disopyramide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 788, "completion_tokens": 71, "total_tokens": 859, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df01ad0819089f3c95899fb9cec", "custom_id": "Famotidine-Formoterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0951b3ee6657446666455c08a1fdf5ae", "body": {"id": "chatcmpl-BNLQLPS8RbysKPOphDsMPnKI3hCM9", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBased on the interaction between the medication that reduces stomach acid production and the long-acting bronchodilator used for asthma and COPD, which of these drugs is associated with weight gain when used with the other?\n\nAnswer: Formoterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 651, "completion_tokens": 49, "total_tokens": 700, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df02c04819091f200cac3b82401", "custom_id": "Repaglinide-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7d5f5b6fc0881f8046b62cd57af9e6f7", "body": {"id": "chatcmpl-BNLQjMe5bfPPG6uLkCwnJMI8Rp2Tt", "object": "chat.completion", "created": 1744903621, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient is taking a medication that promotes insulin release from pancreatic \u03b2-islet cells to manage type 2 diabetes, and another drug that functions as a long-acting ACE inhibitor for hypertension. If this patient experiences nasal sinus congestion as a result of their drug regimen, which agent is implicated as causing this effect in the context of their interaction?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 610, "completion_tokens": 77, "total_tokens": 687, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df040008190b9cdea1317b98e76", "custom_id": "Zolpidem-vincristine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2a8a9b766621ae88f98647375af18305", "body": {"id": "chatcmpl-BNLQkrkhiWwUInJ14YzPuiaxOt3u2", "object": "chat.completion", "created": 1744903622, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhen combined, which agent\u2014either the nonbenzodiazepine hypnotic that acts as a GABAA positive allosteric modulator commonly prescribed for insomnia, or the mitotic inhibitor used intravenously in oncology that binds tubulin\u2014has been associated with causing adenopathy in the setting of their drug-drug interaction?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 753, "completion_tokens": 73, "total_tokens": 826, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df05380819088c503f7b326733d", "custom_id": "Dexpramipexole-Ticlopidine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9833f398436278d98ad9da140618142b", "body": {"id": "chatcmpl-BNLQkUxyf6j7ZDi2qYktDQYQeWyjG", "object": "chat.completion", "created": 1744903622, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBased on their mechanisms and clinical development, which drug, when interacting with the other, is associated with the risk of causing hyperglycaemia during combined use\u2014an investigational medicine that lowers eosinophil levels for eosinophilic asthma or an antiplatelet ADP receptor inhibitor used to reduce stroke risk?\n\nAnswer: Ticlopidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 532, "completion_tokens": 73, "total_tokens": 605, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df06a2c81909e4ccd1e0607d700", "custom_id": "Fentanyl-Zaleplon-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9cb057df4f352e977ef6ececb23e10c7", "body": {"id": "chatcmpl-BNLQMWtZGGlHvu3MjVSLgU78yim85", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient taking a synthetic piperidine opioid agonist known for its high potency and risk of inducing severe central nervous system depression, the emergence of adenopathy is specifically associated with the concurrent use of which sedative-hypnotic, nonbenzodiazepine agent of the pyrazolopyrimidine class rather than being a primary effect of the opioid alone?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 565, "completion_tokens": 83, "total_tokens": 648, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df07d1081909e993b49926bd1b7", "custom_id": "Carvedilol-solifenacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "357d55252970f730ce1db13db7ff329b", "body": {"id": "chatcmpl-BNLQNiD6GkGlEJDRjFJgCPAi6SgmH", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly prescribed for overactive bladder and belonging to the antimuscarinic class, is associated with belching when co-administered with a nonselective beta-adrenergic blocker that also blocks alpha-1 receptors?\n\nAnswer: solifenacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 626, "completion_tokens": 56, "total_tokens": 682, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df090688190bdfff7c48394ac5b", "custom_id": "Cimetidine-Sumatriptan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1e0e8314334a6f51820977b3bf57c754", "body": {"id": "chatcmpl-BNLQloNQk0nziX8tvboRSHJ8YxQyx", "object": "chat.completion", "created": 1744903623, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, used to inhibit stomach acid production, is associated with inducing vasculitic inflammatory reactions when administered in conjunction with the serotonin receptor agonist utilized for migraine relief?\n\nAnswer: Cimetidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 619, "completion_tokens": 42, "total_tokens": 661, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df0a53c8190980037bb55cb0ce4", "custom_id": "Amlodipine-Metolazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4b269f85b0e26892d703446f9fb2754c", "body": {"id": "chatcmpl-BNLQPolIUf69XLvx3QsCtWyyNvkDE", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known as a thiazide-like diuretic used primarily for congestive heart failure and high blood pressure, has been associated with the development of cholecystitis when interacting with a long-acting dihydropyridine calcium channel blocker?\n\nAnswer: Metolazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 552, "completion_tokens": 62, "total_tokens": 614, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df0bb448190966830365908e8aa", "custom_id": "Ketorolac-Duloxetine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "cc247f0a29d1a89d741c06bd21fd9a15", "body": {"id": "chatcmpl-BNLQm9J5kU45F7EVkqVWGjrIx0V8J", "object": "chat.completion", "created": 1744903624, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, by inhibiting prostaglandin synthesis and frequently used as a short-term analgesic for moderate to severe pain, is less likely to be indicated for the management of neuropathic symptoms arising from conditions such as back injury compared to a serotonin\u2013norepinephrine reuptake inhibitor with established efficacy in central sensitization pain?\n\nAnswer: Ketorolac", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 776, "completion_tokens": 77, "total_tokens": 853, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df0d1c48190a171e773e3ea6899", "custom_id": "Doxazosin-Metoprolol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1bc8598af422e913e29218e0dd315bc6", "body": {"id": "chatcmpl-BNLQQFfhwvExfs06y9zKkCIhijL3o", "object": "chat.completion", "created": 1744903602, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where one medication used to manage hypertension and benign prostatic hyperplasia, and acting as a selective \u03b11-adrenergic blocker, is associated with causing gastric inflammation when combined with a cardioselective \u03b21-adrenergic antagonist utilized for angina and tachyarrhythmias, which of these two drugs is implicated as the cause of gastric inflammation in this interaction?\n\nAnswer: Doxazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 636, "completion_tokens": 87, "total_tokens": 723, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df0e3f08190bd06939b31795e5f", "custom_id": "Haloperidol-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c4bd820112595f4ac1a81f1686433f81", "body": {"id": "chatcmpl-BNLQR1CWYjqo408GaRLSRFBM3KmDj", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its antagonism of central dopaminergic D2 receptors in the management of psychotic disorders, may precipitate an episode of apoplexy when used concomitantly with an anticholinergic agent that mitigates overactive bladder symptoms by inhibiting acetylcholine-mediated smooth muscle contraction?\n\nAnswer: Haloperidol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 736, "completion_tokens": 71, "total_tokens": 807, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df0f96081909fe93938e4c67b32", "custom_id": "Furosemide-Rosiglitazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b9f979a7744ff204382a303179efeb04", "body": {"id": "chatcmpl-BNLQTNf1fkQO65hUCxbWp2iXm2URD", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a potent loop diuretic commonly administered for edema and hypertension due to its rapid onset of natriuretic action is associated with a risk of apoplexy when combined with a thiazolidinedione oral antidiabetic agent that was withdrawn from several markets due to cardiovascular safety concerns, which drug is the subject in this adverse interaction?\n\nAnswer: Furosemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 693, "completion_tokens": 81, "total_tokens": 774, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df10c18819091598b6632f115f0", "custom_id": "Fentanyl-Ondansetron-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fb8edd02dea1169928af8ce3cd43d735", "body": {"id": "chatcmpl-BNLQU1KfzOCe6Ag6GHWRrorh43wUn", "object": "chat.completion", "created": 1744903606, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, recognized for its role as a 5-HT3 receptor antagonist in antiemetic protocols and known for adverse effects such as gastrointestinal dysmotility and QT interval prolongation, is linked to adenopathy when used concurrently with a highly potent synthetic opioid agonist employed in severe pain management?\n\nAnswer: Ondansetron", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 719, "completion_tokens": 68, "total_tokens": 787, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df123f08190969fbb6e52a40eea", "custom_id": "Methylphenidate-Modafinil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4851bf5a301417ba73c5fce4fb477488", "body": {"id": "chatcmpl-BNLQWduW8uqaII2033qbVrUYdpZbo", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, a eugeroic agent prescribed for narcolepsy and shift work sleep disorder that carries FDA warnings about use in patients under 17 and potential teratogenicity, may cause back injury when combined with a CNS stimulant that inhibits presynaptic dopamine and norepinephrine transporters, thereby facilitating executive function improvements in ADHD?\n\nAnswer: Modafinil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 645, "completion_tokens": 76, "total_tokens": 721, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df135a8819093ceea8728bdaf87", "custom_id": "Gabapentin-Bimatoprost-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "df8f4d2d153638a995222c7beb87b6c4", "body": {"id": "chatcmpl-BNLQXYp4zL2wBNmBsNJX8KnPI4mtC", "object": "chat.completion", "created": 1744903609, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a patient treated for neuropathic pain via modulation of synaptic glutamate release and calcium channel activity develops exertional dyspnea after adding a prostaglandin analog eye drop used for open-angle glaucoma and eyelash growth to their regimen, which drug is most likely responsible for this new-onset breathing difficulty due to the documented interaction between these agents?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 660, "completion_tokens": 84, "total_tokens": 744, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df14814819091ff106671ca698f", "custom_id": "Lidocaine-Metoprolol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8b6ea965f0671a82fb91dac0ae32388d", "body": {"id": "chatcmpl-BNLQZqb4oNnf695Zb4G6FidJGyRVl", "object": "chat.completion", "created": 1744903611, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly used as an antiarrhythmic and local anesthetic, is associated with the risk of causing cholecystitis when used in combination with a cardioselective \u03b21-adrenergic receptor antagonist primarily prescribed for managing hypertension and angina pectoris?\n\nAnswer: Lidocaine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 743, "completion_tokens": 65, "total_tokens": 808, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df15cf08190abb8397082d70665", "custom_id": "Furosemide-Gemfibrozil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4dfd426194b4ea0bb30e3af7b5f59310", "body": {"id": "chatcmpl-BNLQaOwoNtoHFbzrGl6ztYaAhQIbB", "object": "chat.completion", "created": 1744903612, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the potent loop diuretic used for managing edema and hypertension\u2014whose adverse effects include electrolyte imbalances and potential ototoxicity\u2014and the fibrate used to treat abnormal blood lipid levels\u2014commonly causing headache and intestinal upset\u2014which medication is more likely to cause gastric inflammation when used together, based on their drug-drug interaction?\n\nAnswer: Gemfibrozil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 684, "completion_tokens": 75, "total_tokens": 759, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df16e788190a3baa148d6eca7b8", "custom_id": "Famotidine-Lamivudine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "33ad438f68027660080cc41a4f17989c", "body": {"id": "chatcmpl-BNLQbQcmsZMFAcZuk2v00ENEXZZYd", "object": "chat.completion", "created": 1744903613, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for nucleoside reverse transcriptase inhibition and often used in antiretroviral therapy, is associated with adenopathy when administered concurrently with a histamine H2 receptor antagonist that reduces stomach acid production?\n\nAnswer: Lamivudine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 641, "completion_tokens": 53, "total_tokens": 694, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df181cc8190a9c53a007d7a98fc", "custom_id": "Naproxen-Brimonidine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ad6310ecd9b8d56b09024a8602b2fb05", "body": {"id": "chatcmpl-BNLQcaBtjMeFxbouqlVV33BYid1Kw", "object": "chat.completion", "created": 1744903614, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the nonsteroidal anti-inflammatory agent that inhibits cyclooxygenase enzymes for pain and inflammatory conditions, and the \u03b12-adrenergic agonist primarily used for reducing intraocular pressure and managing rosacea-related erythema, which drug is associated as the causative agent in the occurrence of apoplexy when both are considered for their drug-drug interaction profile?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 710, "completion_tokens": 84, "total_tokens": 794, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df195988190a407278393020810", "custom_id": "Haloperidol-Rosiglitazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3827c37ae1b78cf7027a6e2231439fb7", "body": {"id": "chatcmpl-BNLQeWoDZFQquBCbLU0eM9iw9kUcH", "object": "chat.completion", "created": 1744903616, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for acting as a PPAR\u03b3 agonist to enhance insulin sensitivity in Type 2 diabetes mellitus, is indicated to manage a metabolic adverse effect that can be precipitated by a typical antipsychotic with potent central dopaminergic D2 antagonism and a risk of inducing insulin dependent diabetes mellitus?\n\nAnswer: Rosiglitazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 684, "completion_tokens": 74, "total_tokens": 758, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df1a7108190913a10ece5e9d246", "custom_id": "Famotidine-Exemestane-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "12c03c1706432fa9320271700f52cb21", "body": {"id": "chatcmpl-BNLQfbVUZH4secCqZFRhRBiVPXSsh", "object": "chat.completion", "created": 1744903617, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the medication used to decrease stomach acid production and the aromatase inhibitor prescribed for ER-positive breast cancer, which one is described as causing apoplexy when interacting with the other?\n\nAnswer: Famotidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 532, "completion_tokens": 45, "total_tokens": 577, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df1b854819094763efab4a203b1", "custom_id": "Ciclopirox-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ecbbd55fda32fa0881e8284c850dd869", "body": {"id": "chatcmpl-BNLQhNeMxeTkcBL0qHF1vZpdc3tvE", "object": "chat.completion", "created": 1744903619, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly prescribed for certain cancers due to its tyrosine kinase inhibition, may result in increased asthenia when administered concurrently with the topical antifungal used for onychomycosis and seborrheic dermatitis?\n\nAnswer: Imatinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 569, "completion_tokens": 54, "total_tokens": 623, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df1cb748190b9492e5656f81deb", "custom_id": "Ketoprofen-Sufentanil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9a808c724a91d8a505954f580549129f", "body": {"id": "chatcmpl-BNLQiB3hG47Zt51LtgyCgYt22gEcT", "object": "chat.completion", "created": 1744903620, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known as a synthetic opioid analgesic that is substantially more potent than morphine and fentanyl, can cause abnormal EEG patterns when taken together with a propionic acid class NSAID that inhibits prostaglandin production?\n\nAnswer: Sufentanil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 431, "completion_tokens": 55, "total_tokens": 486, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df1dc9c8190aaa4aa8c9d93e621", "custom_id": "Naproxen-Cetirizine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c5732b6c7641cf79cfb934d5d4073032", "body": {"id": "chatcmpl-BNLQkUmEPPjWzDbXPYWNoYZra4b1c", "object": "chat.completion", "created": 1744903622, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario involving the co-administration of a nonsteroidal anti-inflammatory drug used for pain and inflammatory conditions, which has risks of gastrointestinal and cardiovascular side effects, and a second-generation antihistamine known for its peripheral selectivity and use in allergy management, which agent is implicated as inducing cholecystitis when taken with the other?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 750, "completion_tokens": 78, "total_tokens": 828, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df1ed1081909a5a05fcba778618", "custom_id": "vincristine-Torasemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "40aa94c14572acf71bc6cacfb827dbbc", "body": {"id": "chatcmpl-BNLQlGCUFPaP1VVaa7RIdOrCy2Nx1", "object": "chat.completion", "created": 1744903623, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the intravenous mitotic inhibitor derived from Catharanthus roseus, known for treating various leukemias and lymphomas but associated with severe neurotoxicity and myelosuppression, and the oral loop diuretic used for fluid overload in heart and kidney disease, which drug's toxicity can be increased through co-administration with the other?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 652, "completion_tokens": 77, "total_tokens": 729, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df1fe288190ae09f86f6d6e9b21", "custom_id": "Lamotrigine-Dexpramipexole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "533be1cd10fe5c44074c82d8e79d2908", "body": {"id": "chatcmpl-BNLQnDxcC0WPq6N3giT9clvkY2oJu", "object": "chat.completion", "created": 1744903625, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA phenyltriazine anticonvulsant frequently used for epilepsy and mood stabilization is documented to cause gastric inflammation when co-administered with a first-in-class oral investigational agent for reducing blood eosinophils in eosinophilic asthma. Which of these two drugs is responsible for the gastric inflammation in this drug combination?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 574, "completion_tokens": 76, "total_tokens": 650, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df20f908190bb44a24426bcbcb5", "custom_id": "Candesartan-Dexpramipexole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2c5e7274c4366e89df623a15c725c6ae", "body": {"id": "chatcmpl-BNLQpomd5rQ5uUpMbgflTgoQz5RNT", "object": "chat.completion", "created": 1744903627, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn evaluating a potential case of apoplexy arising from the combined use of a potent AT-1 receptor antagonist prescribed for high blood pressure and an investigational oral therapy that targets and reduces blood and tissue eosinophils, which drug is identified as the one experiencing the apoplexy in this interaction?\n\nAnswer: Candesartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 457, "completion_tokens": 69, "total_tokens": 526, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df21f7081908b5e0f45b3c38d5c", "custom_id": "Temazepam-Zafirlukast-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4bdfb624e5fd12f6cceb56edc43d0a56", "body": {"id": "chatcmpl-BNLQqyFebtzZan9kWu9YorxuvjMKq", "object": "chat.completion", "created": 1744903628, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, between the one primarily used for managing severe insomnia by enhancing GABAergic neurotransmission and the one that attenuates leukotriene-mediated bronchoconstriction as an asthma therapy, is associated with causing dysarthria when involved in an interaction with the other?\n\nAnswer: Temazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 681, "completion_tokens": 63, "total_tokens": 744, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68011df231ec8190aaa5bdb6605def04", "custom_id": "indometacin-Isoniazid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "9a9d63faa9860f37c97bbc043191df1b", "body": {"id": "chatcmpl-BNLQJZnwpHhGGXvC4by8u0io60ePb", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient undergoing treatment for tuberculosis with an antibiotic that is effective against mycobacterial infections develops adenopathy after starting a medication prescribed for reducing pain, fever, and inflammation through prostaglandin inhibition. Which of these two drugs is more likely associated with the development of adenopathy when taken together?\n\nAnswer: Isoniazid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 511, "completion_tokens": 69, "total_tokens": 580, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df245488190bbd0615a7a5bd51e", "custom_id": "Aciclovir-Azelastine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7cfd2737193c710524f05ca46ac75531", "body": {"id": "chatcmpl-BNLQKJzRJYWk9Wk7kVMbxGyvDHz5n", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a guanosine analogue antiviral agent known for its risk of nephrotoxicity and gastrointestinal discomfort is administered alongside a second-generation H1 antagonist used for allergic rhinitis and conjunctivitis, which drug is associated with the appearance of erythema when the two are co-administered?\n\nAnswer: Azelastine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 585, "completion_tokens": 71, "total_tokens": 656, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df257148190af053bbf430c7a88", "custom_id": "Ketorolac-Trazodone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5f3b22d739b55c62125bc12625bc1fd1", "body": {"id": "chatcmpl-BNLQMsRHRoYeRWQ3Qtoq9HNctZBcI", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its strong inhibition of prostaglandin synthesis and frequent use in short-term management of moderate to severe pain, has been associated with the occurrence of cholecystitis when used alongside an antidepressant that acts as a serotonin antagonist and reuptake inhibitor?\n\nAnswer: Ketorolac", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 703, "completion_tokens": 65, "total_tokens": 768, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df268cc8190985703b83345de8e", "custom_id": "Metolazone-Metoprolol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c6c8b9d87b3fc581287972883ce2c953", "body": {"id": "chatcmpl-BNLQNXKXaxq2d39XTOftbNicHleHz", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, primarily used for congestive heart failure and classified as a thiazide-like diuretic, is associated with the risk of cholecystitis when taken together with the cardioselective \u03b21-adrenergic receptor antagonist commonly prescribed for hypertension and tachyarrhythmias?\n\nAnswer: Metolazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 598, "completion_tokens": 69, "total_tokens": 667, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df27c3c8190af154b71304c387a", "custom_id": "Carvedilol-Metolazone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "153229a9a722fde52d4b53d15b8905bb", "body": {"id": "chatcmpl-BNLQOYrdbtR0XsE4toOkKmmX7LUtM", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient receiving one medication that reduces blood pressure by antagonizing adrenergic receptors and another thiazide-like agent that decreases water reabsorption by the kidneys, which drug is more likely to be implicated if the patient develops erythema as a result of their combination therapy?\n\nAnswer: Metolazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 606, "completion_tokens": 66, "total_tokens": 672, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df28f5081908db91ee06dde713f", "custom_id": "Zafirlukast-Duloxetine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6a178f1d3a9f6fd8e171d0de273ee3b0", "body": {"id": "chatcmpl-BNLQPweTazOmV4MyJbFPyAV0D6RX2", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its role as a leukotriene receptor antagonist in asthma management and capable of inhibiting CYP3A4, is associated with the risk of weight loss when co-administered with an agent widely used for depression and neuropathic pain that acts by inhibiting serotonin and norepinephrine reuptake?\n\nAnswer: Zafirlukast", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 677, "completion_tokens": 76, "total_tokens": 753, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df2a20081908757eb85e7093a36", "custom_id": "Diazepam-melphalan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "77b90e676be33622a6b67ddef65d070e", "body": {"id": "chatcmpl-BNLQR7UU1jV0lkaF62QZlBoNg70iV", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with a benzodiazepine that enhances GABA_A receptor-mediated neurotransmission for anxiolytic and anticonvulsant effects, is described in their interaction as being \"bulged\" by the benzodiazepine?\n\nAnswer: melphalan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 723, "completion_tokens": 60, "total_tokens": 783, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df2b5408190b908856439809791", "custom_id": "Celecoxib-Lamotrigine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "62e711abf89e2d47e40d1d363cb8f767", "body": {"id": "chatcmpl-BNLQSxLvZKJ1WoFSlXbh4ASNkdE8M", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient taking a selective COX-2 inhibitor for arthritis develops erythema after starting an anticonvulsant and mood-stabilizing agent known for possible dermatological reactions such as Stevens\u2013Johnson syndrome. Based on a known drug-drug interaction leading to erythema, which medication is most likely responsible for causing this reaction when co-administered with the other?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 729, "completion_tokens": 84, "total_tokens": 813, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df2c67481909a760250de845018", "custom_id": "Furosemide-Indapamide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "79521274bb253c7b593eb71b5f301826", "body": {"id": "chatcmpl-BNLQU8lyucBdt49Hv6g3qaoi5eIDK", "object": "chat.completion", "created": 1744903606, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of two diuretic agents\u2014one acting on the loop of Henle and rapidly increasing diuresis, and the other, a thiazide-like sulfonamide, reducing plasma volume through action on the distal convoluted tubule\u2014if co-administration results in the risk of adenopathy, which drug, acting as the loop diuretic, is more likely to be implicated as the direct association in this interaction compared to its thiazide-like counterpart?\n\nAnswer: Furosemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 716, "completion_tokens": 105, "total_tokens": 821, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df2dce48190905b55768236968c", "custom_id": "Citalopram-Dapsone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "39788e6425ce8555e205f4f61a8d0db4", "body": {"id": "chatcmpl-BNLQVqcNQ1u9oKSrRiyYcvhojMQVD", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, widely utilized for leprosy and certain dermatological conditions and known for its potential to cause serious hematological side effects such as hemolytic anemia and agranulocytosis, has been associated with adenopathy when used concurrently with a chiral selective serotonin reuptake inhibitor indicated for major depressive disorder?\n\nAnswer: Dapsone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 781, "completion_tokens": 72, "total_tokens": 853, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df2eeb08190800ebb40a99d4601", "custom_id": "Gabapentin-Minoxidil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f458c9e090755345805d3fd1336d2c4f", "body": {"id": "chatcmpl-BNLQWhJzI1kiAlvcQQh1btm1Q6Clk", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question: In a patient whose medication regimen includes both a drug primarily used for neuropathic pain and partial seizures through inhibition of presynaptic glutamate release, and a vasodilator commonly indicated for hypertension and pattern hair loss, which agent is associated with an increased risk of insulin-dependent diabetes mellitus when co-administered with the other?\n\nAnswer: Minoxidil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 532, "completion_tokens": 74, "total_tokens": 606, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df2ff608190bde77cf332fe2cf4", "custom_id": "Orphenadrine-Trazodone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fed875e0ea765a2fac522b705ba9ad31", "body": {"id": "chatcmpl-BNLQY6tP8OHUFg54gwpQ403WpkT12", "object": "chat.completion", "created": 1744903610, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in combination with an antidepressant that is also prescribed for insomnia and can cause side effects such as dry mouth and irregular heart rate, is likely being used off-label as an adjunct to treat muscle pain but is not primarily indicated for back ache as described by their interaction?\n\nAnswer: Orphenadrine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 506, "completion_tokens": 67, "total_tokens": 573, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df310588190a173db9778a0cda6", "custom_id": "Ketorolac-Moexipril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1d41807a68b031ca5c9650be133c28e1", "body": {"id": "chatcmpl-BNLQZmAuDfcUDYZixmrvkJz7ZcFIN", "object": "chat.completion", "created": 1744903611, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a nonsteroidal anti-inflammatory agent that inhibits prostaglandin synthesis and is used for short-term management of moderate to severe pain, has been associated with causing nausea when used in combination with an angiotensin converting enzyme inhibitor prescribed for hypertension and heart failure?\n\nAnswer: Ketorolac", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 64, "total_tokens": 706, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df324408190b7b7d95572f06979", "custom_id": "Naproxen-Exemestane-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "acbca1a155456ab48fa58d4636a4d579", "body": {"id": "chatcmpl-BNLQJfjvUW51yJq07VcYx76H72WFH", "object": "chat.completion", "created": 1744903595, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBased on their mechanisms of action\u2014one drug being a nonselective inhibitor of cyclooxygenase (COX) enzymes used for inflammatory pain, and the other being an aromatase inhibitor used to treat hormone-responsive breast cancer\u2014which drug in this pair is more likely to increase the risk of gastric inflammation when co-administered with the other?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 618, "completion_tokens": 78, "total_tokens": 696, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df337a4819081a973a4592259e7", "custom_id": "Fentanyl-Loxapine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7f1e68f0bbd6d9da33a536ea0bb90b92", "body": {"id": "chatcmpl-BNLQaX1MF5Hy3PGOvbT7ygGh1MmrK", "object": "chat.completion", "created": 1744903612, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its exceptional analgesic potency and significant risk of central nervous system depression, is reported to be the precipitating agent in a deglutition (swallowing) disorder when used alongside a tricyclic antipsychotic indicated for schizophrenia treatment?\n\nAnswer: Fentanyl", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 623, "completion_tokens": 63, "total_tokens": 686, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df34a688190a892c3c3e4e88fc1", "custom_id": "Tolbutamide-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5fd416509e572f88ee8565d8b22c5fc6", "body": {"id": "chatcmpl-BNLQLu3pZ2bmxINIi2jbpbXVWSQOO", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used primarily to reduce high blood pressure and cardiovascular strain through inhibition of angiotensin II synthesis, is associated with causing muscle disorder when combined with a first-generation sulfonylurea that stimulates insulin secretion?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 573, "completion_tokens": 53, "total_tokens": 626, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df35cec81908d1a3a5aec32ab7b", "custom_id": "Efavirenz-Lamivudine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4e3ab9487bfd6db62f3e72b50e69c4a9", "body": {"id": "chatcmpl-BNLQbFRrAFACtgPIutAIWPpjMQzKS", "object": "chat.completion", "created": 1744903613, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich antiretroviral agent, despite being contraindicated in pregnancy due to potential teratogenicity, has been associated with causing gastric inflammation when used in combination therapy with its nucleoside counterpart that remains safe for use in pregnancy?\n\nAnswer: Efavirenz", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 682, "completion_tokens": 55, "total_tokens": 737, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df3702881908af48acbb9dda59d", "custom_id": "Dapsone-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "98ebb4f3a5c7c6feef1eb1ea09e70ba9", "body": {"id": "chatcmpl-BNLQMzqxCalXAVGKpfaBlicHzZJev", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, characterized as a sulfone-class antimicrobial with a risk of hematological adverse effects and usage in leprosy management, may experience an increased likelihood of acute kidney failure when co-administered with a long-acting ACE inhibitor prescribed for hypertension and heart failure?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 729, "completion_tokens": 63, "total_tokens": 792, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df380c88190b0329b52b4369f77", "custom_id": "Candesartan-Desloratadine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b6743baf32b9ee34ed70c8f2719b7db5", "body": {"id": "chatcmpl-BNLQcRv9u7XB5162EeNnSVvzNC44B", "object": "chat.completion", "created": 1744903614, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient taking a tricyclic H1 inverse agonist active against allergies also uses an angiotensin receptor blocker known for being a potent AT-1 antagonist with a cascading prodrug metabolism, which drug in this scenario is associated with potentially causing apoplexy when combined with the other?\n\nAnswer: Candesartan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 419, "completion_tokens": 67, "total_tokens": 486, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df394608190b08be0a2c11047a8", "custom_id": "Furosemide-Sorafenib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "7feac20ce1f8e651f324e0fa91b09c4d", "body": {"id": "chatcmpl-BNLQN3RS5i5CjThtXkmiADMJO0MrK", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn patients receiving a loop diuretic that promotes natriuresis and diuresis by inhibiting sodium reabsorption in the kidney and a kinase inhibitor indicated for advanced renal cell carcinoma or liver cancer, which medication is primarily responsible for further potentiating weight loss when the two are administered together?\n\nAnswer: Furosemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 552, "completion_tokens": 69, "total_tokens": 621, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df3a6888190ac484e852c2a20ac", "custom_id": "Megestrol-Desloratadine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "cb4a196f98b7d32caa852c7fcf6f7bea", "body": {"id": "chatcmpl-BNLQPfXl9WSbBslxTtPEvsVdj84IS", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a tricyclic H1 inverse agonist used to treat allergies and active metabolite of loratadine, may experience a loss of weight when taken in combination with a progestin used for disease-related weight loss, endometrial cancer, and breast cancer?\n\nAnswer: Desloratadine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 430, "completion_tokens": 65, "total_tokens": 495, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df3b7348190a118faafc878747a", "custom_id": "Metronidazole-Repaglinide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d67df0102255c52529c039de8be19c2a", "body": {"id": "chatcmpl-BNLQeQNPPC1CPNq8hDSnCzY8BbOAX", "object": "chat.completion", "created": 1744903616, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its role in improving blood sugar control by stimulating pancreatic insulin release in people with type 2 diabetes, has been reported to cause erythema when used in combination with an antimicrobial agent activated under anaerobic conditions that disrupts nucleic acid synthesis?\n\nAnswer: Repaglinide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 626, "completion_tokens": 63, "total_tokens": 689, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68011df3c71c8190b5235172914b7fc8", "custom_id": "Naproxen-Orphenadrine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "8e2b67a89354a2e3cbd39b781c4efc70", "body": {"id": "chatcmpl-BNLQf1qfRXoT4K88dyMwDWrMYYu84", "object": "chat.completion", "created": 1744903617, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when co-administered with an anticholinergic muscle relaxant used for muscle pain and Parkinson\u2019s disease that acts via multiple pathways, is associated with a loss of weight as part of their interaction?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 599, "completion_tokens": 52, "total_tokens": 651, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df3dac48190beefddbbd63629ba", "custom_id": "Triazolam-Zaleplon-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2cde36ecdd727748c0c1bb49eb0beaa4", "body": {"id": "chatcmpl-BNLQQX3NH0QkSGgOkOswea9GxDqrQ", "object": "chat.completion", "created": 1744903602, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, used as a sedative for severe insomnia and belonging to the triazolobenzodiazepine class, is associated with causing deglutition disorder when interacting with a nonbenzodiazepine Z-drug of the pyrazolopyrimidine class?\n\nAnswer: Triazolam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 491, "completion_tokens": 65, "total_tokens": 556, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df3ef888190b3e1de66934eb808", "custom_id": "Naproxen-Carvedilol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4d2c264253990af6b7516badb355b4b0", "body": {"id": "chatcmpl-BNLQRPiFDVmFXjvyfnfZe84JfseiT", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, a nonselective beta-adrenergic blocker with alpha-1 receptor antagonism commonly prescribed for heart failure and hypertension, is associated with adenopathy as a result of its interaction with an NSAID that inhibits cyclooxygenase enzymes?\n\nAnswer: Carvedilol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 711, "completion_tokens": 60, "total_tokens": 771, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df4009c8190b5b7c5a76b2acfee", "custom_id": "Alprazolam-Sorafenib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c2a376c54d38127a99cdcd3efa84d3a6", "body": {"id": "chatcmpl-BNLQgNMYNDEVDQKCihlf9qiXeTB0K", "object": "chat.completion", "created": 1744903618, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when administered in conjunction with a kinase inhibitor indicated for certain advanced cancers, is associated with the risk of thrombocytopenia as a significant adverse effect of their interaction?\n\nAnswer: Alprazolam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 520, "completion_tokens": 45, "total_tokens": 565, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df413c081909c68e2458f4cd046", "custom_id": "Cimetidine-Ibuprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d194907c1dfc8bf1a8e7d49960061ded", "body": {"id": "chatcmpl-BNLQTpDxHTo7CLydwcLAsrxb1V4fX", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in conjunction with an agent that inhibits stomach acid production by blocking histamine H2 receptors, is more likely to contribute to gastric inflammation due to its mechanism of reducing prostaglandin synthesis and propensity for gastrointestinal mucosal irritation?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 626, "completion_tokens": 57, "total_tokens": 683, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df42990819091c0371d29b6562d", "custom_id": "Famotidine-Imatinib-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3a6eb17b6beca01a59a118f90c121834", "body": {"id": "chatcmpl-BNLQhpmMn20d8eALBwCrWbuYk8Qjx", "object": "chat.completion", "created": 1744903619, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhen coadministered, which drug\u2014one that decreases stomach acid production as a histamine H2 receptor antagonist for peptic ulcer disease and GERD, or the other, an orally administered tyrosine kinase inhibitor used in leukemias and gastrointestinal tumors\u2014has been associated with causing erythema as a drug-drug interaction effect?\n\nAnswer: Imatinib", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 675, "completion_tokens": 77, "total_tokens": 752, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df43c44819097699723cce9b542", "custom_id": "Aciclovir-Efavirenz-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4d6c10b33af6e75354edc59f1c16625a", "body": {"id": "chatcmpl-BNLQU27LTrgiGp8h3DpcwS0EdN6YF", "object": "chat.completion", "created": 1744903606, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of antiviral therapies where one agent is a guanosine analogue primarily used for herpesvirus infections and the other is a non-nucleoside reverse transcriptase inhibitor commonly employed in HIV treatment but contraindicated in pregnancy, which drug has been specifically associated with the risk of cholecystitis when co-administered with the other?\n\nAnswer: Efavirenz", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 620, "completion_tokens": 78, "total_tokens": 698, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df44e888190bf94e214dd00f76d", "custom_id": "Ondansetron-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a7c672ebe12b2bbecd0cee4a4827e1c7", "body": {"id": "chatcmpl-BNLQoPtNj4TjbIUMwjc2UUMU0Dzz0", "object": "chat.completion", "created": 1744903626, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its nonbenzodiazepine hypnotic properties used to treat insomnia, poses a risk of methaemoglobinaemia when administered concomitantly with the antiemetic that blocks serotonin 5-HT3 receptors?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 761, "completion_tokens": 58, "total_tokens": 819, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df460e48190ac14a8b0d07cf07d", "custom_id": "Amlodipine-melphalan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "ff6d7110451c2dcfb4cf7569ca1be74d", "body": {"id": "chatcmpl-BNLQVs9Ehczk6MZ5pbDPhoy8CKZTb", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for treating various cancers by interfering with DNA and RNA synthesis, is associated with a periodontitis-related interaction when co-administered with an oral vasodilatory agent commonly used for hypertension and angina?\n\nAnswer: melphalan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 574, "completion_tokens": 53, "total_tokens": 627, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df4724081909216ffa4526c9a27", "custom_id": "Naproxen-Efavirenz-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0cae67e9134d4a37478d3cc31a3fa23f", "body": {"id": "chatcmpl-BNLQqSfBIiAIifrf8KZu1f1EuqAqM", "object": "chat.completion", "created": 1744903628, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for allosterically inhibiting HIV-1 reverse transcriptase and used in both treatment and prophylaxis of HIV, has been associated with weight loss when taken alongside a non-selective cyclooxygenase inhibitor used for pain and inflammation?\n\nAnswer: Efavirenz", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 709, "completion_tokens": 59, "total_tokens": 768, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68011df4861c8190bca5a07cab03fee4", "custom_id": "Capecitabine-Desloratadine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0dd2e3b45f2ffab2e8022a1b5ded3efd", "body": {"id": "chatcmpl-BNLQWCOfZCpMVC4zyKby5C7iZ8oVS", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich oral medication, used to treat breast and colorectal cancers and known for side effects such as vomiting and risk of cardiomyopathy, demonstrates unspecified drug toxicity when administered concurrently with a tricyclic H1 inverse agonist used for allergy treatment?\n\nAnswer: Capecitabine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 524, "completion_tokens": 57, "total_tokens": 581, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df498f481909f388785e240d904", "custom_id": "Famotidine-Darunavir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "124de0f852cb6cf1a3dd968f6156fa93", "body": {"id": "chatcmpl-BNLQstmzq7U8xYtJW4ufFIabFq7ws", "object": "chat.completion", "created": 1744903630, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn the context of drug therapy, which medication\u2014one that decreases stomach acid production as a histamine H2 receptor antagonist or one that is an antiretroviral protease inhibitor requiring pharmacokinetic boosting\u2014is more likely associated with weight loss when interacting with the other?\n\nAnswer: Darunavir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 617, "completion_tokens": 62, "total_tokens": 679, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df4a9948190a8b4c643bc5fa8fa", "custom_id": "Ofloxacin-Oxaprozin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6af4e898d0f750e72c079ecaef782714", "body": {"id": "chatcmpl-BNLQY7o7JolKQbvs14lurhNE1nrEN", "object": "chat.completion", "created": 1744903610, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for its antibacterial activity through inhibition of DNA synthesis, may increase the risk of gastric inflammation when used in combination with a propionic acid-derived NSAID prescribed for joint pain and inflammation?\n\nAnswer: Oxaprozin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 545, "completion_tokens": 48, "total_tokens": 593, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df4b9748190b3439762b1609555", "custom_id": "Citalopram-Salmeterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e5ef922ad2f71eaaa98b8464b7bee79c", "body": {"id": "chatcmpl-BNLQtc9LOpWNC0WaJIULfOoouM1wY", "object": "chat.completion", "created": 1744903631, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, a chiral bicyclic phthalane derivative SSRI primarily used for psychiatric disorders and known for possible cardiotoxicity, when taken with a long-acting bronchodilator used for asthma and COPD, is associated with the risk of cholecystitis as an interaction?\n\nAnswer: Citalopram", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 687, "completion_tokens": 67, "total_tokens": 754, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df4ca948190976eb46b212c59d3", "custom_id": "Orphenadrine-Temazepam-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c5c33a82edf4ab23162bb997b0071de2", "body": {"id": "chatcmpl-BNLQuF7S8LJ1zRaVmLV4uz6ddVRlT", "object": "chat.completion", "created": 1744903632, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, a benzodiazepine hypnotic agent primarily indicated for severe insomnia that acts through GABA-A receptor modulation, is most appropriately considered for addressing musculoskeletal discomfort when used in combination with an anticholinergic muscle relaxant related to diphenhydramine, as indicated by their mutual interaction associated with back ache?\n\nAnswer: Temazepam", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 586, "completion_tokens": 74, "total_tokens": 660, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df4dc988190823f52c468d495fb", "custom_id": "acetazolamide-Lamotrigine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "5899c888c4d2597ed55086ef68b0bb32", "body": {"id": "chatcmpl-BNLQZBqpN8M23voQMSSDKmGDCKblL", "object": "chat.completion", "created": 1744903611, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when combined with a carbonic anhydrase inhibitor used for glaucoma and acute mountain sickness, is associated with the adverse effect of inducing hiccoughs?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 680, "completion_tokens": 43, "total_tokens": 723, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df4eecc8190ab8496bab9a7557c", "custom_id": "Telmisartan-solifenacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d84747ca697c1bee783deab9e7c284ba", "body": {"id": "chatcmpl-BNLQa3v3V4fvyVQBxkdp1c5DwAeh3", "object": "chat.completion", "created": 1744903612, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, either the orally administered angiotensin II receptor antagonist commonly used to treat hypertension and heart failure, or the antimuscarinic agent prescribed for overactive bladder and taken to reduce bladder contractions, is associated with dysarthria when interacting with the other?\n\nAnswer: solifenacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 597, "completion_tokens": 61, "total_tokens": 658, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df5004481908768fb46ae721320", "custom_id": "Temazepam-Emtricitabine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a81f951239492360659c33c4411a272c", "body": {"id": "chatcmpl-BNLQbJ6t9sH3JsiXfLGntmKsyeDnk", "object": "chat.completion", "created": 1744903613, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient concurrently treated with a rapidly-acting hypnotic benzodiazepine commonly utilized in cases of severe, refractory insomnia, and a nucleoside reverse-transcriptase inhibitor prominently featured in first-line combination regimens for HIV management, which agent is associated with an increased heart rate when interacting with the other?\n\nAnswer: Emtricitabine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 706, "completion_tokens": 73, "total_tokens": 779, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df5124081908373ff5c0a4ea80a", "custom_id": "Metoprolol-Acitretin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e75efd36f31b1b2e4fb27be6ce676aee", "body": {"id": "chatcmpl-BNLQcppjqVR56q4y5r2hLpEejA4Kn", "object": "chat.completion", "created": 1744903614, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a cardioselective \u03b21-adrenergic antagonist used for hypertension and secondary prophylaxis post-myocardial infarction is co-administered with an oral retinoid reserved for severe unresponsive psoriasis, which drug\u2014characterized primarily by cardiovascular modulation\u2014has been reported to be associated with weight loss when interacting with the retinoid agent?\n\nAnswer: Metoprolol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 622, "completion_tokens": 84, "total_tokens": 706, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df524e081908ab4aa55c188f5b7", "custom_id": "Candesartan-Lamivudine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1968162e066da52150bd7e057aa1a161", "body": {"id": "chatcmpl-BNLQeCub49VbUrzwcXmBe6OPLqH8L", "object": "chat.completion", "created": 1744903616, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, used to treat HIV and chronic hepatitis B by inhibiting viral reverse transcriptase and often included in antiretroviral regimens, has been associated with cholecystitis when co-administered with an angiotensin receptor blocker that is a potent AT-1 receptor antagonist and a cascading prodrug?\n\nAnswer: Lamivudine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 567, "completion_tokens": 74, "total_tokens": 641, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df535bc8190ae2a1a119ac39864", "custom_id": "Gabapentin-Amiloride-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "d330f2fdcc7e5179594b2a829b964903", "body": {"id": "chatcmpl-BNLQf8IOA43Zfw1NyfkVE2oabaLtn", "object": "chat.completion", "created": 1744903617, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a first agent is primarily used for neuropathic pain and seizures by binding the \u03b12\u03b4-1 subunit of voltage-gated calcium channels, while the second agent acts as a potassium-sparing diuretic inhibiting epithelial sodium channels to treat hypertension and edema, which of these drugs may contribute to increased weight when used in combination according to their interaction profile?\n\nAnswer: Gabapentin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 639, "completion_tokens": 86, "total_tokens": 725, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df548008190a1719e8de0d0c838", "custom_id": "Carvedilol-Pirbuterol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "189e7924a68da277f720367c02089710", "body": {"id": "chatcmpl-BNLQgwPjRuPgIOQj8mqCgOWk2Xgiz", "object": "chat.completion", "created": 1744903618, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with chronic heart failure is being treated with a nonselective beta-adrenergic and alpha-1 antagonist, and is also prescribed a short-acting \u03b22 agonist inhaler for asthma management. Which medication in this combination is implicated as the subject in a drug-drug interaction knowledge graph triple indicating it can cause weight gain when used with the other?\n\nAnswer: Carvedilol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 521, "completion_tokens": 83, "total_tokens": 604, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df559348190a1673ceb4f1035d5", "custom_id": "Dexpramipexole-Trimethoprim-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "549bc07411e9452c3e9cdcbc01d3fdfe", "body": {"id": "chatcmpl-BNLQi3euRFZULriKIF4T07wn9Pb7H", "object": "chat.completion", "created": 1744903620, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known for lowering eosinophil counts and being investigated as an oral treatment for eosinophilic asthma, is linked to weight gain when taken with an antibiotic commonly used for bladder infections?\n\nAnswer: Dexpramipexole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 553, "completion_tokens": 52, "total_tokens": 605, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df569808190ac0c329c5cc61aec", "custom_id": "Metolazone-Dexpramipexole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "aff5796211fbcb46e80c7b665b8f94d9", "body": {"id": "chatcmpl-BNLQjSqcv7bgsFGcLMFm72PUSnoVJ", "object": "chat.completion", "created": 1744903621, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhen combined, which medication\u2014one that is primarily used for treating congestive heart failure and high blood pressure by increasing urine output, or one that is an investigational oral treatment aiming to reduce blood and tissue eosinophils in eosinophilic asthma\u2014has been associated with contributing to weight loss in the other according to drug interaction data?\n\nAnswer: Metolazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 511, "completion_tokens": 78, "total_tokens": 589, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df57ba08190b7c1a98c48372468", "custom_id": "Amlodipine-Ketoprofen-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6785b2e5036d5b425eeedfa8e1cd3aae", "body": {"id": "chatcmpl-BNLQlcU1tu5feMyVHl8unbQARqhck", "object": "chat.completion", "created": 1744903623, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for treating high blood pressure and angina through calcium channel antagonism and vasodilation, can experience its gastrointestinal side effect profile\u2014specifically gastric inflammation\u2014worsened when co-administered with a propionic acid class NSAID that inhibits prostaglandin synthesis?\n\nAnswer: Amlodipine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 465, "completion_tokens": 69, "total_tokens": 534, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df58ea081908f598119c738dbd8", "custom_id": "Gabapentin-Darunavir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "63890e5ccff19891a41f6d612c6985ac", "body": {"id": "chatcmpl-BNLQm8oORkdEFqjocFTGxCGS0kVex", "object": "chat.completion", "created": 1744903624, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a scenario where a patient being treated for neuropathic pain with a medication that binds to the \u03b12\u03b4-1 subunit of voltage-gated calcium channels develops cholecystitis after adding an antiretroviral protease inhibitor prescribed for HIV/AIDS, which drug is most likely implicated as the precipitating agent according to their known drug-drug interaction?\n\nAnswer: Darunavir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 681, "completion_tokens": 82, "total_tokens": 763, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df59f84819086ef2429c7dc8894", "custom_id": "Naproxen-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "35a583f83cb01ed593756eb335e4cdee", "body": {"id": "chatcmpl-BNLQnBFisAAE14rVRwbU9F8Rb0WYO", "object": "chat.completion", "created": 1744903625, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, a nonbenzodiazepine hypnotic primarily indicated for short-term management of sleep disorders, is associated with an interaction involving a nonsteroidal anti-inflammatory agent known for its prostaglandin-inhibiting effects, specifically in the context of the condition adenomyosis?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 791, "completion_tokens": 67, "total_tokens": 858, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df5bc3081909edff6e4ec99efd6", "custom_id": "acetazolamide-Haloperidol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "99e729de5888c73c43f0f1096e3cc8d9", "body": {"id": "chatcmpl-BNLQpNHIpco770s0g0ORIK7DoI1Q5", "object": "chat.completion", "created": 1744903627, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for reducing intraocular pressure by inhibiting carbonic anhydrase and indicated for glaucoma and altitude sickness, can precipitate confusion when used concomitantly with the antipsychotic that blocks central dopamine receptors to treat schizophrenia?\n\nAnswer: acetazolamide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 711, "completion_tokens": 57, "total_tokens": 768, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df5ccec81908662ac5c4e977fa0", "custom_id": "indometacin-Sildenafil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2c49b6d54fa37ad8b31abeff6238dba9", "body": {"id": "chatcmpl-BNLQKpeUpqPqY8zpwwhcdcVbwHJaV", "object": "chat.completion", "created": 1744903596, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its role as a selective PDE5 inhibitor used to promote nitric oxide-mediated vasodilation, is associated with the risk of apoplexy when interacting with a nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase-mediated prostaglandin synthesis?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 626, "completion_tokens": 62, "total_tokens": 688, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df5de2c8190879eb63b27f6dd4e", "custom_id": "Zolpidem-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fea9f7cc23d9c9be4cb0ad0773b617a1", "body": {"id": "chatcmpl-BNLQM6DpZUFSGPIF3UCwENvdrTez9", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when used in conjunction with an agent that induces vasodilation by inhibiting angiotensin II synthesis, is associated with causing a decrease in body weight?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 750, "completion_tokens": 43, "total_tokens": 793, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df5ef208190bea5e29750f7d090", "custom_id": "Ondansetron-Trazodone-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "3851fe02be34c645081c3c17dc06cc78", "body": {"id": "chatcmpl-BNLQNmnZRedpyR2C8bD643GRKGBQ4", "object": "chat.completion", "created": 1744903599, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its sedating antidepressant properties and commonly used to treat major depressive disorder, has been implicated in drug-drug interaction studies with a selective serotonin 5-HT3 receptor antagonist antiemetic in the context of hepatic neoplasia?\n\nAnswer: Trazodone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 631, "completion_tokens": 61, "total_tokens": 692, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df6021481909008c3e0fd603ec2", "custom_id": "Naproxen-Doxazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "fca9a7adfa0da950b683babb70a046c2", "body": {"id": "chatcmpl-BNLQOfm6lPrSNU1ao7dqt1XDivt7S", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly used to manage pain and inflammation via cyclooxygenase inhibition, may interact with a selective \u03b11-adrenergic blocker prescribed for hypertension and benign prostatic hyperplasia in the context of treating a back injury?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 684, "completion_tokens": 55, "total_tokens": 739, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df615d88190a9218b5bbc43943c", "custom_id": "Ketoprofen-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0f4e896c7193d4271bce21ea4d801cea", "body": {"id": "chatcmpl-BNLQPCaSuC3tSFHR1dOsZECL7QUuK", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient is taking an anti-inflammatory drug from the propionic acid class, known for inhibiting prostaglandin production to provide analgesic and antipyretic effects. When combined with a medication that reduces systemic vascular resistance by blocking angiotensin II synthesis, which drug could potentially diminish the blood pressure-lowering efficacy of the other?\n\nAnswer: Ketoprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 521, "completion_tokens": 76, "total_tokens": 597, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df628bc81908f36a10383f21a25", "custom_id": "Dipyridamole-oxybutynin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b1a09dafa44dd414ee5dab8ae8eb5765", "body": {"id": "chatcmpl-BNLQR1boh8wcJLPD98G1Li84AlOwe", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when taken together with an antiplatelet agent that inhibits blood clot formation and causes vasodilation at high doses, is associated with an increased risk of apoplexy according to their documented drug-drug interaction?\n\nAnswer: oxybutynin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 557, "completion_tokens": 55, "total_tokens": 612, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df63c8481908e09dc878b449b87", "custom_id": "Lamotrigine-Amiloride-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "1e6ff5fbb6bbfa48528e6227e3399780", "body": {"id": "chatcmpl-BNLQSKl1XF3H3LoMpNvAevI0KSpab", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication\u2014used as a phenyltriazine anticonvulsant with mood-stabilizing properties in epilepsy and bipolar disorder, or as a potassium-sparing diuretic prescribed to counteract hypokalemia in patients treated with thiazide or loop diuretics\u2014has been observed to cause weight gain when taken in conjunction with the other?\n\nAnswer: Amiloride", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 617, "completion_tokens": 79, "total_tokens": 696, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df6508c81908400a8c9e674e80a", "custom_id": "Sumatriptan-Balsalazide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "80bebc33f21f9c49460f2ea5dbb40f5d", "body": {"id": "chatcmpl-BNLQTpj3fYzAFxvebngSAbWhYcJ0e", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its targeted anti-inflammatory action in the large intestine for treating ulcerative colitis, can potentially cause difficulty breathing when used concurrently with a serotonin receptor agonist intended for migraine relief?\n\nAnswer: Balsalazide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 649, "completion_tokens": 50, "total_tokens": 699, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df6632881908b1f70e75b530ecf", "custom_id": "Temazepam-Bimatoprost-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "38eb142cf4131e2f8e49d00cc62f9ee7", "body": {"id": "chatcmpl-BNLQU2wvp7Ekk6qyDxI7mDpx0k7my", "object": "chat.completion", "created": 1744903606, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBased on their pharmacological profiles, which drug\u2014one being a benzodiazepine hypnotic notable for CNS depressant effects and the other a prostaglandin analog used to lower intraocular pressure\u2014has been associated with causing abnormal electrocardiogram (ECG) results when interacting with the other?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 666, "completion_tokens": 71, "total_tokens": 737, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df6762c8190bb8b60d459253f63", "custom_id": "Doxazosin-Dexpramipexole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "cc18230d3d4eba48e7e2bf86ec5d8f4e", "body": {"id": "chatcmpl-BNLQVwIk4LcGGWn3FTvo3HxmGZd9H", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to treat symptoms such as benign prostatic hyperplasia and hypertension and known to act as a selective \u03b11-adrenergic blocker, is at risk of contributing to an increased chance of apoplexy when co-administered with a first-in-class investigational agent that lowers blood eosinophils for eosinophilic asthma?\n\nAnswer: Doxazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 550, "completion_tokens": 80, "total_tokens": 630, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df689488190ab69658395592593", "custom_id": "Telmisartan-Bimatoprost-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "089100b22648c9d8e897a8bceb876c46", "body": {"id": "chatcmpl-BNLQWNsPRpaGOYThAbMHHDTEbAYUX", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, used to treat glaucoma via increasing aqueous humor outflow, may have diminished effectiveness in reducing intraocular pressure if co-administered with an angiotensin II receptor antagonist primarily used for lowering blood pressure?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 608, "completion_tokens": 52, "total_tokens": 660, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df69bc881909656a5526dcdb585", "custom_id": "Amlodipine-Sufentanil-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "defcbf6d698dc7fbdfe8289cbe3dd37a", "body": {"id": "chatcmpl-BNLQYOJklRMuQ91i0h72iB1hh8CKj", "object": "chat.completion", "created": 1744903610, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient with hypertension managed by a long-acting dihydropyridine calcium channel blocker that acts via vasodilation, co-administration of which ultra-potent synthetic opioid analgesic may increase the risk of right heart failure as a drug-drug interaction?\n\nAnswer: Sufentanil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 527, "completion_tokens": 62, "total_tokens": 589, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df6b1488190bd72c33096a92488", "custom_id": "Ibuprofen-Perindopril-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2c5b99b88a44028b61dd12be20849329", "body": {"id": "chatcmpl-BNLQZZr7HRLhGwnQkzf8Bro7IZJHT", "object": "chat.completion", "created": 1744903611, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the drug that reduces pro-inflammatory prostaglandin synthesis as an NSAID and the medication that functions as a long-acting ACE inhibitor for hypertension, which one is more likely to exacerbate gastric inflammation when administered in combination with the other?\n\nAnswer: Ibuprofen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 696, "completion_tokens": 56, "total_tokens": 752, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df6c2f08190bbab310b67031015", "custom_id": "Zafirlukast-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b6d07b6ccbac173796e0701a7c3395c5", "body": {"id": "chatcmpl-BNLQaR0alOnOGL0I8pDR9fCiWr9V7", "object": "chat.completion", "created": 1744903612, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nConsidering that one medication modulates leukotriene-mediated inflammatory responses via CysLT1 receptor antagonism and inhibits CYP3A4, and the other is a nonbenzodiazepine hypnotic imidazopyridine indicated for short-term treatment of insomnia, which of these drugs is most likely implicated alongside its counterpart in the manifestation of erythema according to documented drug-drug interactions?\n\nAnswer: Zafirlukast", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 732, "completion_tokens": 89, "total_tokens": 821, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df6d2a48190a3684b332f07326a", "custom_id": "Ranitidine-Adapalene-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "86cfcb54e74c6f4a2e8837aeda6ffcca", "body": {"id": "chatcmpl-BNLQcCc4GmbYVWq76ReEGrZbGH1Ld", "object": "chat.completion", "created": 1744903614, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when its mechanism of reducing gastric acid secretion is considered alongside a topical retinoid used for mild-to-moderate acne, is associated with an interaction leading to gastric inflammation?\n\nAnswer: Ranitidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 696, "completion_tokens": 46, "total_tokens": 742, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df6e434819087ac79397da2a061", "custom_id": "Amlodipine-Metronidazole-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0d26078c57885574cae92deedbe70d77", "body": {"id": "chatcmpl-BNLQdNOOGksBTdcKTZwpSeiMpLGzD", "object": "chat.completion", "created": 1744903615, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich of the two drugs\u2014a long-acting calcium channel antagonist used for vasodilation and blood pressure control, or a nitroimidazole antimicrobial effective against anaerobic infections\u2014has been implicated in a drug-drug interaction with the other that involves the development or exacerbation of cholecystitis?\n\nAnswer: Metronidazole", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 634, "completion_tokens": 70, "total_tokens": 704, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df6f4488190a8f5aef757f1f5b2", "custom_id": "Naproxen-Risedronic acid-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "435e5b5296a125d9452ac6a2e29b3dcb", "body": {"id": "chatcmpl-BNLQeeTOrvxCN6pd6apsulRszUvRE", "object": "chat.completion", "created": 1744903616, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for slowing the activity of bone-resorbing cells in conditions like osteoporosis and Paget\u2019s disease, can develop erythema as an interaction when co-administered with a non-selective cyclooxygenase inhibitor commonly prescribed for pain and inflammation?\n\nAnswer: Risedronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 573, "completion_tokens": 63, "total_tokens": 636, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df7059c819086348b96dcdf3998", "custom_id": "Metronidazole-Fosphenytoin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "4af4ca081af9580ef86c66059fd3dc25", "body": {"id": "chatcmpl-BNLQgCtZWRkIU8zXUGXCT9qTwxf71", "object": "chat.completion", "created": 1744903618, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, known primarily as a water-soluble prodrug used intravenously to manage acute convulsive status epilepticus, has also been identified in clinical contexts as a potential treatment for the neuropathic pain of trigeminal neuralgia when considered alongside a nitroimidazole antimicrobial with broad-spectrum antibacterial and antiprotozoal activity?\n\nAnswer: Fosphenytoin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 565, "completion_tokens": 79, "total_tokens": 644, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df715b88190b515ae5d7720913f", "custom_id": "Temazepam-Bosentan-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "111fd858dd109ed53e517fc298e86772", "body": {"id": "chatcmpl-BNLQhiyW3cubVgCoNOioQcvf28HYX", "object": "chat.completion", "created": 1744903619, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nGiven one drug that enhances GABAergic neurotransmission to manage severe insomnia and another that acts as a dual endothelin receptor antagonist for pulmonary arterial hypertension, which of these agents has been linked in a drug-drug interaction knowledge graph as potentially associated, in combination, with subarachnoid haemorrhage when co-administered with the other?\n\nAnswer: Bosentan", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 550, "completion_tokens": 77, "total_tokens": 627, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df727308190a49e2743e9b9875e", "custom_id": "Pyridostigmine-Telithromycin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "6fc80044272ad79df126aa837515fa2b", "body": {"id": "chatcmpl-BNLQisuwBRqMXDSx1Z40HAnC4M8VH", "object": "chat.completion", "created": 1744903620, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly indicated for managing myasthenia gravis and functioning as a cholinesterase inhibitor, has been reported to induce speech difficulties (dysarthria) when used in combination with a semi-synthetic erythromycin derivative approved in 2001 for treating community-acquired pneumonia?\n\nAnswer: Pyridostigmine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 659, "completion_tokens": 70, "total_tokens": 729, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df7385081908a3890b8a8f18ee1", "custom_id": "Lamotrigine-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "edb830c082ca7e7b4890d6296d893d9a", "body": {"id": "chatcmpl-BNLQj7flQS1EeSZ9rpEM2qPHfy6h3", "object": "chat.completion", "created": 1744903621, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for potentiating inhibitory GABAergic transmission to treat sleep disorders, has been associated with interstitial cystitis when co-administered with the anticonvulsant that modulates voltage-sensitive sodium and calcium channels?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 747, "completion_tokens": 55, "total_tokens": 802, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df7495081909de4dbd693f4b919", "custom_id": "Lamotrigine-Fosphenytoin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2469c7bac29c59d20efd7ff4699c86f4", "body": {"id": "chatcmpl-BNLQlefCiPt6SGHKEBUsAWBegJrCU", "object": "chat.completion", "created": 1744903623, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich anticonvulsant, when co-administered with a water-soluble prodrug designed for intravenous management of convulsive status epilepticus, has been associated with the increased risk of bradycardia as a drug-drug interaction?\n\nAnswer: Lamotrigine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 544, "completion_tokens": 58, "total_tokens": 602, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df75a9c81909cd40f77dd086622", "custom_id": "Brimonidine-Terazosin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "a354e953c4f790474d61863465df71fd", "body": {"id": "chatcmpl-BNLQmcOCq5PbBXmChtdLYZnzWtgiz", "object": "chat.completion", "created": 1744903624, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when used in conjunction with an \u03b12-adrenergic agonist that decreases intraocular pressure and alleviates rosacea erythema, has been associated with the potential to induce weight gain as part of their interaction?\n\nAnswer: Terazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 622, "completion_tokens": 56, "total_tokens": 678, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_267d0ae600"}}, "error": null}
{"id": "batch_req_68011df76c708190b5bfb46b1181668f", "custom_id": "Fluorouracil-Fulvestrant-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "f5ab46d154fdbb528ae7ed78acf03ff6", "body": {"id": "chatcmpl-BNLQnlq3lEbOMD6EcxbeYm8nSSg4H", "object": "chat.completion", "created": 1744903625, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a patient undergoing treatment with one agent that disrupts pyrimidine biosynthesis to treat various carcinomas and another that degrades estrogen receptors to manage hormone receptor-positive advanced breast cancer, which is associated with a reported loss of weight when used with the other?\n\nAnswer: Fluorouracil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 619, "completion_tokens": 62, "total_tokens": 681, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df77d9881909f7f7fc6c8b7b83b", "custom_id": "Naproxen-Gabapentin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "298956326525089d07ab35428bc26b7d", "body": {"id": "chatcmpl-BNLQojqA7av4GD6LM3b0gBoUyKzne", "object": "chat.completion", "created": 1744903626, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, when taken in conjunction with another commonly prescribed agent for neuropathic pain that binds to the \u03b12\u03b4-1 subunit of voltage-gated calcium channels, is most associated with an increased risk of gastric inflammation due to its non-selective inhibition of cyclooxygenase enzymes?\n\nAnswer: Naproxen", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 732, "completion_tokens": 67, "total_tokens": 799, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df78f588190bfb9e72ccfedcfb3", "custom_id": "alendronic acid-Efavirenz-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "defe5d7db361abd49baf649b31d3be2c", "body": {"id": "chatcmpl-BNLQL6UNbam3XHAF6rvy97CFaycDH", "object": "chat.completion", "created": 1744903597, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for its use in osteoporosis management via bone resorption inhibition, has been associated with adenopathy when interacting with an antiretroviral agent that allosterically inhibits HIV-1 reverse transcriptase?\n\nAnswer: alendronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 625, "completion_tokens": 52, "total_tokens": 677, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df7a1888190875c327916bb0cc0", "custom_id": "Carvedilol-Darunavir-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "b1de8a722aa10202de16a756e80c06b3", "body": {"id": "chatcmpl-BNLQMVRgXWSRDDSOwYoewZC9kJkGJ", "object": "chat.completion", "created": 1744903598, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario where a patient prescribed a nonselective beta-adrenergic blocker with alpha-1 antagonism for hypertension and heart failure develops coughing up blood after initiating an antiretroviral protease inhibitor for HIV requiring a pharmacokinetic booster, which of these two drugs is more likely implicated as the source of this adverse event in relation to the drug-drug interaction?\n\nAnswer: Carvedilol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 661, "completion_tokens": 86, "total_tokens": 747, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df7b49c8190867769b17ee598e6", "custom_id": "Triazolam-solifenacin-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "98ed06155b0b417c68e0c4e45e7e6426", "body": {"id": "chatcmpl-BNLQOwuFpNWNXN1VMGOgIzaY49D0g", "object": "chat.completion", "created": 1744903600, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for treating overactive bladder and neurogenic detrusor overactivity, has been observed to increase white blood cell count when used in combination with a central nervous system depressant tranquilizer used primarily for severe insomnia?\n\nAnswer: solifenacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 593, "completion_tokens": 54, "total_tokens": 647, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df7c8a881909e3eb31fea8a5cbe", "custom_id": "Furosemide-Zolpidem-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c6193368517015d9866eae4acb394836", "body": {"id": "chatcmpl-BNLQP5HjpZwNOiLGfOQxyDZGUpWiD", "object": "chat.completion", "created": 1744903601, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of insomnia treated by a nonbenzodiazepine hypnotic that acts as a positive allosteric modulator of the GABAA receptor and frequently causes somnolence and neuropsychiatric effects has experienced fracture nonunion when co-administered with another drug, a potent loop diuretic commonly used for edema and hypertension by inhibiting the Na-K-2Cl symporter in the renal loop of Henle. Which of these two drugs is directly associated with an increased risk of fracture nonunion due to this drug-drug interaction?\n\nAnswer: Zolpidem", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 789, "completion_tokens": 123, "total_tokens": 912, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68011df7deb88190947e4fb996e4d5fd", "custom_id": "Famotidine-Pilocarpine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "e1819f89a8a024dc93c50496929b3f4e", "body": {"id": "chatcmpl-BNLQRlR6kR2WfbvfxGS4AB6JEY2Wc", "object": "chat.completion", "created": 1744903603, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, commonly used as a muscarinic agonist for acute glaucoma and xerostomia, may be associated with the onset of deglutition disorder when interacting with a histamine H2 receptor antagonist that reduces stomach acid production?\n\nAnswer: Pilocarpine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 636, "completion_tokens": 57, "total_tokens": 693, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df7f32081908f5c02a8b81a3e8a", "custom_id": "Theophylline-Bumetanide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "c13df99153e9775296f6e9f3d0bfcc3e", "body": {"id": "chatcmpl-BNLQSg0x5xEiISHWs7BTZACo77yrg", "object": "chat.completion", "created": 1744903604, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, commonly used to treat chronic obstructive pulmonary disease and asthma due to its action as a phosphodiesterase inhibitor and adenosine receptor blocker, is associated with abnormal ECG findings when taken in combination with a potent loop diuretic used for edema management?\n\nAnswer: Theophylline", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 619, "completion_tokens": 62, "total_tokens": 681, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68011df806dc81908dc1b317c772a830", "custom_id": "Celecoxib-Labetalol-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "0acc6415a491e26107dbbcd97b9b995b", "body": {"id": "chatcmpl-BNLQTWEI2uXtys2EQ7rmp41dp9fNo", "object": "chat.completion", "created": 1744903605, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient who is taking a selective cyclooxygenase-2 inhibitor for pain and inflammation management reports developing back ache after starting an antihypertensive medication that blocks \u03b2- and \u03b1-adrenergic receptors. According to documented drug-drug interactions, which of these two drugs is more likely associated with the occurrence of back ache in this combination?\n\nAnswer: Labetalol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 715, "completion_tokens": 79, "total_tokens": 794, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df818dc81908b8c90562653f4f0", "custom_id": "Risedronic acid-Torasemide-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "aa1726030feb928e80b511074b904cc5", "body": {"id": "chatcmpl-BNLQVhhqT86nTkpXDtDoKoCf1exQf", "object": "chat.completion", "created": 1744903607, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIf a patient with osteoporosis is taking a bisphosphonate that slows bone breakdown and also begins using a sulfonamide loop diuretic for heart failure, which medication in this combination could be associated with an increased risk of gastric inflammation, as described in their pharmacological interaction?\n\nAnswer: Risedronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 509, "completion_tokens": 65, "total_tokens": 574, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_a1102cf978"}}, "error": null}
{"id": "batch_req_68011df82b3c819088f741678bf501b7", "custom_id": "Amlodipine-Desloratadine-DDI-Bio-1_hop", "response": {"status_code": 200, "request_id": "2209056ed8fe68504420f19667d5b77b", "body": {"id": "chatcmpl-BNLQWMQBGnZNHgunsI09K9BYj2wgv", "object": "chat.completion", "created": 1744903608, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nBetween the long-acting calcium channel antagonist commonly used for hypertension and the tricyclic H1 inverse agonist applied for allergy treatment, which drug is implicated in causing myelodysplasia when interacting with the other?\n\nAnswer: Amlodipine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 485, "completion_tokens": 53, "total_tokens": 538, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
